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1 Zusammenfassung 
Candida glabrata ist ein opportunistischer humanpathogener Pilz. Nach Candida 
albicans stellt er die zweithäufigste Ursache für Pilzerkrankungen durch Candida spp. dar. 
Die Infektion mit C. glabrata kann zu Erkrankungen der Haut oder der Schleimhäute bis hin 
zur lebensbedrohlichen systemischen Infektion bei immunsupprimierten Patienten führen. 
Hauptvirulenzfaktoren von C. glabrata sind sowohl eine erhöhte natürliche Resistenz gegen 
Azolverbindungen, als auch eine große Anzahl verschiedener Adhesine. Welche 
molekularen Mechanismen diesen Virulenzfaktoren zu Grunde liegen, ist größtenteils noch 
unbekannt. 
Genomik und phänotypische Analyse von Deletionsmutanten stellen einen Ansatz 
dar, um neue Virulenzfaktoren pathogener Pilzen zu identifizieren. Für diese Doktorarbeit 
wurden C. glabrata Sequenzdaten verwendet, um nicht essentielle, zu Saccharomyces 
cerevisiae homologe Gene auszuwählen. Mit Hilfe eines revers-genetischen Ansatzes wurde 
dann eine Kollektion von Deletionsmutanten erstellt. Diese Stammbibliothek diente als 
Ausgangsbasis für die phänotypische Analyse der Mutanten zur Identifizierung neuer Gene, 
die die Pathogenität und Azolresistenz von C. glabrata beeinflussen. Insgesamt umfasst die 
Kollektion 476 einzelne, mit einem molekularen Barcode versehene Stämme, bei denen 
Signaltransduktionsgene, Transkriptionsfaktoren, Zellwandbiosynthesegene, Resistenzgene 
und C. glabrata spezifische Gene deletiert wurden. Es wurden 103 Mutanten identifiziert, die 
Wachstumsdefekte unter Zellwandstress, in Gegenwart von  Antimykotika, bei 
Temperaturstress, Osmolaritätsänderungen, Kontakt mit Detergenzien oder beim Wachstum 
auf Minimalmedium aufzeigen.  
Die Interaktion zwischen Makrophagen und C. glabrata wurde in vitro durch die 
Detektion von reaktiven Sauerstoffmolekülen (ROS) getestet. Dadurch wurden mehrere 
Zellwandmutanten entdeckt, die eine erhöhte ROS-Produktion durch die Makrophagen 
verursachen. 
Mehrere Deletionsstämme zeigten Phänotypen, die sich von den bekannten S. 
cerevisiae Mutanten unterscheiden. Es konnten Gene identifiziert werden, die noch nicht mit 
Caspofunginsensitivität assoziiert worden sind. Darunter befanden sich auch Gene, die keine 
Orthologe in S. cerevisiae haben. 
CgCBK1 wurde aufgrund des schweren Zellteilungsdefekts näher charakterisiert. Die 
Transkriptionsanalyse des Cgcbk1∆ Stammes zeigte, dass bestimmte Zellwandgene 
unterschiedlich exprimiert werden. 
Diese Sammlung von Deletionsstämmen ist eine der größten weltweit und ist somit 
von sehr großem Nutzen für das Studium der Pathogenität von C. glabrata. Zukünftige in 
vivo Experimente werden unter Ausnützung der integrierten „molekularen Barcodes“ die 
Identifizierung neuer Virulenzfaktoren ermöglichen. 
Summary   
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2 Summary 
Candida glabrata is an opportunistic human fungal pathogen. It is the second most 
frequent cause of Candida-derived infections after Candida albicans. Infection with either one 
of the two pathogenic fungi can result in diseases ranging from superficial cutaneous or 
mucosal to life-threatening systemic infections in immunocompromised individuals. Well-
documented virulence attributes of C. glabrata are the inherent reduced azole susceptibility 
and a large repertoire of adhesin genes, which are regulated by transcriptional silencing. 
However, the molecular basis of C. glabrata antifungal drug resistance and additional 
virulence factors is not well understood. 
The combination of fungal genomics and large-scale phenotypic profiling of deletion 
mutants represents a powerful approach to identify new factors contributing to fungal 
virulence. For this doctoral thesis, the C. glabrata genome sequence data were used to 
select genes with non-essential functional orthologues of the non-pathogenic yeast 
Saccharomyces cerevisiae. Based on this selection, a large-scale reverse genetics approach 
was initiated to identify novel genes implicated in C. glabrata pathogenicity and drug 
resistance. A bar-coded C. glabrata deletion strain collection was engineered comprising 
some 500 single gene deletion mutants affected in signaling functions, regulation of gene 
expression, cell wall biogenesis, transport processes, drug resistance, stress response and 
metabolism. Phenotypic profiling identified a total of 103 C. glabrata genes involved in 
resistance to cell wall-perturbing compounds, antifungal drugs, heat stress, osmosensitivity, 
metal ion or detergent tolerance, growth on minimal medium and phenotypic switching. 
Host-pathogen interaction related phenotypes were analyzed using an in vitro assay 
detecting reactive oxygen species (ROS). Screening for ROS elicited by primary mouse 
bone-marrow-derived macrophages co-incubated with C. glabrata mutants resulted in the 
identification of mutants lacking cell wall-related genes. 
Taken together, numerous deletion strains showed growth phenotypes different from 
known phenotypes of S. cerevisiae. For example, genes were identified, which have 
previously not been associated with sensitivity to the glucan synthase inhibitor Caspofungin. 
This also included C. glabrata genes, which do not have orthologues in baker’s yeast. 
The function of CgCBK1 gene has been studied in more detail, because it exhibits 
severe cell separation defects. Transcriptional profiling of this mutant showed differential 
expression of a distinct set of genes with cell wall-associated functions. 
In summary, the generated C. glabrata gene deletion strain collection is one of the 
largest collections of fungal deletion strains in the world and represents a powerful tool to 
study the virulence of a human fungal pathogen. Future studies based on the in vitro results 
will exploit the signature-tag strategy to identify novel virulence-associated factors in vivo. 
  3 Introduction 
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3 Introduction 
3.1 The fungal jungle 
Life is divided into three major domains: Eukaryota, Bacteria and Archaea. The idea 
to classify all living beings into specific groups goes back to the founder of taxonomy, 
Carolus Linnaeus. He tried to sort the diversity of life into systematic hierarchical categories. 
In 1969 the ecologist Robert Whittaker proposed a new classification introducing five 
kingdoms including animalia, plantae, fungi, protista and monera (Whittaker, 1969). Having 
been considered to be plants for a long time, this classification created an own taxonomic 
kingdom for fungi. It is estimated that the kingdom of fungi consists of up to 1.5 million 
different species, which evolved over more than 500 million years. Fungi comprise seven 
proposed phyla: Dikarya (Ascomycota and Basidiomycota), Microsporidia, Chytridiomycota, 
Neocallimastigomycota, Blastocladiomycota and Glomeromycota (Hibbett et al., 2007). The 
vast number of different fungal species is also vividly reflected in their enormous 
morphological diversity in nature. Fungi are able to grow in vastly different environments, 
occupying great many distinct ecological niches. They display numerous different 
morphologies, and can live as symbionts, commensals and pathogens. They are found in soil 
or on fruits, as well as on the skin or in the gastro-intestinal tract of many mammals. 
Commonly known examples for a symbiotic form of fungi are lichens, which consist of a 
fungal and a photosynthetic organism. Fungi have also been exploited by humans, who 
benefit from the fungal capability to ferment soy, rice and malt and to synthesize 
antimicrobial substances.  
 
 
 
Figure 1. Different fungal organisms A) Electron micrograph of non-pathogenic S. cerevisiae (taken from 
www.bath.ac.uk/bio-sci/research/profiles/wheals-a.html); B) DIC image of C. glabrata; C) Yeast, pseudohyphal, and true hyphal 
cells of C. albicans  (Berman & Sudbery, 2002); D) A. fumigatus E) F. solani (taken from www.mycology.adelaide.edu.au) 
 
Although fungi are found virtually everywhere, there are only about 300 fungal 
species causing diseases in humans (Taylor et al., 2001). These pathogenic fungi include 
organisms across the whole phylum (Figure 1 and 2), including Ascomycota such as 
Candida spp., Aspergillus spp. and Fusarium spp., Basidiomycota such as Cryptococcus 
neoformans, Zygomycetes such as Rhizopus oryzae, and dermatophytes such as 
Trichophyton rubrum. 
3 Introduction   
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Figure 2. Fungal phylogeny: the phylogeny displays the relationship of 60 taxa, including pathogenic and non-pathogenic 
fungi such as the C. glabrata, C. albicans, the non-pathogenic baker’s yeast S. cerevisiae, as well as more distantly related but 
medical relevant species such as A. fumigatus, C. neoformans or R. oryzae (taken from (Marcet-Houben & Gabaldon, 2009)) 
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3.2 Medical relevance of fungal pathogens 
Fungal organisms can cause a variety of infections, with superficial cutaneous 
mycoses representing most prevalent infections. A public health problem of increasing 
importance is the emergence of opportunistic mycoses. Candida and Aspergillus spp. are the 
most frequent causes of mycoses-related deaths and are associated with high morbidity and 
mortality (Horn et al., 2009, Mean et al., 2008, Nace et al., 2009, Neofytos et al., 2009, 
Pfaller & Diekema, 2007, Wenzel & Gennings, 2005). 
The most important causative fungal agent worldwide remain Candida spp. Candida 
spp. represent the fourth-leading cause of hospital-acquired infections and account for about 
8 to 10% of all nosocomial blood stream infections (Edmond et al., 1999, Wisplinghoff et al., 
2004). The overall mortality of systemic Candida infections can be as high as 40% (Pfaller & 
Diekema, 2007, Gudlaugsson et al., 2003, Wenzel & Gennings, 2005). The second most 
frequent cause of nosocomial infections are Aspergillus spp., whereas infections with other 
molds such as Mucorales or Fusarium are relatively rare but increasing (Fridkin, 2005, Marr 
et al., 2002, Pfaller & Diekema, 2004a, Richardson & Lass-Florl, 2008, Nucci & Marr, 2005).  
Several factors influence the predisposition to acquire fungal infections. 
Immunocompromised individuals are at high risk. Well-established risk factors comprise 
organ or bone marrow transplantation, acquired immune deficiency syndrome, neutropenia, 
intensive chemotherapy regimens, as well as long-term hospitalization and intensive care 
unit stays. Additional conditions include mucosal and cutaneous barrier disruptions, 
neutrophil dysfunctions, and defects in cell-mediated immunity. Further, metabolic disorders, 
extremes of ages, indwelling vascular catheters, and the increasing use of broad-spectrum 
antibiotics are considered as risk factors (Safdar et al., 2001, Pfaller & Diekema, 2007, 
Richardson & Lass-Florl, 2008).  
Invasive fungal infections are associated with significant medicare costs and with 
longer hospital stays (Morgan et al., 2005, Pfaller & Diekema, 2007). Because the incidence 
and mortality of fungal infections are increasingly frequent problems in the nosocomial 
setting, the development of new antifungal drugs and diagnostic tools are urgently needed. 
Recent epidemiological studies also observed a shift to non-albicans Candida spp., such as 
C. glabrata and C. krusei, both of which display reduced susceptibilities to antifungal drugs 
(Malani et al., 2005, Safdar et al., 2001, Panackal et al., 2006, Magill et al., 2006). Therefore, 
the choice of the proper antifungal drug is essential for a successful treatment. In 
consequence, the correct identification of fungal pathogens to the species level is critical for 
the initiation of appropriate antifungal therapies (Perlroth et al., 2007, Pfaller & Diekema, 
2007). Hence, further research is needed to improve diagnostics, to develop new antifungal 
strategies, to identify risk factors and to establish common guidelines for prophylactic, pre-
emptive, and empirical therapies to effectively combat fungal infections. 
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3.3 The genus Candida – a group of opportunistic fungal pathogens 
Candida spp. belong to the phylum Ascomycota, which includes a great variety of 
different fungi pathogenic to plants as well as to humans (see Figure 2). Candida spp. are 
found in diverse habitats and can be isolated from soil, fruits or animals. Furthermore, 
Candida spp. live as commensals on the skin and mucosal layers of otherwise healthy 
human hosts and commonly colonize the gastro-intestinal tract of healthy individuals (Khatib 
et al., 2001). 
The genus Candida consists of more than 100 different species comprising non-
pathogenic organisms as well as opportunistic fungal pathogens. With 48% to 58%, C. 
albicans is the most frequently isolated cause of candidemia (Pfaller et al., 2008). However, 
the distribution of Candida spp. varies by geographic regions. Notably, C. glabrata ranks 
second in Northern America and the European Union representing 14% to 24% of all clinical 
isolates (Pfaller et al., 2008). It is followed by Candida parapsilosis and Candida tropicalis, 
which are more prominent in Latin America and the Asian-Pacific region. Other species 
associated with candidemia are Candida krusei, Candida lusitaniae, Candida dubliniensis 
and Candida guilliermondii (Pfaller et al., 2008, Richardson & Lass-Florl, 2008).  
In immunocompetent humans, Candida spp. can cause superficial infections of the 
skin (Odds, 1994). For example, oral thrush and diaper dermatitis are well known infections 
in infants (Figure 3 A). Further, the majority of healthy women suffer from vaginal candidiasis 
at least once in a life time (Mardh et al., 2002). Those infections are usually not dangerous 
for healthy immunocompetent individuals. 
Importantly, Candida spp. can cause systemic life-threatening disease in 
immunocompromised patients (Figure 3C, D). In case of systemic and invasive Candidiasis, 
the causative species is able to penetrate epithelial tissues, to enter the blood stream and to 
disseminate into different organs (Mavor et al., 2005). 
 
 
Figure 3. Manifestations of Candida infections A) Diaper dermatitis (taken from http://www.doctorfungus.org/); B) C. 
albicans infection of skin and nail (taken from http://www.doctorfungus.org/); C) Oral Candidiasis caused by C. albicans (taken 
from www.oralcancerfoundation.org/dental/candida.htm); D) Esophageal candidiasis in an immunosuppressed patient (taken 
from www.merck.com/mmpe/sec14/ch180/ch180e.html) 
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3.4 Candida glabrata 
3.4.1 General characteristics of C. glabrata 
The haploid genome of C. glabrata has been sequenced and assembled by the 
Genolevures consortium (http://cbi.labri.fr/Genolevures/) (Dujon et al., 2004). The 12.3 Mb 
size genome displays a low GC content, containing a total of 5283 putative open reading 
frames (ORFs) distributed over 13 chromosomes. Taxonomy originally classified both  
C. glabrata and C. albicans into the same taxonomic category. However, based on 
comparative genomic approaches and phylogenetic comparisons, it appears obvious that C. 
glabrata and S. cerevisiae share a common ancestor, which underwent whole-genome 
duplication (WGD) (Fitzpatrick et al., 2006, Scannell et al., 2007). This is supported by the 
high sequence identity and high degree of gene synteny in both organisms. As shown in 
Figure 4, C. glabrata and S. cerevisiae are grouped in the WGD clade (red boxes) whereas 
C. albicans belongs to the CTG clade (grey box). This group comprises species that translate 
the CTG codon into serine instead of leucine (Santos et al., 1997).  
 
 
 
CTG 
 
 
 
 
WGD 
 
 
 
 
Figure 4. Phylogeny showing the distance between C. glabrata, C. albicans and their non-pathogenic relative S. 
cerevisiae. C. glabrata and S. cerevisiae belong to the whole-genome duplication (WGD) clade marked in red, C. albicans 
(orange box) belongs to CTG clade in the grey box (Fitzpatrick et al., 2006). 
 
After the divergence C. glabrata may have experienced a greater gene loss than S. 
cerevisiae, resulting in the smaller genome (Dujon et al., 2004, Scannell et al., 2007). A 
possible explanation for this gene loss is the adaptation of C. glabrata to its human host. A 
total of 29 genes are lost compared to four other hemiascomycete yeast species, including 
genes implicated in galactose, phosphate, nitrogen and sulfate metabolism, as well as genes 
involved in cell rescue (Dujon et al., 2004). In total, it is assumed that several hundred genes 
are not shared between S. cerevisiae and C. glabrata (Kaur et al., 2005). For example, our 
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own bioinformatic analysis also showed that homologues of the S. cerevisiae MAPK 
(mitogen-activated protein kinase) pathway genes ScSSK22 and ScMKK2 are not present in 
C. glabrata (Gregori et al., 2007). 
C. glabrata is auxotrophic for thiamine, pyridoxine and nicotinic acid (Domergue et al., 
2005, Ma et al., 2007). The nicotinic acid auxotrophy of C. glabrata has an important 
influence on adhesion and host colonization. C. glabrata lacks most BNA genes 
(biosynthesis of nicotinic acid), which encode the de novo nicotinic aicd biosynthesis 
pathway enzymes. Therefore, C. glabrata must rely on the uptake of NAD+ precursors from 
its environment. However, several different NAD+ precursors such as nicotinic acid, 
nicotinamide and nicotinamide riboside can be utilized by C. glabrata through uptake and a 
functional Preiss-Handler salvage pathway (Ma et al., 2007). During infection nicotinamide 
riboside appears to be a primary source of NAD+. Interestingly, the histone deacetylase 
CgHst1 is a major regulator of genes, which are expressed in response to nicotinic acid 
limitation, including the transporters CgTNA1, CgTNR1 and CgTNR2 (Ma et al., 2009). 
In addition, C. glabrata is only able to utilize glucose and trehalose as carbon sources 
(Land et al., 1996), which is exploited in diagnostic tests to distinguish between different 
Candida isolates.  
C. glabrata has been classified as an asexual haploid organism, displaying a 
pronounced clonal population structure (Dodgson et al., 2005). Nevertheless, the C. glabrata 
genome harbors three mating type-like loci (MTL1, MTL2, MTL3) and a- and α-pheromone-
expressing strains exist (Srikantha et al., 2003). The expression pattern reflects either the 
genotype of the MTL1 or MTL2 locus. Interestingly, orthologues of the mating pheromone 
response pathway, as well as of meiotic and recombination genes have been identified in C. 
glabrata (Wong et al., 2003), showing that a large part of the mating machinery in C. glabrata 
may exist. In fact, there is some evidence for recombination, indicating that mating at least 
occurred during the evolution of C. glabrata and may still occur randomly (Dodgson et al., 
2005). Recently, expression analysis showed also that pheromone receptor genes are 
expressed in C. glabrata. However, these appear insensitive to synthetic pheromone 
peptides (Muller et al., 2008). 
Although C. glabrata and C. albicans both live as human opportunistic pathogens, 
colonize the same host and share similar niches, the phylogenetic studies confirm that both 
organisms diverged early and underwent distinct evolutionary developments. Therefore, on 
one hand, both pathogens developed their own specific strategies to colonize the human 
host. On the other hand, they are likely to share some common virulence features, which 
may be important for fungal virulence in general. In addition, both pathogens share certain 
characteristics with the non-pathogenic baker’s yeast S. cerevisiae. These characteristics are 
summarized in Table 1 and will be discussed in more detail further below.  
 
  3 Introduction 
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  C. albicans C. glabrata S. cerevisiae Ref.* 
Taxonomy Ascomycota (CTG clade) Ascomycota (WGD clade) Ascomycota (WGD clade) (Marcet-Houben & Gabaldon, 2009) 
Genome size 8 chromosomes (n),  6563 ORFs 
13 chromosomes (n),  
5274 ORFs 
16 chromosomes (n), 
6607 ORFs (Dujon et al., 2004) 
Ploidy Diploid/tetraploid Haploid Haploid/diploid - 
Codon usage Alter. yeast (CTG – Ser not Leu) Standard Standard (Santos et al., 1997) 
Sexual cycle Known (cryptic) Unknown Known - 
Mating genes Present Present Present 
(Srikantha et al., 
2003, Wong et al., 
2003) 
Colony 
morphology Smooth (+ wrinkled) colonies Small, white/creamy colonies White, round shaped colonies - 
Cell morphology Dimorphic: yeast, hyphae, pseudohyphae, chlamydospores
Monomorphic: budding yeast 
(pseudohyphae) Budding yeast (pseudohyphae) 
(Csank & Haynes, 
2000) 
Biofilm formation Present Present Present (Iraqui et al., 2005, Shin et al., 2002) 
Phenotypic 
switching 
Present (yeast - hyphae; white - 
opaque) 
Present (visible on CuSO4 
media) Absent 
(Lachke et al., 2002, 
Lachke et al., 2000) 
Auxotrophy (WT) Absent Niacine, thiamine, pyridoxine Absent (Domergue et al., 2005) 
Sugar utilization Glucose, maltose, galactose, trehalose Glucose, trehalose 
Glucose, maltose, galactose, 
sucrose, melibiose (Land et al., 1996) 
Natural habitat Microbial flora of humans Microbial flora of humans Plants, fruits (grapes) (Khatib et al., 2001) 
Adhesins Lectins (Hwp1, Als family) Lectins (Epa family) Sexual agglutinins, lectins (Flo family) 
(Cormack et al., 
1999) 
Azole resistance Susceptible Decreased susceptibility Susceptible (Pfaller & Diekema, 2004b) 
Sites of infection/ 
isolation 
Feces, urine, blood, vagina, 
oral, disseminated 
Feces, urine, blood, vagina, 
oral, disseminated - - 
Virulence Opportunistic pathogen Opportunistic pathogen Non - pathogenic - 
Clinical 
significance 50 % of Candida isolates Up to 25% of Candida isolates No significance (Horn et al., 2009) 
 
Table 1. Comparison of the main characteristics. The two pathogenic yeast C. albicans and C. glabrata and the non-
pathogenic S. cerevisiae are compared. WGD = whole-genome duplication, WT = wild type, ORF = open reading frame; * 
references refer to C. glabrata literature 
3.4.2 C. glabrata morphology and its influence on virulence 
C. glabrata displays a mainly monomorphic morphology, growing as budding yeast 
with ellipsoid cells of about 2-4 µm in diameter. Under laboratory conditions C. glabrata forms 
smooth, white colored colonies. Clinical isolates of C. glabrata from humans are normally 
also obtained in the budding yeast form. However, pseudohyphae formation of wild type cells 
has been reported as well as induction of invasive pseudohyphae upon nitrogen starvation in 
vitro (Csank & Haynes, 2000, Odds et al., 1997). Several other morphological traits may 
influence the pathogenicity of C. glabrata, including phenotypic switching, pigmentation, and 
biofilm formation. 
 
Phenotypic switching. Phenotypic switching is a known attribute of several 
dimorphic fungal species. In the monomorphic yeast C. glabrata, phenotypic switching refers 
to a high-frequency core switching phenotype and a reversible switching system (Lachke et 
al., 2000, Lachke et al., 2002). The C. glabrata core switching system distinguishes four 
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phenotypes, according to the intensity of the brown colony color when cultured on CuSO4-
containing media. The reversible system is characterized by a spontaneous switch between 
irregular wrinkled and smooth colonies. In vivo, different phenotypes of the core switching 
system may develop from a single strain, when growth occurs at different anatomical sites of 
the host (Brockert et al., 2003). In vaginitis patients, phenotypic switching occurs at the site 
of infection and emphasises the dark-brown phenotype (Brockert et al., 2003). Notably, cells 
of the dark brown phenotype may have a colonization advantage over cells of other switch 
phenotypes (Srikantha et al., 2008). 
 
Pigmentation. Several fungi of clinical relevance are able to synthesize colored 
pigments, which may be associated with their virulence. For instance, the human pathogenic 
basidiomycetal yeast Malassezia furfur displays colored pigmentation, consisting of a variety 
of different indole compounds (Mayser et al., 1998, Mayser et al., 2004, Hort et al., 2009). 
Melanin pigments are also described for other human pathogenic fungi such as 
Cryptococcus neoformans or Aspergillus fumigatus (Casadevall et al., 2000, Langfelder et 
al., 2003, Brakhage & Liebmann, 2005). Both fungi are able to synthesize melanins, which 
have been implicated in pathogenicity (Casadevall et al., 2000). Although the function of 
melanin as a virulence factor in these fungi remains unclear, it is known that the cAMP-
signaling pathway is linked to melanin production (Langfelder et al., 2003). 
Interestingly, pigment production can be induced in C. glabrata when grown on media 
containing tryptophan as a sole nitrogen source (Mayser et al., 2007, Brunke). Since 
virulence factors of C. glabrata are weakly defined, it is of certain interest to determine, 
whether these C. glabrata pigments contribute to its pathogenicity. 
 
Biofilm formation. Biofilm formation is another fungal trait, which is implicated in the 
development of fungal disease and drug resistance. In natural habitats, microbial 
communities predominantly exist as biofilms rather than planktonic cells (Costerton et al., 
1995). A biofilm is a structured community of individual cells, embedded in extracellular 
matrix developing and growing on a variety of different surfaces (Figure 5 B). Indwelling 
medical devices, such as catheters or heart valves provide surfaces to which 
microorganisms can adhere and initiate biofilm formation. A crucial attribute of biofilms is 
their significantly lower sensitivity to antimicrobial drugs (Mah & O'Toole, 2001). 
Several consecutive steps lead to biofilm formation (Douglas, 2003). First, individual 
cells adhere to a surface. Second, these cells form microcolonies, which produce 
extracellular matrix. Finally, the biofilm matures, giving rise to hyphal as well as yeast cells 
embedded by extracellular matrix (Figure 5 B). 
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Although C. glabrata grows in the budding yeast morphology only, it is able to form 
biofilms (Figure 5 A) (Shin et al., 2002, Iraqui et al., 2005). Two adhesins, Epa6 and Epa7, 
belonging to the large EPA gene family, are required for biofilm formation of C. glabrata 
(Iraqui et al., 2005). Epa6 appears as the major adhesin involved in biofilm formation, since 
its expression is highly induced in biofilms. Deletion of EPA6 results in reduced capability to 
form biofilms in vitro. Interestingly, Epa6 and Epa7 expression is regulated by subtelomeric 
silencing, which in turn may be directly controlled by biofilm formation or via a Yak1 kinase-
dependent mechanism (Iraqui et al., 2005). Regulation by silencing is confirmed in Cgsir4∆, 
Cgsir3∆ and Cgrif1∆ mutants, which display increased adherence to plastic surfaces. EPA6 
and EPA7 expression is upregulated in these silencing mutants, connecting the subtelomeric 
silencing machinery to biofilm formation (Castano et al., 2005, Iraqui et al., 2005). Thus, 
transcriptional silencing is a distinct mechanism, through which C. glabrata controls biofilm 
formation by adhesins and which may contribute to its virulence. 
 
 
Figure 5. Biofilm formation in C. glabrata A) C. glabrata BG2 wild type cells form biofilms on plastic surfaces (top left) 
whereas biofilm negative strains form smaller structures (top right). A Biofilm++ mutant shows extensive biofilm formation 
(bottom); taken from (Iraqui et al., 2005). B) Schematic, showing the steps of biofilm formation (Douglas, 2003). 
3.4.3 The hypervirulence factor CgAce2 and the RAM network 
Since virulence factors of C. glabrata are weakly defined, several attempts have been 
made to identify novel virulence-associated genes in this organism. A new virulence factor, 
CgACE2, was identified by exploiting a library of insertional signature-tagged mutants. The 
deletion of this transcription factor gene results in a strain defective in cell separation (Figure 
6 B) and strongly enhances the formation of large cell aggregates (Kamran et al., 2004). The 
use of a neutropenic mouse infection model showed that Cgace2∆ mutants are hypervirulent, 
causing 100% death after only four days. The acute mortality is apparently not due to 
vascular clogging by the clumpy growth phenotype. Instead, the hypervirulence may at least 
in part be caused by elevated levels of proinflammatory cytokines (Kamran et al., 2004). 
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Abnormal exposure of fungal cell wall components may be the cause for this cytokine 
stimulation. 
This is further supported by the analysis of proteomic changes in Cgace2∆ mutants. 
In total, 123 proteins are identified, including more abundant proteins associated with 
metabolism and less abundant proteins being related to cellular transport and protein 
synthesis. Interestingly, the expression of several genes involved in morphogenesis and cell 
wall remodelling is down-regulated (Stead et al., 2005).  
CgAce2 is part of the RAM (Regulation of Ace2 activity and cellular morphogenesis) 
network, which regulates polarized growth and cell separation, and influences the budding 
pattern (Figure 6 A). C. glabrata harbors homologues of all RAM network genes. The kinase 
CgCbk1 regulates the transcription factor CgAce2 and deletion of CgCBK1 results in a 
similar clumpy cell morphology as seen for the Cgace2∆ mutant (Schwarzmüller, 
unpublished results). 
 
 
 
Figure 6. RAM network in S. cerevisiae and phenotypes of cbk1∆ and ace2∆ deletion strains. (A) RAM network 
components in S. cerevisiae. (B) Deletion strain phenotypes of C. glabrata and S. cerevisiae cbk1∆ and ace2∆ strains. S. 
cerevisiae pictures taken from (Bidlingmaier et al., 2001). 
 
Similarly, in S. cerevisiae the components of the RAM network regulate polarized 
growth and ScAce2 activity (Nelson et al., 2003). The network includes several genes, all of 
which are required for polarized growth. Microarray studies revealed that strains lacking one 
of the genes including ScCBK1, ScMOB2, ScKIC1, ScHYM1 or ScTAO3, show overlapping 
expression profiles. ScKic1, ScHym1 and ScTao3 regulate the transcription factor ScAce2 
via the ScCbk1-ScMob2 complex (Nelson et al., 2003, Bidlingmaier et al., 2001, Colman-
Lerner et al., 2001). ScAce2 then localizes to the nucleus of the daughter cell, mediating the 
separation of mother and daughter cells and activates expression of early G1-phase genes. 
ScAce2 is required for expression of distinct target genes involved in cell separation such as 
the chitinase ScCTS1, the putative glucanase ScSCW11 and the daughter-specific genes 
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ScDSE1-4 (O'Conallain et al., 1999, Colman-Lerner et al., 2001). Deletion of ScACE2 
causes a cell separation defect similar to the phenotype of the Cgace2∆ strain (Figure 6 B), 
resulting in pseudohyphal growth and agar invasion (King & Butler, 1998). 
ScSsd1, a protein involved in cell wall integrity, has been identified by yeast two-
hybrid screening as binding partner of ScCbk1 (Racki et al., 2000). Remarkably, deletion of 
ScSSD1 in wild S. cerevisiae strains isolated from plants or from clinical isolates results in 
hypervirulent strains in a mouse model of systemic infection. Alteration in the cell wall 
composition of the Scssd1∆ mutant induces proinflammatory cytokines in macrophages, 
implying that the increased virulence is due to a stronger immune response (Wheeler et al., 
2003).  
Taken together, the disturbance of the RAM network or associated proteins may lead 
to perturbations of the cell wall architecture and exposure of otherwise not accessible cell 
wall components. This exposure may trigger cytokine production by immune cells, thus 
inducing septicemia. However, the responsible cell wall components still have to be identified 
although glucans may be the major inducing structural constituent. 
3.4.4 Antifungal drugs and drug resistance mechanisms in C. glabrata 
A particular characteristic phenotype of C. glabrata is its reduced susceptibility to 
clinically used azoles. The inherent resistance against this class of antifungals may be a 
major virulence factor of C. glabrata. This view is supported by the finding that C. glabrata is 
often isolated from patients undergoing azole therapy (Pfaller & Diekema, 2004a, Bouchara 
et al., 2000). Moreover, the prophylactic use of azoles in treatment of Candida infections may 
actually contribute to the clinical prevalence of C. glabrata. However, the increase in C. 
glabrata blood stream infections may not only be due to drug pressure but may also be 
affected by geographic location, age and other yet ill-defined factors (Pfaller & Diekema, 
2007). 
The molecular basis of antifungal drug resistance in C. glabrata depends on similar 
mechanisms, also operating in other fungal organisms (Figure 7). These mechanisms 
comprise reduced uptake, upregulation of drug efflux pumps, sequestration of toxic 
substances in the vacuole, intracellular drug inactivation, changes in membrane permeability 
and alteration of drug targets (Cowen & Steinbach, 2008). 
The best studied drug resistance mechanism in C. glabrata is the upregulation of 
ABC transporters in response to azole exposure. Azole resistance is rapidly acquired by 
overexpression of the efflux pumps CgCdr1 and CgPdh1 (CgCdr2), orthologues of the S. 
cerevisiae ABC transporter ScPdr5 and C. albicans efflux pumps CaCdr1 and CaCdr2 
(Sanglard et al., 1999, Miyazaki et al., 1998, Izumikawa et al., 2003). Interestingly, disruption 
of CgPDH1 alone does not affect azole susceptibility. However, a Cgcdr1∆ Cgpdh1∆ double 
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deletion results in drug hypersusceptibility (Sanglard et al., 2001). Both ABC pumps are part 
of the pleiotropic drug resistance (PDR) network, which has been originally described in 
baker’s yeast (Balzi et al., 1987, Sipos & Kuchler, 2006). CgSNQ2 belongs to the C. glabrata 
PDR network as well and mediates resistance to azole drugs (Torelli et al., 2008). 
 
Figure 7. Resistance mecha-
nisms of fungal cells. These include 
(1) reduced uptake of xenobiotics, (2) 
increased efflux by upregulation of 
drug efflux proteins, (3) sequestration 
of toxic substances to the vacuole, (4) 
intracellular drug inactivation, (5) 
alteration of drug targets or their 
transcriptional activators. Furthermore, 
signaling and general stress response 
pathways contribute to drug 
resistance. Taken from (Kuchler K.). 
 
 
 
 
 
The transcription factor CgPdr1 is the master regulator of the C. glabrata PDR 
network. It mediates resistance to azoles by controlling CgCDR1, CgPDH1 and CgSNQ2 
gene expression (Vermitsky & Edlind, 2004, Vermitsky et al., 2006, Torelli et al., 2008). 
Moreover, a putative pleiotropic drug-response element (PDRE) in the promoter region of 
CgPDR1 suggests an autoregulatory loop (Vermitsky et al., 2006, Tsai et al., 2006). In 
contrast to S. cerevisiae, the PDR network of C. glabrata is under control of only one 
transcriptional regulator CgPdr1. In addition, the regulation of drug efflux via CgCdr1 and 
CgPdh1 is also controlled by phosphorylation of the ABC pumps through protein kinase A 
activity (Wada et al., 2002, Wada et al., 2005).   
Interestingly, strains with CgPDR1 gain-of-function mutations are more virulent in a 
mouse model when compared to strains with wild type alleles (Ferrari et al., 2009). These 
mutations are not only associated with elevated azole resistance but also with a gain in 
fitness and virulence. Since these strains show a higher fitness in vivo, it is, thus, possible 
that the increased virulence phenotype is due to the gained fitness. 
Recently, the molecular mechanisms underlying Pdr1-mediated resistance have been 
identified. CgPdr1 directly binds structurally different xenobiotics in a similar manner as 
known from mammalian PXR nuclear receptors (Thakur et al., 2008, Kliewer et al., 2002). 
Direct binding of drugs activates the expression of drug efflux pumps. In addition, the 
mediator complex subunit Gal11 interacts with Pdr1 and is essential for mediating multidrug 
resistance. Interestingly, C. glabrata has two homologues of the baker’s yeast ScGAL11 
gene. Only deletion of CgGAL11A leads to decreased CgCDR2 expression, rendering cells 
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more susceptible to azoles (Thakur et al., 2008). This discovery may open the possibility for 
the development of new antifungal drugs acting on novel targets. 
The regulation of C. glabrata ABC transporters is also influenced in so-called petite 
mutants (Brun et al., 2003, Brun et al., 2004). Petite mutants lack mitochondrial DNA, 
resulting in mitochondrial dysfunction and respiratory deficiencies (Locker et al., 1979, 
Slonimski et al., 1968). In S. cerevisiae, the petite phenotype leads to up-regulation of Pdr3p 
function and increased ScPDR5 expression (Hallstrom & Moye-Rowley, 2000, Zhang & 
Moye-Rowley, 2001). Azole-resistant C. glabrata petite mutants show elevated CgCDR1 and 
CgPDH1 levels and increased drug efflux in vitro (Sanglard et al., 2001, Brun et al., 2003, 
Brun et al., 2004, Defontaine et al., 1999). Interestingly, C. glabrata petite mutants appear to 
be less virulent than the isogenic wild type strain in a mouse model of systemic candidiasis 
(Brun et al., 2005). In contrast, a clinical isolate from a bone marrow transplant recipient with 
elevated resistance to several azoles is a petite mutant (Bouchara et al., 2000). This 
demonstrates that the selective pressure imposed during azole treatment may result in 
selection of azole-resistant mutants in vivo. This mechanism may partially contribute to 
clinical failures of antifungal azole therapy of C. glabrata infections. 
A C. glabrata strain, lacking CgPGS1, shows overexpression of drug efflux pumps 
(Batova et al., 2008). CgPGS1, encoding a phosphatidylglycerolphosphate synthase, is an 
enzyme involved in the synthesis of phospholipids and is essential for functional 
mitochondria. In this mutant, the absence of anionic phospholipids results in dysfunctional 
mitochondria, which are associated with increased azole resistance. 
C. glabrata also carries a transporter of the major facilitator superfamily (MFS), 
CgFLR1, which contributes to drug resistance (Chen et al., 2007). Expression of CgFLR1 is 
controlled by the transcriptional regulator CgAp1. CgAp1 mediates resistance to diverse 
compounds, such as hydrogen peroxide, benomyl, cadmium chloride and fluconazole (Chen 
et al., 2007). 
Most if not all azoles block ergosterol biosynthesis (Figure 8), which leads to a 
depletion of essential ergosterol in the plasma membrane (Ghannoum & Rice, 1999, Cowen 
& Steinbach, 2008). The fungal plasma membrane depends on ergosterol, which is the 
principal sterol component of the fungal cell membrane and required to establish proper 
membrane function. 
A variety of azole drugs selectively inhibit Erg11, a cytochrome P450 lanosterol 14-
alpha-demethylase (Akins, 2005). Two possible explanations for the toxic effect of azoles 
exist. Inhibition of Erg11 leads to accumulation of lanosterol, which is further converted to a 
toxic intermediate being responsible for growth inhibition (Akins, 2005). On the other hand, 
the growth inhibitory effect can be explained by the lack of membrane ergosterol. Resistance 
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to azoles may occur by point mutations in ERG11, overexpression or gene amplification, 
leading to dosage compensation (Henry et al., 2000, Niimi et al., 2002, Redding et al., 2003). 
 
Figure 8. Mechanism of action of the 
different antifungal drugs targeting the 
ergosterol biosynthesis pathway. Ergosterol is 
the major sterol component of the fungal cell 
membrane and is required for proper membrane 
fluidity and function. Ergosterol is synthesized 
from a squalene precursor. Several antifungal 
drugs selectively inhibit distinct enzymes of this 
pathway. Terbinafine inhibits the squalene 
epoxidase Erg1, azoles inhibit the C14α-
demethylase, a cytochrome P-450 enzyme, 
encoded by ERG11 and amorolfine inhibits Erg24 
and Erg2. Amphotericin B leads to cell leakage by 
binding to ergosterol. Taken from (Lupetti et al., 
2002, White et al., 1998) 
 
 
 
 
 
 
 
The contribution of CgERG11 in C. glabrata azole resistance is less well understood 
when compared to C. albicans. In azole-resistant clinical isolates, expression levels of 
CgERG11 are unchanged and no mutations are found in the gene, suggesting that 
CgERG11 is not involved in C. glabrata azole resistance (Henry et al., 2000, Vermitsky & 
Edlind, 2004, Sanguinetti et al., 2005, Redding et al., 2003). 
In C. glabrata, CgAUS1 is the only homologue of the S. cerevisiae ABC transporters 
ScAus1 and ScPdr11, which are required for sterol uptake from media under anaerobic 
conditions (Nakayama et al., 2007). In contrast to baker’s yeast, C. glabrata may be able to 
take up sterols from serum-supplemented media under aerobic conditions. For instance, 
growth of a strain lacking CgERG9 can be rescued in medium supplemented with serum. 
Likewise, when CgERG11 is inhibited by fluconazole growth is restored by serum addition 
(Nakayama et al., 2000); and Cgerg1∆ cells show enhanced uptake of exogenous 
cholesterol (Tsai et al., 2004). Furthermore, repression of the sterol transporter CgAUS1 
renders cells hypersensitive to fluconazole in spite of the presence of serum. This effect is 
not observed for non-azole antifungals such as amphotericin B (Nakayama et al., 2007). 
Perhaps uptake of serum cholesterol by CgAus1 can compensate for the lack of ergosterol, 
and thereby protect C. glabrata against fluconazole. This may represent a particular drug 
resistance mechanism of C. glabrata. 
Many reports suggest that cross-resistance to other drugs commonly occurs in azole-
resistant C. glabrata strains (Borst et al., 2005, Magill et al., 2006, Panackal et al., 2006, 
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Pfaller et al., 2004). This is problematic in a clinical setting and may give an explanation for 
the observed shift from infections with C. albicans to other Candida spp. (Pfaller & Diekema, 
2007). Currently, azole drugs are also mainly used in antifungal therapy because of their 
efficacy and relatively low toxicity. However, most azoles are fungistatic rather than 
fungicidal. Therefore, the development of novel antifungal drugs acting on new targets is an 
important field of research. 
 
Antifungal class Drug Mechanism of action Clinical use Ref. 
Azole Fluconazole Inhibition of ergosterol biosynthesis Systemic opportunistic mycoses 
(Richardson et al., 
1985, Troke et al., 
1985) 
 Voriconazole  (yeasts, moulds) (George et al., 1996) 
 Itraconazole   (Heeres et al., 1984) 
 Ketoconazole   (Heeres et al., 1979) 
Allylamine Terbinafine Inhibition of ergosterol biosynthesis 
Cutaneous infections 
(dermatophytes) 
(Petranyi et al., 
1984) 
Poylenes Amphotericin B Disruption of membrane by binding of ergosterol  
Systemic opportunistic mycoses 
(yeasts, moulds) 
(Donovick et al., 
1955) 
Nucleoside analog 5-Flucytosine Inhibition of DNA and RNA synthesis Combination therapy only (yeasts) 
(Heidelberger et al., 
1957, Holt & 
Newman, 1973) 
Echinocandins Caspofungin Inhibition of β-glucan synthase Candidiasis, Aspergillosis 
(Masurekar et al., 
1992) 
 Micafungin   (Iwamoto et al., 1994) 
 Anidulafungin   (Nyfeler & Keller-Schierlein, 1974) 
 
Table 2. The major classes of antifungal drugs used in clinical antifungal therapy (Chen & Sorrell, 2007, Cowen & 
Steinbach, 2008, Ghannoum & Rice, 1999, Denning, 2003) 
 
In addition to azoles a variety of other drugs exist for the treatment of fungal infections 
(Table 2 & Figure 8). The allylamine terbinafine blocks ergosterol biosynthesis by inhibiting 
the squalene epoxidase Erg1 (Klobucnikova et al., 2003, Ryder, 1992). Terbinafine is mainly 
used for the treatment of dermatophyte infections. However, the in vitro combination of 
terbinafine with azoles or calcineurin inhibitors showed a putative extended spectrum of 
terbinafine action (Jessup et al., 2000, Ryder, 1999). For example, combining terbinafine with 
the calcineurin inhibitor FK506 resulted in growth inhibition of C. glabrata (Onyewu et al., 
2003). 
Amphotericin B is an effective therapy for fungal infections. The fungicidal effect of 
the polyene drug amphotericin B is due to its complex formation with membrane ergosterol, 
leading to permeabilization of the membrane and leakage of cell contents (Table 2, Figure 9). 
The mode of action also explains the broad antifungal spectrum of amphotericin B on diverse 
fungal species (Ghannoum & Rice, 1999). Nevertheless, strong side effects, such as 
nephrotoxicity, are problematic with the clinical use of amphotericin B (Bates et al., 2001). 
Flucytosine is a nucleoside analog which develops its antifungal properties after 
cellular conversion to 5-fluoruracil (Table 2, Figure 9). 5-fluoruracil is incorporated into RNA, 
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resulting in disruption of protein synthesis. It also affects thymidilate synthase and therefore 
DNA synthesis (Ghannoum & Rice, 1999). Flucytosine uptake requires a permease. 
Therefore the use of flucytosine is limited to pathogenic fungi such as Candida spp., which 
harbor cytosine permeases (Odds et al., 2003). 
 
Figure 9. Mechanisms of action of four 
antifungal drug classes and their targets. 
Azoles target the ergosterol biosynthesis 
pathway, Amphotericin B binds to membrane 
ergosterol forming pores in the membrane, 5-
Flucytosine is an inhibitor of DNA and RNA 
synthesis and echinocandins inhibit β-glucan 
synthase and interfere with cell wall integrity 
(Cowen, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Echinocandins represent a relatively new class of antifungal drugs, targeting the 
assembly of the fungal cell wall. Three different drugs - Caspofungin, Micafungin and 
Anidulafungin - have been approved for clinical therapy of candidiasis and aspergillosis 
(Denning, 2003). The advantage of these antifungal agents is that they target an enzyme 
specific to fungal organisms, their low toxicity and the absence of cross-resistance with other 
antimycotic drugs. Echinocandins are fungicidal by inhibiting the fungal glucan synthase 
complex (Onishi et al., 2000). This enzyme is responsible for the synthesis of β-1,3 glucan, a 
major constituent of the fungal cell wall. Since echinocandins are poor substrates of ABC 
transporters, these pumps probably do not contribute to echinocandin resistance (Bachmann 
et al., 2002, Posteraro et al., 2006). However, overexpression of C. albicans CDR2 confers 
caspofungin resistance in vitro (Schuetzer-Muehlbauer et al., 2003). 
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Other known caspofungin resistance mechanisms are based on point mutations in the 
subunits of the glucan synthase genes, FKS1 and FKS2. Those point mutations have been 
identified in the glucan synthase genes of clinical isolates of different Candida spp., including 
C. glabrata (Katiyar et al., 2006, Park et al., 2005, Thompson et al., 2008, Cleary et al., 2008, 
Garcia-Effron et al., 2009). Overall, echinocandins seem to be a good choice for treatment of 
azole-resistant and cross-resistant pathogenic yeast. 
Interestingly, S. cerevisiae PKC pathway mutants (i.e. lacking components of the cell 
integrity pathway) show severe growth defects when exposed to Caspofungin (Reinoso-
Martin et al., 2003). Therefore, the ability to sense cell wall damage exerted by cell wall-
perturbing drugs is essential for the survival of fungi. Sensing of diverse stress factors and 
accurate signal transduction is a general theme for adaptation of fungal cells to changing 
environmental conditions. This may be true in particular for pathogenic yeasts, which have to 
adapt rapidly to extreme changes in the host environment. 
3.4.5 Environmental stress sensing - signaling pathways in C. glabrata 
Fungal cells are exposed to fluctuating environmental conditions in their natural 
habitats: temperature, pH, availability of nutrients, osmolarity and oxygen supply. Fungal 
pathogens have to deal with additional challenges mostly exerted by the host. During the 
different stages of infection – adhesion, invasion, colonization and dissemination – the fungal 
pathogen has to adapt to a variety of changing conditions and to counteract or evade 
immune surveillance. To assure its survival, pathogens must react appropriately and quickly. 
Yeast cells possess several different pathways, transducing a signal from the cell 
surface located sensor to the nucleus. These signaling pathways are involved in nutrient and 
environmental stress sensing. The protein kinase A (PKA) pathway is involved in 
metabolism, stress resistance and proliferation related to nutrient availability (Thevelein & de 
Winde, 1999). The TOR (target of rapamycin) pathway controls cell growth and metabolism 
in response to environmental cues and regulates protein synthesis at multiple levels (De 
Virgilio & Loewith, 2006), while the Rim101 pathway is required for growth at alkaline 
conditions (Lamb et al., 2001). Calcineurin governs gene expression in a species-dependent 
fashion as a central stress response regulator. It is also implicated in temperature and cell 
wall stress (Kraus & Heitman, 2003). Further, it may play a virulence-associated role in 
fungal pathogens (Karababa et al., 2006). Finally, mitogen-activated protein kinase pathways 
(MAPK) represent an essential part of the cell’s ability to sense, respond and communicate 
with its environment.  
The canonical MAPK pathway contains a core module composed of a three-tiered 
kinase cascade. Upon activation of the MAP kinase kinase kinase (MAPKKK), the MAP 
kinase kinase (MAPKK) is phosphorylated, which in turn activates the MAP kinase (MAPK). 
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MAPK signaling drives a diverse set of transcription factors, controlling a multitude of 
different cellular processes by integration of extracellular and intracellular stimuli. Upstream 
components include G protein-coupled receptors and a p21-activated protein kinase (PAK) 
(Chen & Thorner, 2007). 
Five MAPK signaling pathways (Figure 10) implicated in stress response and 
regulation of cellular processes are described in S. cerevisiae. The protein kinase C or cell 
wall integrity pathway (PKC), the high osmolarity glycerol pathway (HOG), the mating 
pheromone response pathway, the filamentous growth pathway and the spore wall assembly 
pathway (Chen & Thorner, 2007).  
 
 
 
Figure 10. Schematic diagram of MAPK signaling pathways in baker’s yeast. The five MAPK signaling pathways in S. 
cerevisiae (PKC, HOG, mating, filamentous growth, sporulation pathway) are principally conserved in C. glabrata. Taken from 
(Qi & Elion, 2005). 
 
C. glabrata harbors putative orthologues of almost any gene of the different S. 
cerevisiae signaling pathways. Several of these genes have already been studied in C. 
glabrata with respect to their influence on growth and virulence properties. 
The HOG pathway is a prominent example for a conserved pathway in C. glabrata. 
The HOG pathway consists of two branches, the so-called Sho1 and Sln1 branch (Figure 
10). S. cerevisiae cells lacking the kinases ScPBS2 or ScHOG1 are osmosensitive, whereas 
no obvious phenotype is seen when a single mutation occurs in only one of the branches 
(Brewster et al., 1993).  Remarkably, a C. glabrata Cgsho1∆ strain displays severe 
osmosensitivity (Gregori et al., 2007). However, this phenotype is restricted to a mutant in 
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the ATCC2001 background. The wild type strain ATCC2001 carries a genomic mutation in 
CgSSK2 (Cgssk2-1 allele), resulting in the loss of the kinase domain. Since the C. glabrata 
genome does not harbor a CgSSK22 gene (a functional redundant homologue of ScSSK2 in 
S. cerevisiae), the Cgssk2-1 mutation renders the CgSln1 branch inactive. Interestingly, 
when Cgssk2-1 is restored by a fully functional CgSSK1 gene, CgHog1 displays increased 
levels of phosphorylation in strain ATCC2001. This suggests that the Cgssk2-1 mutation may 
be a natural occurring mutation, suppressing associated toxicities of a constitutively activated 
Hog1 kinase (Gregori et al., 2007).  
C. glabrata CgSte11 is required for adaptation to hypertonic stress and is implicated 
in nitrogen starvation-induced filamentation. Cgste11∆ mutants are attenuated in virulence 
(Calcagno et al., 2005). CgSte12 shows only a modest influence on virulence. However, it is 
also required for nitrogen starvation-induced pseudohyphal formation and regulation of cell 
wall biogenesis (Calcagno et al., 2003). The C. glabrata PAK kinase homologue CgSte20 is 
implicated in cell wall integrity, adaptation to hypertonic stress and wild-type levels of 
virulence (Calcagno et al., 2004). These studies on different components of signaling 
pathways demonstrate that sensing of extracellular stresses, which result in transcriptional 
changes, can influence the morphology and cell wall composition and hence the virulence 
properties of C. glabrata. 
Cell wall integrity is a tightly controlled process. In response to various adverse 
conditions such as heat stress, hypoosmotic shock, cell wall-affecting agents and mating 
pheromone, the cell wall integrity MAPK pathway is activated (Levin, 2005). In C. glabrata, 
the PKC pathway is involved in resistance to Caspofungin and azole drugs, as well as in cell 
wall maintenance and regulation of chitin synthesis (Cota et al., 2008, Edlind et al., 2005). 
Our own studies showed that a C. glabrata slt2∆ mutant is sensitive to Caspofungin. 
However, cells lacking the PKC pathway sensor WSC1, display severe growth defects under 
various stress conditions, such as heat, Calcofluor White, Congo Red, SDS and 
Caspofungin, all of them affecting cell wall integrity. 
During infection, C. glabrata has to cope with oxidative and osmotic stress exerted by 
the host. Environmental stress response (ESR) is accomplished among others by the 
transcription factors CgMsn2 and CgMsn4. Hyperosmotic shock leads to CgMsn2 mediated 
activation of specific ESR genes, such as the trehalose genes CgTPS1 and CgTPS2. 
Transcriptional profiling revealed a conserved regulation of MSN2 in C. glabrata and S. 
cerevisiae (Roetzer et al., 2008). 
Immune cells produce a variety of different oxygen radicals to fight invading 
pathogens. Notably, the transcription factors CgYap1 and CgSkn7 are involved in oxidative 
stress resistance. Together with CgMsn2 and CgMsn4 they regulate CgCta1 catalase activity 
(Cuellar-Cruz et al., 2008). 
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C. glabrata can occupy several habitats with ambient changes in pH such as the skin, 
the gastro-intestinal tract and the vaginal mucosa. Therefore, the ability to adapt to changing 
pH levels is essential for survival in the host. Although there is no morphological change of 
C. glabrata in response to changing pH conditions, gene expression levels change. A 
proteomics study revealed four clusters of C. glabrata genes regulated in a pH-dependent 
manner, including amino acid, carbohydrate and lipid metabolism, stress response, and 
protein synthesis genes (Schmidt et al., 2008). In contrast to other fungal pathogens, such as 
C. albicans, acidic pH levels appear to be less stressful for C. glabrata than alkaline pH 
conditions. 
Although many homologues of S. cerevisiae and C. albicans signaling genes and 
transcription factors can be identified in C. glabrata, differences likely exist in sensing, and 
signaling mechanisms as well as transcription. New transcription patterns may be formed by 
different mechanisms such as changes in a transcriptional regulator, resulting in the control 
over new genes or mutations/loss of promoter sequences, which may put individual genes 
under control of a different transcriptional regulator. This transcriptional rewiring affects cis-
regulatory as well as trans-acting elements and is thought to be a key mechanism by which 
complexity, diversity and phenotypic novelty can arise (Tsong et al., 2006). By comparison of 
S. cerevisiae and C. albicans circuitries, transcriptional rewiring of the mating circuit, of 
mitochondrial and cytoplasmic ribosomal genes or of ribosomal regulation have been 
identified (Ihmels et al., 2005, Tanay et al., 2005, Tsong et al., 2006). Therefore, comparison 
of C. glabrata with S. cerevisiae or C. albicans will probably allow the identification of new 
regulatory modules and genes influencing stress response patterns and drug resistance. 
3.4.6 The yeast cell wall and adhesion in C. glabrata 
The fungal cell wall is a complex and protective multilayer barrier consisting of 
polysaccharides and proteins, which together ensure structural integrity of the fungal cell. In 
spite of its rigid nature and mechanical stability, the cell wall does not resemble an inert 
structure as its composition continuously changes during growth. Growth, cell division and 
adaptation to environmental stresses influence biogenesis, assembly and composition of the 
cell wall. Its unique structure and the differences to the mammalian extracellular matrix, 
makes the fungal cell wall an excellent target for antifungal drugs. The main constituents are 
glucan, chitin and mannoproteins (Figure 11) (Klis et al., 2006, Lesage & Bussey, 2006). 
The innermost layer consists of chitin, a linear polymer of β-1,4-N-acetyl glucosamine, 
which is synthesized and deposited by chitin synthases. Chitin represents only a minor part 
(1 – 3%) of the lateral cell wall and is more abundant at the bud neck and scars (Klis et al., 
2006, Lesage & Bussey, 2006). 
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The core structure of the cell wall consists of long branched β-1,3 glucans (1500 
glucose residues), which are covalently linked to β-1,6 glucan and chitin. It makes up to 45 % 
of the cell wall mass and serves as a three-dimensional scaffold for the outer layer of cell 
wall proteins (Klis et al., 2006, Lesage & Bussey, 2006). Glucan synthesis is accomplished 
by two highly homologous transmembrane proteins, ScFks1 and ScFks2, which catalyze the 
polymerisation of β-1,3 glucan from UDP-glucose. In S. cerevisiae, a third homologue 
ScFks3 appears to be connected to sporulation (Lesage et al., 2004). β-1,6 glucan is a 
second type of glucan molecule present in the fungal cell wall. It is shorter (150 glucose 
molecules) and only contributes to about 10% of the total cell wall mass. Covalently linked to 
β-1,3 glucan, chitin and the mannoproteins, β-1,6 glucan connects the cell wall constituents 
to each other (Klis et al., 2006). β-1,6 glucan is found in many different fungi with a variable 
degree of branching (Lesage et al., 2004). 
Both, covalently and non-covalently bound mannoproteins are embedded in the 
glucan network and form the outer mannan layer of the fungal cell wall, being responsible for 
the majority of the cell wall mass. Cell wall proteins (CWP) usually are heavily glycosylated 
proteins. Two types of glycosylation exist: protein N-glycosylation adds a complex 
oligosaccharide to the protein and O-glycosylated CWPs carry short chains of mannosyl 
residues (Dempski & Imperiali, 2002, Strahl-Bolsinger et al., 1999). 
 
 
 
Figure 11. Exemplary structure of the fungal cell wall. Shown are the major cell wall components: chitin, β-1,3 glucan 
and attached mannoproteins. The magnification shows the structural composition of single polymer components. Modified from 
(Netea et al., 2008). 
 
The largest group of CWPs consists of glycosyl-phosphatidylinostiol (GPI)-anchored 
proteins which are attached to β-1,6 glucan. GPI-anchored proteins contain serine/threonine-
rich domains, which are highly mannosylated. Flocculins (ScFlo), sexual agglutinins (ScAga), 
the ScTir protein family (ScTir, ScDan), and the ScGas family are examples for GPI-CWPs 
(Lesage & Bussey, 2006). GPI-CWPs stabilize the cell wall and mutants often show 
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hypersensitivity to cell wall-damaging agents (Klis et al., 2006). A second CWP family 
contains proteins that are released by treatment with mild alkali conditions. This group 
includes the Pir proteins, which have putative roles in forming a barrier and strengthening the 
cell wall, thereby influencing cell wall permeability (Mrsa et al., 1997). Several other cell wall 
proteins execute glycolytic activities. Among those are for example the glucanases ScBgl2 
and ScExg1, as well as the chitinase ScCts1 (Klis et al., 2006, Lesage & Bussey, 2006).  
The great number of different CWPs demonstrates that the structural composition of 
the outer cell wall layer can vary significantly among different fungal species. In addition, the 
cell wall composition depends on growth form, growth stage, cell cycle-dependent 
expression and environmental influences. The outer layer does not only act as barrier by 
regulating permeability but may also widely affect hydrophobicity, adhesion, antigenicity and 
pathogenicity of the fungal cell (Batova et al., 2009, de Groot et al., 2008, Kaur et al., 2007, 
Netea et al., 2008).  
The cell wall composition of C. glabrata differs considerably from the cell wall of S. 
cerevisiae or C. albicans, although the general constituents are the same (Table 3). The C. 
glabrata cell wall contains almost 50 percent more protein and consists of significantly more 
mannan than the cell wall of S. cerevisiae (de Groot et al., 2008). The amounts of alkali-
insoluble glucan as well as chitin levels are relatively low in C. glabrata, implying that fewer 
connections between glucan and chitin exist. The core glucan structure may be thinner 
whereas the mannan layer is thicker (de Groot et al., 2008). Masking glucans under a dense 
layer of mannan may be an advantage for C. glabrata to successfully escape host immune 
surveillance. Shielding proinflammatory pathogen-associated molecular patterns (PAMPs) 
from recognition by the host’s immune cells, is generally thought to be an escape mechanism 
of fungal pathogens (Netea et al., 2008). 
 
 
Table 3. Cell wall composition of C. glabrata, S. cerevisiae and C. albicans. The C. glabrata cell wall contains almost 50 
percent more protein and more mannan than S. cerevisiae; (de Groot et al., 2008). 
 
Recent studies addressed the distinct composition of the cell wall of fungal pathogens 
to identify possible components contributing to fungal pathogenicity. An in-silico analysis 
identified 106 putative GPI-anchored proteins of different functional groups, five CgPir family 
and five CgBgl2 family members in C. glabrata (Weig et al., 2004). A follow-up study 
revealed a total of 67 adhesin-like proteins in C. glabrata, most of which are located in 
subtelomeric regions. Mass spectrometry analysis identified several known CWPs and 
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defined Awp1-4 as a new family of adhesin-like wall proteins (de Groot et al., 2008). 
Remarkably, the presence of adhesins strongly depends on the genetic background and the 
growth phase. For example, the novel adhesins Awp1 and Awp4 are only expressed in 
stationary phase cells.  
Despite a suspected high number of GPI-linked proteins in C. glabrata, only a few 
have been studied in detail. For instance, the CgGAS gene family shares significant 
homologies with the S. cerevisiae GPI-CWP ScGas1 (Weig et al., 2001). Disruption of 
CgGAS1 or CgGAS2 results in cell aggregates, suggesting a cell wall-related function. 
The largest group of GPI-anchored adhesins in C. glabrata is encoded by the lectin-
like EPA (epithelial adhesin) gene family. EPA homologues are present in several fungal 
species and share a similar domain structure. The family consists of multiple adhesins of at 
least 23 related genes (Kaur et al., 2005, De Las Penas et al., 2003). In vitro adherence of 
up to 95 % is largely mediated by the major lectin Epa1. However, its influence on virulence 
is not fully understood because no difference exists in colonization and persistence between 
the isogenic wild-type and the epa1∆ strain (Cormack et al., 1999). Interestingly, the majority 
of EPA genes are expressed at low levels. This may be partly explained by their localization 
to subtelomeric regions, where expression is controlled by the silencing machinery (Castano 
et al., 2005). 
The transcriptional silencing machinery of C. glabrata involves CgRap1, CgSir2, 
CgSir3, CgSir4 and CgRif1. C. glabrata mutants lacking CgSIR3 or CgRIF1 show higher 
expression of EPA6 and EPA7, as well as EPA1. In addition, cells with mutations in genes 
encoding components of the silencing machinery are hyperadherent to epithelial cells in 
culture and biofilm-positive (Iraqui et al., 2005). These strains also show a more efficient 
colonization of the kidney when compared to the wild type strain in a murine model of 
disseminated candidiasis, implying that the silencing machinery is involved in regulation of 
virulence factors (Castano et al., 2005). The use of glycan microarrays further demonstrated 
that Epa1, Epa6 and Epa7 bind to a different range of carbohydrates and that the ability to 
adhere strongly depends on the host cell type (Zupancic et al., 2008). 
The regulation of EPA genes depends on specific environmental signals, showing 
that C. glabrata closely adapted its physiology to the human host. Limitation of nicotinic acid 
induces EPA expression probably mediated by the silencing machinery (Domergue et al., 
2005). Interestingly, nicotinic acid is a precursor for NAD+, which itself serves as a cofactor of 
the histone-modifier CgSir2. CgSir2 controls expression of Epa adhesins by transcriptional 
silencing. In consequence, the low nicotinic acid concentration in the urinary tract leads to 
decreased CgSir2 activity, resulting in induction of EPA6 expression. Consistently, a triple 
epa1∆ epa6∆ epa7∆ mutant shows reduced ability to colonize the bladder (Domergue et al., 
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2005). This is a remarkable example of how C. glabrata can adapt to a specific ecological 
host niche. 
In addition, EPA6 expression is induced after exposure to sorbic acid and parabens, 
which are used as preservatives in food and health products. The induction of EPA6 
transcription upon weak-acid stress is CgFlo8 and Mss11 dependent and leads to increased 
adherence to vaginal epithelial cells (Mundy & Cormack, 2009). 
Another gene family encoding C. glabrata GPI-anchored proteins appears 
upregulated after phagocytosis by macrophages (Kaur et al., 2007). C. glabrata has eleven 
yapsin-like genes, of which CgYPS1 and CgYPS7 are closely related to the baker’s yeast 
yapsins. CgYPS1 and CgYPS7 are implicated in cell wall integrity and survival in stationary 
phase cells (Kaur et al., 2007). Eight YPS genes are found in a C. glabrata specific cluster, 
which are transcriptionally induced after coincubation with macrophages. Interestingly, a 
strain disrupted for CgYPS1 and CgYPS7 or a strain lacking all eleven CgYPS genes shows 
reduced virulence in a mouse model of disseminated candidiasis. The strains are highly 
attenuated in kidney and liver when compared to the wild type. These data imply that CgYPS 
genes play a role in the infection process and survival of C. glabrata in the host (Kaur et al., 
2007).  
3.5 The host side 
To counteract a microbial infection, the host immune system has to mount a rapid 
response. The vertebrate immune system consists of two major components, the innate and 
the adaptive arm. The first defence line is composed of cells of the innate immune system. 
Neutrophils, monocytes, macrophages and dendritic cells are present at tissues, such as 
mucosal surfaces and epithelial cell barriers (Netea et al., 2008, Romani, 2004). The cells of 
the innate immunity are equipped with a limited number of surface receptors, so-called 
pattern recognition receptors (PRR), which enable recognition of conserved microbial 
structures, collectively termed pathogen-associated molecular patterns (PAMPs) (Kopp & 
Medzhitov, 2003). These PRRs (Figure 12) enable the host to rapidly recognize a broad 
range of pathogens and to start coordinating a protective immune response. The immediate 
innate response involves phagocytosis and secretion of microbial compounds, as well as 
cytokine production to instruct and modulate the adaptive immune response.  
Recognition of fungal pathogens by Toll-like receptors (TLRs), the mannose receptor, 
complement receptors, scavenger receptors or dectin-1, trigger the uptake of the microbial 
cell (Netea et al., 2008). Distinct microbial surface molecules serve as ligands for these 
receptors (Figure 12). For example, the macrophage mannose receptor binds to branched N-
bound mannans, whereas O-linked mannan is detected by TLR4 and galectin recognizes β-
mannosides (Netea et al., 2008). Further, β-glucans are ligands for the complement receptor 
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CR3, and dectin-1 specifically recognizes β-1,3 and β-1,6 glucans (Brown, 2006, Taylor et 
al., 2007). TLRs expressed by phagocytes and dendritic cells recognize different PAMPs, 
often involving a co-receptor (Gantner et al., 2003). Several receptors also show overlapping 
functions. For instance, both TLR2 and TLR4 have been implicated in recognition of C. 
albicans (Netea et al., 2002). Notably, immune cells are also able to discriminate between 
different fungal morphologies such as yeast and hyphae (d'Ostiani et al., 2000, Jouault et al., 
2006). 
 
Figure 12. Pattern recognition receptors of innate immune cells. A great variety of pattern recognition receptors of 
monocytes, macrophages and dendritic cells recognize different fungal cell wall components. Recognition is mediated by Toll-
like receptors and lectin receptors such as the mannose receptor (MR), dectin 1 and a putative chitin receptor. Signal 
transduction is carried out through MAPK and NF-κB pathways (Netea et al., 2008). 
 
TLR-dependent signaling activates innate as well as adaptive immunity to fungi, 
including the production of proinflammatory cytokines, IL-12 production by dendritic cells and 
induction of the respiratory burst (Romani, 2004). Other antifungal mechanisms involve 
degranulation and release of small molecules such as defensins (Romani, 2004). 
The respiratory burst is an effective mechanism to fight fungal pathogens. Upon 
interaction with a pathogen, phagocytic cells produce reactive oxygen species (ROS), 
involving NADPH oxidase and nitric oxide synthase as key enzymes. ROS include 
superoxide anions, which are converted to hydrogen peroxide and hydroxyl radicals (Babior, 
2000). These radicals can kill microbial pathogens (Missall et al., 2004). However, fungal 
pathogens developed certain molecular mechanisms to degrade host-derived ROS (Frohner 
et al., 2009).  
The study of the particular defence mechanisms and molecular components of the 
innate and the adaptive immune response, as well as fungal escape and survival 
mechanisms will allow to gain a deeper understanding of the interaction between fungal 
pathogens and their hosts. This may also help to understand the differences between and to 
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define commensalism and virulence. Exploiting genomic and proteomic studies in both, 
pathogens and host immune cells, may help to elucidate some of the fundamental 
processes. 
3.6 Genomic studies 
A multitude of different methods and techniques have been developed to study all 
aspects of the biology of the model yeast S. cerevisiae. Given the emerging number of fungal 
opportunistic pathogens, the specific differences between pathogenic and non-pathogenic 
fungi became an attractive topic. However, specific problems hampered studies of the 
underlying molecular mechanisms of fungal pathogenesis. For example, C. albicans is a 
diploid organism with a very flexible genome. Therefore, efficient strategies had to be 
developed to delete both alleles (Berman & Sudbery, 2002, Hibbett et al., 2007). In addition, 
the use of the auxotrophic URA3 marker is problematic for virulence studies in vivo (Brand et 
al., 2004, Reuss et al., 2004). 
Although being a haploid organism and closer related to baker’s yeast, existing tools 
and techniques from S. cerevisiae are of limited applicability for C. glabrata. However, a 
decent methodological repertoire to study virulence properties exists now for C. glabrata and 
for other fungal pathogens, including transformation protocols, auxotrophic strains and 
corresponding marker cassettes, plasmids for complementation, reporter plasmids, a 
conditional deletion system and a strain library of insertional mutants (Castano et al., 2003, 
El Barkani et al., 2000, Frieman et al., 2002, Kitada et al., 1995, Kitada et al., 1997, 
Nakayama et al., 1998, Willins et al., 2002). 
The genomic era allows new approaches for gene profiling. After the full sequencing 
of the S. cerevisiae genome, first attempts were undertaken to precisely delete every single 
gene, generating complete deletion strain collections (Giaever et al., 2002, Winzeler et al., 
1999). These libraries are used to perform functional profiling. The use of signature-tagged 
(bar-coded) deletion strains, enables the analysis of growth phenotypes and fitness of a large 
number of strains in parallel. In principle, two possibilities exist for quantification of the 
upstream and downstream barcode tags, which are introduced during the gene deletion 
process: quantitative PCR or hybridization of the amplified barcode oligonucleotides to a 
microarray. Both techniques allow the quantification of the relative abundance of each strain 
in the input and recovered output pool. This technique makes it possible to assess individual 
contribution of single genes to the fitness or virulence of an organism. 
In recent years, this technology has also been applied for selected fungal pathogens 
to study their fungal virulence at a genome-wide scale. A strategy for a systematic large-
scale gene disruption has been developed to study C. albicans virulence (Noble & Johnson, 
2005). Recently, a systematic genome-wide study of the pathogenicity in C. neoformans 
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identified many virulence-related genes implicated in capsule formation, melanization, growth 
and infectivity (Liu et al., 2008). In this study pools of barcoded deletion strains were used to 
screen a suitable mouse model for pulmonary infection. The relative abundance of each 
strain was measured after recovery from tissue, using quantitative PCR. This screen of 
signature-tagged deletion strains identified a number of putative virulence factors, affecting 
known as well as novel virulence attributes and even the characterization of a transcription 
factor involved in a previously unknown virulence mechanism. 
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3.7 Aims of the thesis 
C. glabrata represents the second most frequent cause of Candidiasis. However, the 
specific attributes that turn C. glabrata into a successful fungal pathogen remain elusive. Its 
inherent resistance to azoles is a major characteristic of this monomorphic human fungal 
pathogen. In contrast to the dimorphic yeast C. albicans, which can form true hyphae and 
possesses virulence-associated secreted proteases and phospholipases, C. glabrata lacks 
most of these putative virulence factors. Interestingly, both opportunistic yeasts are usually 
found as harmless commensals of immunocompetent hosts, colonizing mucosal surfaces, 
the skin and the gastro-intestinal tract. Nevertheless, C. glabrata displays additional 
characteristic virulence traits such as a large repertoire of adhesins, which are regulated by 
transcriptional silencing, the hypervirulence factor CgAce2, and a very dynamic genome, 
which might influence its virulence and adaptation capabilities. 
Understanding the molecular basis, contributing to the pathogenicity and the mutual 
interaction of C. glabrata with the host immune system, may help to better understand its 
specific virulence. So far, the lack of a full sexual cycle and the low recombination efficiency 
still hamper efficient genome-wide studies on the specific pathogenicity of C. glabrata. 
However, the availability of the complete genome sequence enables these genome-wide 
studies. 
The aim of this thesis was to identify new putative virulence factors of C. glabrata, 
using a large-scale reverse-genetics approach. This included: 
• the selection of categorized candidate genes based on the homology to S. 
cerevisiae genes, using bioinformatics and literature research, 
• establishing a protocol for more efficient gene deletion by homologous 
recombination (fusion PCR approach) to generate a genome-wide signature-tagged 
C. glabrata deletion strain library, 
• phenotypic profiling of the generated gene deletion strain library in vitro and ex vivo, 
• characterization of single gene deletion mutants. 
Approximately 1000 candidate genes have been chosen for gene deletion. The 
deletion mutants are arranged in sets, each containing some 90 mutants. Every mutant of 
one set is marked by a unique pair of upstream and downstream barcode sequences, which 
allow for accurate identification. The generated strain collection was subsequently screened 
for growth phenotypes on a variety of compounds and media to identify putatively novel 
virulence and drug resistance-related genes. The deletion strains were also studied for cell 
and colony morphology phenotypes. Single mutants displaying differences to known S. 
cerevisiae phenotypes were further characterized by microbiological, genetic and 
biochemical methods for their phenotypes and putative implication in virulence-related 
functions. 
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4 Materials and Methods 
4.1 Materials 
4.1.1 Yeast media 
Rich media (YPD) and synthetic media (SC) were prepared essentially as described 
elsewhere (Kaiser et al., 1994). All media were autoclaved at 121°C. Heat sensitive 
substances were sterile filtered and added to the media (~50°C) afterwards. For all plates, 
250 ml of 4 % agar were added to 250 ml of medium. 
Rich medium: 
50 ml of 20 % sterile glucose was added to 450 ml 1 x YPD to prepare liquid medium with a 
final concentration of 2 % glucose. YPD plates contained glucose at a final concentration of 
2%. 
1 x YPD   2 x YPD 
Yeast extract     10 g/l     20 g/l 
Peptone     20 g/l     20 g/l 
Glucose (w/v)        2 %        4 % 
NAT-plates: Nourseothricin (100 mg/ml, H2O) was added to a final concentration of 
200µg/ml. 
 
Minimal medium: 
Minimal medium was prepared with 2 x YNB without amino acids and glucose added to a 
final concentration of 2 %. MM plates contain glucose at a final concentration of 2 %. 
     1 x MM 
Bacto-YNB w/o aa    6.7 g/l  
Glucose (w/v)       2 % 
 
Drop-out media: 
SC medium (500 ml) was prepared with 2 x SC medium and 250 ml sterile H2O and glucose 
were added to a final concentration of 2 %. 5 ml of the required amino acids from 100 x 
stocks were added. SC plates contained glucose at a final concentration of 2 %. 
   2 x SC  
Bacto-YNB w/o aa and (NH4)2SO4      3.4 g/l  
Ammonium sulfate      10.0 g/l  
Amino acid mix      2.86 g/l 
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Sterile stock solutions: 
Glucose: 20 % 
Agar: 4 % 
100 x URA:   4 g/l L-Uracil in H2O  
100 x HIS:    6 g/l L-Histidine in H2O  
100 x LEU: 26 g/l L -Leucine in H2O  
100 x TRP:   8 g/l L-Tryptophane in H2O (filter-sterilized, 4°C) 
Amino acid mix (per 29 g): 
0.4 g L-arginine   0.6 g L-tyrosine  
0.6 g L-isoleucin   8.0 g L-serine 
1.0 g L-phenylalanine  2.0 g L-glutamic acid  
2.0 g L-aspartic acid   3.0 g L-valine  
3.0 g L-methionine   3.6 g L-lysine  
4.0 g L-threonine   0.8 g adenine 
4.1.2 E. coli media 
For LB plates, agar was added to a final concentration of 2 % to 2 x LB. For LB-amp plates, 
ampicillin (100 mg/ml stock, H2O) was added to a final concentration of 100 µg/ml; for LB-kan 
plates, kanamycin (50 mg/ml stock, H2O) i was added to a final concentration of 50 µg/ml; for 
LB-cam plates, Chloramphenicol (10 mg/ml stock, EtOH) was added to a final concentration 
of 40 µg/ml. 
1 x LB    2 x LB   SOB 
Tryptone   10 g/l     20 g/l    20 g/l 
Yeast extract     5 g/l     10 g/l      5 g/l 
NaCl    10 g/l    20 g/l     10 mM 
 KCl     -      -   2.5 mM 
 MgCl2     -      -    20 mM 
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4.1.3 Buffer and solutions 
Buffer/ solution Concentration Chemical 
Anode buffer I 0.3 M 
20 % (v/v) 
Tris Base 
Methanol 
Anode buffer II 
25 mM 
20 % (v/v) 
Tris Base 
Methanol 
Blocking buffer 1 x 
5 % 
0.1 % 
TBS 
milk powder 
Tween 20 
Cathode buffer 
25 mM 
40 mM 
Tris Base 
6-Amino-n-Hexanoic acid 
Coomassie staining solution (2 l) 200 ml 
500 ml 
0.67 g 
1300 ml 
Glacial acetic acid 
Isopropanol 
Coomassie Blue G250 
 
Destaining solution (1 l) 
250 ml 
70 ml 
680 ml 
Methanol 
Glacial acetic acid 
H2O 
DNA loading buffer (10 x) 100 mM 
60 % (v/v) 
0.25 % (w/v) 
0.25 % (w/v) 
EDTA pH 8.0 
Glycerol 
Bromphenolblau 
Xylen Cyanol 
Denhardts reagent 
 1% (w/v) 
1% (w/v) 
1% (w/v) 
Ficoll 400 
Polyvinylpyrrolidone 
BSA 
in sterile H2O, sterile filter 
DNA extraction buffer 
 
2% (v/v) 
1% (v/v) 
100mM 
1mM 
Triton X-100 
SDS 
Tris/HCl pH 8.0 
EDTA 
DTT 
1 M dissolved in 0.01M NaOAc pH 5.2 
Hybridisation buffer (microarray) 
 4 x 
0.1 % 
SSC 
SDS 
Prehybridisation buffer (microarray) 
 4 x 
0.1 % 
10 mg/ml 
SSC 
SDS 
BSA 
PCR buffer (10 x) 500 mM 
100 mM 
1 % 
15 mM 
KCl 
Tris-HCl pH 9.0 
Triton X-100 
MgCl2 
PBS pH 7,4 
87.7 g 
2.6 g 
22.5 g 
NaCl 
NaH2PO4 
Na2HPO4 
Prehybridisation solution (Southern Blot) 
2 ml 
1 ml 
1 ml 
5.5 ml 
40 µl 
50x Denhardts reagent 
20x SSC 
10% SDS 
H2O 
ssDNA 
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Protein sample buffer 40 mM 
8 M 
5 %  (w/v) 
0.1 mM 
1 %  (v/v) 
0.1 g/l 
0.1 M 
Tris-HCl pH 6.8 
Urea 
SDS 
EDTA 
ß-Mercaptoethanol 
Bromphenolblue (freshly added) 
Tris base (freshly added) 
RNase A-Lösung (100 x) 
10mg/ml RNase A in 1Vol. 10mM NaAc pH 5.2, 15min 100°C, + 0.1 Vol 1M Tris pH 7.5 
Running buffer (SDS PAGE, 1l) 1.5 g 
7.2 g 
4.0 g 
Tris 
Glycine 
SDS 
Running gel (SDS PAGE, 10 %, 2 gels) 4.2 ml 
2.5 ml 
3.3 ml 
10 µl 
100 µl 
100 µl 
H2O 
1.5 M Tris pH 8.8 
Acrylamide (30%) 
TEMED 0.1 g/l 
APS (10%) 
SDS (10%) 
SSC (20 x, 1l) 
175.3g 
88.2g 
NaCl 
Sodium citrate 
(adjust pH to 7.0 (with 37% HCl), autoclave) 
Stacking gel (SDS PAGE, 4,5 %, 4 gels) 3 ml 
1.25 ml 
0.75 ml 
25 µl 
10 µl 
100 µl 
H2O 
0.5 M Tris pH 6.8 
Acrylamide (30%) 
SDS (10%) 
TEMED 
APS (10%) 
STET- buffer 8 % 
50mM 
50mM 
5 % 
Saccharose 
Tris/HCl pH 8.8 
EDTA pH 8.0 
Triton X-100 
Stripping buffer (Western Blot) 62.5 mM 
100 mM 
2 % 
Tris-HCl pH 6.7 
ß-Mercaptoethanol 
SDS 
TE 
100 mM 
10mM 
Tris-HCl pH 7.5 
EDTA pH 8.0 
TB 
10 mM 
55 mM 
15 mM 
250 mM 
PIPES 
MnCl2 
CaCl2 
KCl       (dissolved in H2O, pH adjusted to pH 6.7 
with KOH, MnCl2 added & filter sterilised, stored 
at 4°C) 
TBE (10 x) 108 g/l 
55 g/l 
40 ml 
Tris base 
Boric acid 
0.5 M EDTA pH 8.0 
TBS (10 x) 1.44 M 
0.5 % 
250 mM 
NaCl 
Tween 20 
Tris-HCl pH 7.5 
TBS-T 
1 x 
0.1 % 
TBS 
Tween 20 
Yex-lysis buffer 1.85 M 
7.5 % 
50% (w/v) 
NaOH 
ß-Mercaptoethanol (v/v) (freshly added) 
TCA 
 
Table 4. Buffer compositions and solutions used in this study. Buffers were autoclaved or sterile filtered, when 
necessary. 
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4.1.4 Chemicals and computing software 
Manufacturer Location Chemicals 
Becton Dickinson USA Bacto Peptone, Yeast extract, Yeast Nitrogen Base, Tissue Culture plates, Casamino acids 
Dako GmbH Austria Fluorescent mounting medium 
Discovery Fine 
Chemicals United Kingdom Fluconazole, Ketoconazole, Itraconazole, Voriconazole, Amphotericin B 
Eurogentec Belgium Oligonucleotides, Mesa green qPCR MasterMix plus dTTP 
Fermentas Austria Restriction enzymes, PageRuler PLUS protein ladder, RiboLock RNase inhibitor, dNTPs, M-MuLV Rev. Transcriptase, DNaseI 
GE Healthcare Europe Austria Hybond-N+ Membrane, Cy5 dCTP (25nmol), Cy3 dCTP (25nmol), DNA probe Labeling Kit, Klenow polymerase 
Greiner Bio-One Austria 96 well cell culture plates 
Hanke Lab Products Austria α32P dCTP 
Harvard Apparatus USA 96 well electroporation plates 
Invitrogen (Molecular 
Probes) USA FCS, HBSS, Superscript III Reverse Transcriptase, β-mercatpoethanol 
Lonza (Cambrex) Belgium TaKaRa ExTaq, Mighty Ligation Mix, Agarose 
Merck Austria Glucose, CuSO4, MgCl2, ZnCl2, KCl, Tris, Sodium Citrate, NaOH 
NEB Germany Phospho-p44/42 MAPK (T202/Y204) Antibody 
PAA Laboratories Austria DMEM w L-glutamine 
Promega Austria pGEM cloning kit, RNA extraction kit 
Santa Cruz Biotech. Germany BSA 
Seikagaku Japan Zymolyase 100T, 20T 
Sigma, Fluka USA 
Calcofluor White, Congo Red, 5’-Flucytosine, DMSO, Triton X-100, Tween 20, 
Anitbiotics, SDS, Lithiumacetate, PEG 3500, TEMED, APS, EDTA, , NaCl, 
Luminol,Isoluminol, Zymosan, Amino acids, PCI, IPTG, Ampicillin, Kanamycin, 
DTT, D-Sorbitol, Ammonium sulfate, MnCl2, LiCl, Phenol, glass beads, 
Ficoll400, Polyvinylpyrolidone,  
Singer Instruments UK PlusPlates, RePads (short and long pins) 
THP Medical Products Austria CL-XPosure Film 5x7 inches 
VWR Austria Electroporation cuvettes, Petri dishes, Falcon tubes, Ammonium sulfate, 96 deep well plates 
Werner Bioagents Germany Nourseothricin 
 
Software Manufacturer Location Resource 
Gene Pix Pro4.1 Molecular Devices USA CD, license 
Photoshop CS3, Illustrator CS3 Adobe USA ZID, license 
ApE v1.12 Davis M. W. USA www.biology.utah.edu/jorgensen/wayned/ape/ 
Realplex 2.0 Eppendorf Austria CD, license 
Filemaker 9.0 FileMaker USA ZID, license 
GraphPad Prism 4 GraphPad USA ZID, license 
Vector NTI 10 Invitrogen USA license 
Perlprimer v1.1.14 Marshall O. USA perlprimer.sourceforge.net 
Soft Imaging Viewer 5.0 Olympus Germany www.olympus-sis.com 
FlowJo 7 TreeStar USA CD, license 
 
Table 5. Chemicals and software used in this study. 
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4.1.5 Organisms 
4.1.5.1 Bacterial strains 
Strain Genotype Reference 
DH5α F
-, λ-, endA1, hsdR17(rk-, mk+), supE44, thi-1, recA, gyrA96, 
relA1, Φ80lacZΔM15 (Hanahan, 1983) 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG Invitrogen 
 
Table 6. Bacterial strains used in this study. 
 
4.1.5.2 S. cerevisiae strains 
Strain Genotype Reference 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 (Brachmann et al., 1998) 
slt2∆ BY4741 Mat a his3∆1 leu2∆0 met15∆0 ura3∆0 YHR030c::kanMX4 
(Brachmann et al., 
1998) 
 
Table 7. S. cerevisiae strains used in this study. 
 
4.1.5.3 C. glabrata strains 
Strain Genotype Reference 
ATCC2001 C. glabrata wild type strain www.attc.org 
HTL his3∆::FRT leu2∆::FRT trp1∆::FRT Jungwirth H., Lechner S. 
H Isogenic to ATCC2001; his3∆::FRT Jungwirth H., Lechner S. 
T Isogenic to ATCC2001; trp1∆::FRT Jungwirth H., Lechner S. 
L Isogenic to ATCC2001; leu2∆::FRT Jungwirth H., Lechner S. 
HT Isogenic to ATCC2001; his3∆::FRT trp1∆::FRT Jungwirth H., Lechner S. 
TL Isogenic to ATCC2001; trp1∆::FRT  leu2∆::FRT Jungwirth H., Lechner S. 
HL Isogenic to ATCC2001; his3∆::FRT leu2∆::FRT Jungwirth H., Lechner S. 
HTL reference his3∆::FRT leu2∆::FRT trp1∆::NAT1 (barcode) this study 
All deletion strains All strains isogenic to HTL; gene∆::NAT1 this study 
Cgfks1∆ Isogenic to HTL; fks1∆::HIS3 this study 
Cgace2∆ Isogenic to HTL; ace2∆::HYGr this study 
 
Table 8. C. glabrata strains used in this study. For better reading, the addition of “Cg” has been skipped in the results and 
discussion chapters. Only where necessary to underline the difference between genes/proteins of C. glabrata and other 
organisms “Cg” is added. Genes and proteins of S. cerevisiae are marked with “Sc”, of C. albicans with “Ca”. 
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4.1.5.4 Cell lines and primary cells 
Cell line Genotype Reference 
BMDM WT C57BL/6 mice (George-Chandy et al., 2008) 
gp91phox-/- C57BL/6 mice 
(Frohner et al., 2009) 
(Lundqvist & Dahlgren, 
1996) 
 
Table 9. Mammalian primary cells used in this study. 
 
4.1.6 Plasmids 
Name Marker Description Insert Reference 
pGEM-T ampR ampR, cloning of PCR products - Promega 
pACT CgTRP1 ampR, CEN, ARS - (Gregori et al., 2007) 
pBM51 ScHIS3 CEN, ARS - from Biao Ma 
pJK863 NAT1 ampR, NAT1, recombinase NAT1 (Shen et al., 2005) 
pTS50 ampR Carries NAT1 with U2 & D2 adaptor seq. U2-NAT1-D2 this study 
pSFS2a ampR ampR, SAT1 marker, recombinase SAT1-caFLP 
(Reuss et al., 
2004) 
pGRB2.0 ampR, ScURA3 CEN, ARS - (Frieman et al., 2002) 
pGRB2.3 ampR, ScURA3 CEN, ARS, GFP - (Frieman et al., 2002) 
pGRB2.0HIS ampR, ScHIS3 CEN, ARS - this study 
pGRB2.3HIS ampR, ScHIS3 CEN, ARS, GFP - this study 
pGRB2.0HIS-
SLT2 ampR, ScHIS3 CEN, ARS, CgSLT2 (own promotor) CgSLT2 this study 
pBM51-CBK1 ampR, ScHIS3 CEN, ARS, CgCBK1 (ScPGK1 promotor) CgCBK1 this study 
pBM51-DSE2 ampR, ScHIS3 CEN, ARS, CgDSE2 (ScPGK1 promotor) CgDSE2 this study 
pACT-DSE2 ampR, ScTRP1 CEN, ARS, CgDSE2 (own promotor) CgDSE2 this study 
pBM51-ACE2 ampR, ScHIS3 CEN, ARS, CgACE2 (ScPGK1 promotor) CgACE2 this study 
 
Table 10. Plasmids used and generated in this study.
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4.1.7 Oligonucleotides 
Name Sequence Description 
fp_NAT1-U2 5’-CGTACGCTGCAGGTCGACagcttgcctcgtccccgccg-3’ 
forward primer to add U2 
marker; ready to add 
barcode  
rp_NAT1-D2 5’-CTACGAGACCGACACCGctggatggcggcgttagtatcg-3’ 
reverse primer to add U2 
marker; ready to add 
barcode 
Heukan2 5’-CGTCAAGACTGTCAAGGAGGG-3’ Internal 5’ reverse control primer 
Heukan3 5’-CATCATCTGCCCAGATGCGAAG-3’ Internal 3’ forward control primer 
5M-marker 5’-ccgctgctaggcgcgccgtgBARCODE-UPcgtacgctgcaggtcgac-3’ Forward primers to add unique barcode sequences 
3M-marker 5’-gcagggatgcggccgctgacBARCODE-DOWNctacgagaccgacaccg-3’ Reverse primers to add unique barcode sequences 
f_ctrl_pGRB 5’-aggctgcgcaactgttgg-3’ Control primer for pGRB plasmids 
r_ctrl_pGRB 5’-gcggataacaatttcacacagg-3’ Control primer for pGRB plasmids 
pGRBctrl 5’-CACACAGGAAACAGCTATGACC-3’ Control primer for pGRB plasmids 
pGRB2.3ctrl 5’-CGTAGTTTTTCAAGTTCTTAGATGC-3’ Control primer for pGRB plasmids 
fCBK1_BamH 5’-agtGGATCCatgtttggtggcgagtatgatcac-3’ Clone CgCBK1 into pBM51 
rCBK1_EcoRI 5’-atcGAATTCttataatgcattctttctcgtcaagtag-3’ Clone CgCBK1 into pBM51 
fCBK1_EP_EcoRI 5’-tcaGAATTCgcattggcggctatgactgtg-3’ Clone CgCBK1 into pGRB2.0HIS3 
rCBK1_EP_EcoRI 5’-tgaGAATTCacacacatgcataggcacacag-3’ Clone CgCBK1 into pGRB2.0 HIS3 
fDSE2_Xba 5’-agtcTCTAGAatgcaattccgtgccgctacac-3’ Clone CgDSE2 into pBM51 
rDSE2_Xho 5’-gactCTCGAGttaattagcagaaacagttttgtataccg-3’ Clone CgDSE2 into pBM51 
fDSE2_EcoRI 5’-agtcGAATTCaacccctatgaaatcaggggc-3’ Clone CgDSE2 into pGRB2.0 HIS3 
rDSE2_EcoRI 5’-gactGAATTCggacagtgaatagaatgctggc-3’ Clone CgDSE2 into pGRB2.0 HIS3 
fACE2_EcoRI 5’-agtcGAATTCatgaatactttccaggcggattgg-3’ Clone CgACE2 into pBM51 
rACE2_SalI 5’-agtcGTCGACtatactactcctcaatcgtccc-3’ Clone CgACE2 into pBM51 
fp-CBK1 5’-TGATATACCTCAGTTACACCCTTCC-3’ qRT-PCR 
rp-CBK1 5’-GTTGTTCATGTTACTTGTGCTCGG-3’ qRT-PCR 
fp-ACE2 5’-GACAGGAGAGCATCAACATCGT-3’ qRT-PCR 
rp-ACE2 5’-GACAGGAGAGCATCAACATCGT-3’ qRT-PCR 
fp-DSE2 5’-ATCTGCTTCCTCTAGTAGTGTTTCC-3’ qRT-PCR 
rp-DSE2 5’-TACACTTGAGCTATCGTTGTCTAGG-3’ qRT-PCR 
fp-CTS1 5’-AATGTCCATACCCAGATGCCTC-3’ qRT-PCR 
rp-CTS1 5’-GAAATTCTTCCAGTCGTCCCAG-3’ qRT-PCR 
fp-PGK1 5’-TCATTGCTGACGCTTTCTCC-3’ qRT-PCR 
rp-PGK1 5’-CGAACAACTTTCTGGACTCTGG-3’ qRT-PCR 
fp_cgFLO9 5’-GTGAGTAAGACTATTTCCAGCGG-3’ qRT-PCR 
rp_cgFLO9 5’-GGTCCCACCATCACTTACAG-3’ qRT-PCR 
fp_cgSED1 5’-ACTACCACTGTCTCTTCTACTACC-3’ qRT-PCR 
rp_cgSED1 5’-GTAAGCAGTAACAACTTCGATCTC-3’ qRT-PCR 
fp_cgMUC1 5’-GCTAACAAATCCGTCATCTACTG-3’ qRT-PCR 
rp_cgMUC1 5’-ATTGTCAGGTCCCGTAATATAGG-3’ qRT-PCR 
4 Materials and Methods   
 40 
fp_cgKSS1 5’-CATCCTTTCTTAGCAACATACCAC-3’ qRT-PCR 
rp_cgKSS1 5’-CTGTCGTCTGTCCCATATCC-3’ qRT-PCR 
fp-cgSCW4  5’-ATGCTCATGCTTACTTTGACCA-3’ qRT-PCR 
rp-cgSCW4  5’-CTTTCTTACCGTCACAAGCAGTC-3’ qRT-PCR 
fp-EPA1 5’-GCGTAATCAAGGAAACCAAAGAC-3’ qRT-PCR 
rp-EPA1 5’-GTTCCACCTAAAGACTCATAACTG-3’ qRT-PCR 
fp-EPA7 5’-AGATCCGAACCCTGTAATAGAC-3’ qRT-PCR 
rp-EPA7 5’-TCAACACCGATGATTGTAGATGAG-3’ qRT-PCR 
fp-EXG1 5’-CCGCTTTAACCGATTGTACCA-3’ qRT-PCR 
rp-EXG1 5’-TGAACCTATGTAAGAAGAGCCC-3’ qRT-PCR 
   
 
Table 11. Single primers used in this study. Primers used for generation of deletion cassettes are deposited in the C. 
glabrata gene deletion collection. Oligonucleotides fp_NAT1-U2 and fp_NAT1-D2 were used to amplify the dominant marker 
NAT1 and addition of the constant regions U2 and D2 (italic, bold). Oligonucleotides Heukan2 and Heukan3 were used as 
control primers for colony PCR binding inside the NAT1 marker. Oligonucleotides 5M-marker and 3M-marker were used to 
amplify the NAT1 marker from plasmid pTS50 adding the unique individual barcode sequences and the constant regions U1 
and D1 (bold) which are used for fragment fusion as well as amplification of barcodes. BARCODE-UP/BARCODE-DOWN are 
placeholders for the unique barcode sequences listed in Table 12.  
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4.1.8 Barcode sequences used for signature tags 
well UPTAG Sequence Uptag 5’-3’ DOWNTAG Sequence Downtag 5’-3’ 
A1 BC_UP_A1 5’-CGCCTAAGACCGGATAAAGC-3’ BC_DN_A1 5’-GGGCTCGAGATTTAAACGGC-3’ 
A2 BC_UP_A2 5’-CGATTCGATAAATGACGCGA-3’ BC_DN_A2 5’-CGGCCTAAGTTTCGGTTCGT-3’ 
A3 BC_UP_A3 5’-GCTACAAACATAAGTGCGGC-3’ BC_DN_A3 5’-CCGAGTTCTACTAGGTGTTA-3’ 
A4 BC_UP_A4 5’-ATCGAACGTGTGTCAAACGC-3’ BC_DN_A4 5’-ATAGCCGACTAACGAGCGTC-3’ 
A5 BC_UP_A5 5’-AAGATAGTCGCCGAACTCGC-3’ BC_DN_A5 5’-AATCGACGCTAACGACTGAG-3’ 
A6 BC_UP_A6 5’-ATCGAGCACGTAACCGTTGC-3’ BC_DN_A6 5’-ATATGATACTCACGACCCGG-3’ 
A7 BC_UP_A7 5’-AATGTCGCGTAATGGCTTAG-3’ BC_DN_A7 5’-ACCTTATGTGTAATGAGCGG-3’ 
A8 BC_UP_A8 5’-AGGCAGATACGATTAGTACG-3’ BC_DN_A8 5’-AAGTCTATATCAGTAGCGGG-3’ 
A9 BC_UP_A9 5’-AAGCATCGTTAAGGCTGCCG-3’ BC_DN_A9 5’-ATTGGTCAGCGAGCCCTACT-3’ 
A10 BC_UP_A10 5’-ATAGATGACTACCGCGTCCG-3’ BC_DN_A10 5’-ACTTGAGGCGTAGACCTGCT-3’ 
A11 BC_UP_A11 5’-AATCGACTGTAAGTATCGCG-3’ BC_DN_A11 5’-AACGTGGGATCACTCGTGCT-3’ 
A12 BC_UP_A12 5’-ATAGCCTTCTAAGAGCGGCG-3’ BC_DN_A12 5’-AATCGGCGCTCACGCTTAGT-3’ 
B1 BC_UP_B1 5’-ATCGGCCTGTAATCGGATCG-3’ BC_DN_B1 5’-ACGATTGCGCGATTCGAGTT-3’ 
B2 BC_UP_B2 5’-AATTAGCACTGACGGCCTCG-3’ BC_DN_B2 5’-ATGCGACCTTGTGGCAATTT-3’ 
B3 BC_UP_B3 5’-ATAGTTCCCGCAGCTCGTTG-3’ BC_DN_B3 5’-CGCCGTGTGAAACATACTAA-3’ 
B4 BC_UP_B4 5’-ACAGCTATTAGGACGTGTTG-3’ BC_DN_B4 5’-ATGACGGATGTATGACGACT-3’ 
B5 BC_UP_B5 5’-AGTAGTACAGCCCGCGTCAT-3’ BC_DN_B5 5’-CCCATTAGTCGCAAGAGTTA-3’ 
B6 BC_UP_B6 5’-ATGCCCGAGTTGTCGCCATT-3’ BC_DN_B6 5’-CGCGTTATGCAATACGGTTA-3’ 
B7 BC_UP_B7 5’-CCGCGTCGTAAATGATTAGA-3’ BC_DN_B7 5’-ATACACCGGCATAATCTGTC-3’ 
B8 BC_UP_B8 5’-CGCCCGAACGGAAGATATGA-3’ BC_DN_B8 5’-ATGTACCGAGCATTGCACGG-3’ 
B9 BC_UP_B9 5’-CCATATTTGCGAAGGTCGGC-3’ BC_DN_B9 5’-CGCATTCAGTACATTTACCG-3’ 
B10 BC_UP_B10 5’-CGGATATGTACTAATTGGGC-3’ BC_DN_B10 5’-CCGCGTCTAGTATAGTATGT-3’ 
B11 BC_UP_B11 5’-CGGCCTAACTGTAATTGATC-3’ BC_DN_B11 5’-CTCGACGCTGGACGTTATGT-3’ 
B12 BC_UP_B12 5’-CCCTGTTATGAACCTTGATC-3’ BC_DN_B12 5’-CGCTTCGAGTATGGGATATT-3’ 
C1 BC_UP_C1 5’-CGCGCAGAGGTTAGATAAAT-3’ BC_DN_C1 5’-CTGTACGTGCGATACTCGTT-3’ 
C2 BC_UP_C2 5’-CGACCCTGATGATCCTTTAT-3’ BC_DN_C2 5’-GCCTATACCCAACTAATGGA-3’ 
C3 BC_UP_C3 5’-CGGACGGTATTCATTCATCT-3’ BC_DN_C3 5’-GCCGAACCTTCAACAGAGTA-3’ 
C4 BC_UP_C4 5’-GTGAGCGAAACACCGCGTAA-3’ BC_DN_C4 5’-GCGTGTGAATAATACGGAAC-3’ 
C5 BC_UP_C5 5’-GTGCGAACCAACGTACTACA-3’ BC_DN_C5 5’-GGTCGATAATAACACGCCAC-3’ 
C6 BC_UP_C6 5’-GGGTACTCCACAACATTACA-3’ BC_DN_C6 5’-GAAGTACGCTCAAGACCGAC-3’ 
C7 BC_UP_C7 5’-GCTAATCGCTAATTCGTTCC-3’ BC_DN_C7 5’-GCGACCCTATAATTCTTGAC-3’ 
C8 BC_UP_C8 5’-GCATTAACGGGAACTAGAGC-3’ BC_DN_C8 5’-GTTAGGTCCATCCGCCATTG-3’ 
C9 BC_UP_C9 5’-GCCATTCGTATAACCGTGTC-3’ BC_DN_C9 5’-GCGAGACCGCTTTACCAGAT-3’ 
C10 BC_UP_C10 5’-GATTATACGCTATCCGAGGT-3’ BC_DN_C10 5’-GACTCCGTACTCACTAGGAT-3’ 
C11 BC_UP_C11 5’-GTATTCCGACTGCGGCACTT-3’ BC_DN_C11 5’-TCGGTTAGAACAGTAGAGAC-3’ 
C12 BC_UP_C12 5’-TAATACCCGATCACTGGTGG-3’ BC_DN_C12 5’-TACACTCGACGACACGGTAG-3’ 
D1 BC_UP_D1 5’-AAATTGGTCGTAATGCGTCG-3’ BC_DN_D1 5’-TATGTCGGACGCCGTAGACT-3’ 
D2 BC_UP_D2 5’-ATTACGAGGTACGCGCTTCG-3’ BC_DN_D2 5’-TTTGCGTACTGAGGACCGCT-3’ 
D3 BC_UP_D3 5’-ATTACCTAGTCGGAGACAGG-3’ BC_DN_D3 5’-TATCAGTTCCGCAGACGGGT-3’ 
D4 BC_UP_D4 5’-ATTAGCGTCTCGACTACCTT-3’ BC_DN_D4 5’-ACGGACCTTGTACGCGATCT-3’ 
D5 BC_UP_D5 5’-ACCGACGGCTTAGCGATCTT-3’ BC_DN_D5 5’-ACCCGAGCGTTGATAATTCT-3’ 
D6 BC_UP_D6 5’-ACTAGATACACATGCGTGCC-3’ BC_DN_D6 5’-ATTATCCTTAGGCGCGGCGT-3’ 
D7 BC_UP_D7 5’-CCGACCGTATAAGTTCTATC-3’ BC_DN_D7 5’-AATTCGTATGCACCGGGCGT-3’ 
D8 BC_UP_D8 5’-CCGTTATACGAATATCGACC-3’ BC_DN_D8 5’-CCCGGTACTACAATACGAGA-3’ 
D9 BC_UP_D9 5’-CAGAGTAAGTAACGGTTCGC-3’ BC_DN_D9 5’-ATCGCGCAGGTCGGACATAT-3’ 
D10 BC_UP_D10 5’-CCGGCTAGTTAATTTGACTC-3’ BC_DN_D10 5’-GGCTCCACTAAATAGACGCA-3’ 
D11 BC_UP_D11 5’-GGCTAACCGAAACCGTGACA-3’ BC_DN_D11 5’-TCATAGCCAACACAGGGCGA-3’ 
D12 BC_UP_D12 5’-GGTGTACCTCCAACTTACTA-3’ BC_DN_D12 5’-GCTCCTAGAGTATGAGAGAT-3’ 
E1 BC_UP_E1 5’-TAGTGACTTAGACCCTCCGT-3’ BC_DN_E1 5’-ATTGCGACCTCGTCATGGCT-3’ 
E2 BC_UP_E2 5’-TATAGTTCGGGCCATACGGT-3’ BC_DN_E2 5’-GGTATTCCATAATCGCTCTC-3’ 
E3 BC_UP_E3 5’-TAAGGCGTCGTCACTACGGT-3’ BC_DN_E3 5’-TCTATTAGTGGACAGTACGG-3’ 
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E4 BC_UP_E4 5’-TTACTTGCCCGAGCCGGATT-3’ BC_DN_E4 5’-CACCCGAGTTACGATCAAAT-3’ 
E5 BC_UP_E5 5’-TATTAGTGCGGACCCGGCTT-3’ BC_DN_E5 5’-CGGGAGGATTTATACTCAGT-3’ 
E6 BC_UP_E6 5’-TTCTACCGTCGGAGGCAGTT-3’ BC_DN_E6 5’-TTACGACCAGAACGGGACAC-3’ 
E7 BC_UP_E7 5’-TTTAGTGTCCGCGCCACGTT-3’ BC_DN_E7 5’-TATACTTGCGTAACGGGCCG-3’ 
E8 BC_UP_E8 5’-TATTCTCCGTGACGCGGGTT-3’ BC_DN_E8 5’-AATTTAGGTGCGACCGCCCT-3’ 
E9 BC_UP_E9 5’-AATCGGTACTAAGTCGGTTC-3’ BC_DN_E9 5’-CGGGTGTAGAAACCGACTAA-3’ 
E10 BC_UP_E10 5’-CCCGATTGGTTAATACCGAT-3’ BC_DN_E10 5’-AAGAAGGTTTAATTCGCCCG-3’ 
E11 BC_UP_E11 5’-GGACCGACTATTCCCTAAAT-3’ BC_DN_E11 5’-GCGCGGTCAGAACTAATATA-3’ 
E12 BC_UP_E12 5’-GCGCTGCAATCAGAAAGGTA-3’ BC_DN_E12 5’-CCAATGTACGCCAAGGTATA-3’ 
F1 BC_UP_F1 5’-AGCATGTCTCTAACTGGACG-3’ BC_DN_F1 5’-TCTATTCGGCGAGGCTGACT-3’ 
F2 BC_UP_F2 5’-ATATAGCGTGACAGAGTACG-3’ BC_DN_F2 5’-AAGTCAGGTCAATCATGCCC-3’ 
F3 BC_UP_F3 5’-ATATACGTGGAATGACTGGC-3’ BC_DN_F3 5’-TGACTCCTACGAGGTGCGAT-3’ 
F4 BC_UP_F4 5’-ACATGGTTGAAAGCGCGTCA-3’ BC_DN_F4 5’-TATGACTGCGGACGTTCGCT-3’ 
F5 BC_UP_F5 5’-CGACTATTGTGACATACCTG-3’ BC_DN_F5 5’-ACGTTGATCGCATGAGATTG-3’ 
F6 BC_UP_F6 5’-TGGATTCGACTCGCTCGCAT-3’ BC_DN_F6 5’-CATTACGTCAGATAGGGCTG-3’ 
F7 BC_UP_F7 5’-ATTTCGGCACGCTCACGATG-3’ BC_DN_F7 5’-TAACGCGACAGACGATATGC-3’ 
F8 BC_UP_F8 5’-GAGCTTGACTCACCGTCTTG-3’ BC_DN_F8 5’-TAACTCGTACTAGCGATCTG-3’ 
F9 BC_UP_F9 5’-GCGGCGGATATGCTATAAAT-3’ BC_DN_F9 5’-AATAGAGACGGCTCGATCTG-3’ 
F10 BC_UP_F10 5’-TACTCGGCAACAGGTCGGTA-3’ BC_DN_F10 5’-ATTCTCGATAGAGCGTGCTG-3’ 
F11 BC_UP_F11 5’-TATGGCACCACACGAAGGAC-3’ BC_DN_F11 5’-GACGCGAGTCGATGATACCT-3’ 
F12 BC_UP_F12 5’-GGGCTACCTCTCAATTATAC-3’ BC_DN_F12 5’-CGCTCCTAAGACATTGTTAC-3’ 
G1 BC_UP_G1 5’-GCCCACATGGATAACATTAC-3’ BC_DN_G1 5’-CGTAATAAGTGGGTAGAACC-3’ 
G2 BC_UP_G2 5’-AGACTAAGACCATTGTACCC-3’ BC_DN_G2 5’-GGTAACACTATCTCAAGACC-3’ 
G3 BC_UP_G3 5’-TAGCCAGTAACAGTAGGCCC-3’ BC_DN_G3 5’-GGTATGACGATAACCCATCC-3’ 
G4 BC_UP_G4 5’-GCCCAAATAAGACGTGAGCC-3’ BC_DN_G4 5’-AGCACACGTAGGAACTATCC-3’ 
G5 BC_UP_G5 5’-TAAGAATCGTTAGCAAGGCC-3’ BC_DN_G5 5’-CACGACGTAACATGAGGTCC-3’ 
G6 BC_UP_G6 5’-AGAGATTCGCTTAACGCCCG-3’ BC_DN_G6 5’-ATTCCGAGCGGCAGCGATAT-3’ 
G7 BC_UP_G7 5’-CATAAGCGTTGTGAATCGCG-3’ BC_DN_G7 5’-TATACTGCGCGACATGCGAG-3’ 
G8 BC_UP_G8 5’-TGCGCGGTCAAACCAAGCAA-3’ BC_DN_G8 5’-TAATCGCTACGAATGCTACC-3’ 
G9 BC_UP_G9 5’-TTCACCGAGACAAGGCGAGA-3’ BC_DN_G9 5’-AATAGGACGGAACGCCATCC-3’ 
G10 BC_UP_G10 5’-TCCATACCGATAAAGCTCGA-3’ BC_DN_G10 5’-ATATACGGGTAACCAGCCGC-3’ 
G11 BC_UP_G11 5’-TACTGACGCGGGACTGACTT-3’ BC_DN_G11 5’-CGGAGAGACAGATTACACGC-3’ 
G12 BC_UP_G12 5’-TAACTGCCGCGAGTCGTCTT-3’ BC_DN_G12 5’-AGTATCACACGAGCTTACGC-3’ 
H1 BC_UP_H1 5’-TATCCTGTCGGAGCGCGTTT-3’ BC_DN_H1 5’-TTAGGTACACTACACGTCGC-3’ 
H2 BC_UP_H2 5’-ACGGACACGACAGTAGTTCC-3’ BC_DN_H2 5’-CCAGGGCGTGTTCATAAATA-3’ 
H3 BC_UP_H3 5’-GGGTACATACGCATATTAGC-3’ BC_DN_H3 5’-TCATCCGAGCGACTTAGTGG-3’ 
H4 BC_UP_H4 5’-AAGCCAAACGAACTTGCGGC-3’ BC_DN_H4 5’-ATACCTTACTCAGCGGGTGG-3’ 
H5 BC_UP_H5 5’-CCGAGTTAGGAATGTTATGC-3’ BC_DN_H5 5’-TACGGAATTCGTACGTGCTC-3’ 
H6 BC_UP_H6 5’-TACCTATTGACCAGTGGGCG-3’ BC_DN_H6 5’-TACGGATGTCGACTAACCAT-3’ 
H7 BC_UP_H7 5’-ATTGAGCCTGACCACATGCG-3’ BC_DN_H7 5’-TAGGTTGAGGCGATCGCGAT-3’ 
H8 BC_UP_H8 5’-CCTAGAGACGTAGATATGCG-3’ BC_DN_H8 5’-ATACACATCGGGTTAAGCGG-3’ 
H9 BC_UP_H9 5’-ACACCGTATTTAAGACTGCG-3’ BC_DN_H9 5’-GTTATTACCCTACATCGTCG-3’ 
H10 BC_UP_H10 5’-ATCTCGCGTGACGATAGGCT-3’ BC_DN_H10 5’-TACCTTAGGAGGCGTAAATG-3’ 
H11 BC_UP_H11 5’-GATGCGGCACTATCGCTCAT-3’ BC_DN_H11 5’-CAGCGCGTACTAGACTGGAT-3’ 
H12 BC_UP_H12 5’-AGGAGCTTGTCTAATATCGG-3’ BC_DN_H12 5’-CAGCATTGTAAATAGGCGGA-3’ 
 
Table 12. Unique barcode sequences used to label C. glabrata deletion strains with a unique signature tag. 2 x 96 
upstream and downstream barcodes are reused for every set of 96 gene deletion strains and can be amplified from the constant 
regions (U1 + U2; D1 + D2). Barcode sequences from the systematic S. cerevisiae gene deletion project were adopted 
(http://www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html; (Giaever et al., 2002, Winzeler et al., 1999)). 
The reference strain carries a unique barcode not used for any other strain. 
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Reference strain barcodes: The reference strain contains the following barcodes to be 
tracked as a positive control during parallel experiments: 
uptag 5’-CGATGCAGGTTATAGACGAT-3’  downtag 5’-GGCACTACTCAAGCATCTTA-3’ 
 
 
Constant and overlap sequences, flanking unique barcodes: 
U1 overlap 5’-ccgctgctaggcgcgccgtg-3’ (overlap sequence for fusion PCR) 
U2 marker 5’-cgtacgctgcaggtcgac-3’ (amplification of marker + addition of barcode) 
 
D1 overlap 5’-gcagggatgcggccgctgac-3’ (overlap sequence for fusion PCR) 
D2 marker 5’-ctacgagaccgacaccg-3’ (amplification of marker + addition of barcode) 
4.2 Methods 
4.2.1 Cultivation and storage of organisms 
4.2.1.1 Cultivation and storage of E. coli 
E. coli strains were cultured in liquid or on solid LB medium, when necessary 
supplemented with antibiotics for selection and incubated at 37°C. For long term storage the 
cells were suspended in 15% sterile glycerol, frozen in liquid nitrogen and stored in cryotubes 
at -80°C. 
4.2.1.2 Competent bacteria and E. coli transformation  
E. coli strain DH5α was grown in 250 ml SOB medium at 18°C or RT to an OD600 of 
0.6. The bacterial culture was chilled on ice for 20 minutes and harvested (1000g, 4°C, 10 
min). The pellet was resuspended in 15 ml ice-cold TB buffer, further incubated on ice for 10 
minutes and pelleted again (1000g, 4°C, 10 min). The pellet was resuspended in 15 ml of ice 
cold TB buffer, DMSO added to a final concentration of 7% (v/v) and incubated on ice for 10 
minutes. 400 μl aliquots were prepared, frozen in liquid nitrogen and stored at -80°C.  
4.2.1.3 Transformation of competent E. coli – heat shock 
Competent cells were slowly thawed on ice. 1 to 10 μl of DNA (e.g. 100 ng DNA) 
were added to 100 μl of cells and incubated on ice for 30 minutes. The cells were heat-
shocked at 42°C for 45 sec, cooled on ice for 2 minutes and after addition of 900 µl of LB 
medium incubated on a shaker at 37°C for one hour. The cells wer plated on a LB plate 
containing the appropriate antibiotic and incubated at 37°C overnight. 
4.2.1.4 Cultivation and storage of C. glabrata strains 
Cells were routinely grown in rich media (YPD) and synthetic media (SC), prepared 
essentially as described elsewhere (Kaiser et al., 1994). Unless otherwise indicated, all 
strains were grown routinely at 30°C. For solid media, 2% agar (w/v) was added. For 
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selection of nourseothricin resistant transformants, plates were supplemented with 200 µg/ml 
nourseothricin (Werner Bioagents, Jena, Germany). Supplements were filter sterilized prior 
to be added to the autoclaved media at appropriate concentrations.  
For short term storage strains were kept on YPD plates at RT in the dark. For long 
term storage the cells were suspended in 15% sterile glycerol, frozen in liquid nitrogen and 
stored in cryotubes at -80°C. Strains of the deletion collection were stored in triplicates in 
200µl 15% sterile glycerol in 96 well plates as well as in single cryotubes. 
4.2.2 General genetic and molecular techniques 
Standard methods (restriction digestion, dephosphorylation, ligation, agarose gel-
electrophoresis, standard PCR, determination of nucleic acid concentration) were performed 
according to Sambrook et al. (Sambrook et al.). Plasmid preparations from E. coli were 
routinely done by boiling preparation (STET method) or with the Quiagen Miniprep kit 
according to the manufacturer’s instructions. For elution of DNA fragments from agarose gels 
after preparative gel-electrophoresis the Peqlab gel extraction kit was used according to the 
manufacturer’s instructions.  
4.2.2.1 DNA precipitation 
DNA precipitation was carried out by adding 1/10 of the volume 3 M Na-acetate (pH 
5,3) to the DNA solution. After addition of 3 volumes of cold 100% ethanol the solution was 
incubated at - 80°C for 60 minutes, centrifuged for 15 minutes at 18.000g and washed with 
cold 70% ethanol. The DNA pellet was dried at 55°C and resuspended in sterile water 
(bidest.). 
4.2.2.2 Sequencing analysis 
DNA sequencing was carried out using the BigDye Terminator Cycle Sequencing Kit 
Ver. 3.0 according to the manufacturer’s instructions and the ABI PRISM Sequencing 
System 310 (Applied Biosystems, Germany), or using the sequencing service of the 
institutes IMP/IMBA. 
4.2.2.3 Generation of deletion cassettes by fusion PCR 
The dominant marker NAT1 was amplified from plasmid pJK863 (Shen et al., 2005) 
with primers fp_NAT1-U2 and rp_NAT1-D2 to add the constant 20 bp sequences U2 and D2. 
The PCR product was ligated into pGEM-T vector (Promega), generating plasmid pTS50. 
Fusion PCR: Deletion cassettes were generated using a modified fusion PCR protocol 
(Noble & Johnson, 2005, Wach, 1996) (see Figure 14 A). Briefly, 500bp long flanking 
homology regions were amplified from ATCC2001 genomic DNA with primer pairs 5’5’/5’3’ 
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and 3’5’/3’3’ adding the constant overlap sequence (U1/D1) of 20 bp and purified by ethanol 
precipitation. The conditions for a 50 µl reaction were as follows: 1x Taq buffer (50 mM KCl, 
10 mM Tris-HCl (pH 9.0, 25°C), 0.1% TritionX-100, 1.5 mM MgCl2), 0.2 µM dNTPs, 0.5 µM 
each primer, 1 µl Taq-Polymerase and genomic wild type DNA from strain ATCC2001; 93°C 
for 5 minutes, 35 cycles 93°C for 30s, 45°C for 30s, 72°C for 90s, finally 10 minutes at 72°C. 
The dominant marker NAT1 was amplified from plasmid pTS50 in a separate PCR reaction 
using primers 5M and 3M, adding unique barcode tags and constant complementary U1 and 
D1 sequences. The marker fragment was gel-purified over a 0.7% agarose gel. The 
conditions for a 50 µl reaction were as follows: 1 x Taq buffer, 0.2 µM dNTPs, 0,5 µM each 
primer, 1 µl Taq-Polymerase and plasmid TS50; 93°C for 3 minutes, 32 cycles 93°C for 30s, 
49°C for 30s, 72°C for 2,5 minutes, finally 10 minutes at 72°C. Fusion PCR was carried out in 
a 50 µl volume with the same conditions as above: 1x ExTaq buffer, 0.2 µM dNTPs, 0.5 µM 
each primer, 0.5 µl ExTaq-Polymerase (TaKaRa) and 3 µl marker fragment, 1.25 µl each 
flanking homology fragment; 93°C for 3 minutes, 35 cycles 93°C for 30s, 45°C for 30s, 72°C 
for 3 minutes, finally 10 minutes at 72°C. The final deletion construct was purified by ethanol 
precipitation. 
4.2.2.3 Transformation of C. glabrata by electroporation 
For transformation of the background strain HTL, we used a modified electroporation 
protocol (Reuss et al., 2004). 50 ml of a C. glabrata culture in YPD at an optical density of 
600nm (OD600) of 1.3 were harvested, washed with H2O, resuspended in 1x TE buffer, 
100mM LiAc and incubated at 30°C for 30 minutes with slow shaking (130rpm). After addition 
of 250 µl 1M DTT and further incubation at 30°C for 60 minutes (130rpm), 40 ml of H2O were 
added and the cells were harvested at 1000g for 5 minutes at 4°C. The cells were washed 
with 25 ml H2O, subsequently with 5 ml 1 M cold sorbitol, finally resuspended in 550 µl 1 M 
sorbitol and kept on ice until use. Sterile electroporation cuvettes were precooled on ice and 
loaded with a mix of 40 - 45 µl electrocompetent cells and 5 - 10 µl linear DNA deletion 
construct (app. 2 - 3 µg DNA). Cells were left on ice for 10 minutes and electroporation was 
carried out with a BioRad GenePulser (200Ω, 1.5kV, 25µF). For recovery, 950 µl YPD was 
added and cells incubated for 4 h shaking at 30°C, before plating on YPD supplemented with 
200 µg/ml Nourseothricin (Werner Bioagents, Jena). The plates were incubated for 48 hours 
at 30°C.  For auxotrophic marker constructs the cells were recovered for 1 h at 30°C before 
plating on selective SC medium. Transformants were patched on YPD/Nourseothricin plates 
for colony PCR. For 96 well parallel electroporation, 300 ml of culture were grown to OD600 of 
1.3, split into 50 ml aliquots and treated as described above. For electroporation, a BTX 
Harvard Apparatus ECM630 electroporation device with a HT-100 plate handler was used.  
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4.2.2.4 Transformation of C. glabrata by heat shock 
For heat shock transformation a modification of the LiAc method was used (Gietz et 
al., 1992). Cells were grown to early log phase in YPD (OD=1 to 2), harvested (3 minutes, 
1000g) and washed with 25 ml sterile H2O. Cells were resuspended in 1 ml 100 mM LiAc, 
transferred into an Eppendorf tube and pelleted 15 seconds at 1000g. The supernatant was 
removed completely, the cells resuspended in 400 µl 100mM LiAc and distributed in 50 µl 
aliquots. The cells were pelleted again, the supernatant removed completely and following 
solutions were added: 240 μl 50% PEG (3500), 36 μl 1 M LiAc, 50 μg of heat-denatured 
salmon sperm DNA and transforming DNA dissolved in 50 μl of sterile water. After mixing the 
cells were incubated for 30 minutes at 30°C. Then 45 µl DMSO was added, mixed 
immediately and the cells heat shocked for 15 minutes at 42°C. The cells were pelleted (2 
minutes, 3400g), resuspend in 200 µl sterile H2O and plated on selective plate. 
4.2.2.5 Verification by yeast colony PCR 
Strains were verified by colony PCR and “loss-of-gene” PCR according to the 
following protocol (Figure 14 C). Transformants were patched on selective plates and 
incubated at 30°C for 24h. Cells were resuspended in 40 µl PCR mix 1 (0.2µM dNTPs, 0.5 
µM of each gene specific primer 5c/3c up-/downstream of the homology region and marker 
specific primer 5M/3M) and heated for 10 minutes at 93°C. After cooling on ice, 10 µl 
polymerase mix (5 µl 10 x PCR buffer and 1 µl Taq-Pol.) were added per reaction and a 
regular PCR was performed (93°C for 5 min, 25 cycles 93°C for 30s, 45°C for 30s, 72°C for 
90s, final 10 min 72°C). To verify the loss of the coding sequence (CDS), colony PCR was 
essentially performed the same way. Oligonucleotides used to screen for CDS loss bind 
inside the CDS to generate a product of 500bp. All internal primers were also checked for 
functionality in a separate PCR reaction, amplifying the fragment from genomic wild type 
DNA. 
4.2.2.6 Isolation of genomic DNA from yeast 
Genomic DNA was isolated according to a modified protocol as described in 
Sambrook et al (Sambrook et al.). Cells from 10 ml of overnight culture in YPD were 
harvested by centrifugation, washed once with 10 ml sterile water and then resuspended in 
500 µl H2O. The cell suspension was transferred into a screw cap tube and resuspended in 
200 µl of DNA lysis buffer. One volume of glass beads (Sigma 425-600 µm, acid-washed) 
and 200µl phenol-chloroform-isoamylalcohol (PCI, 25:24:1, Fluka) were added and the cells 
were broken, using a Vibrax vortex (15 minutes, 4°C) or alternatively a Fastprep (40s, 5m/s, 
RT; MPBiomedicals). 200 µl sterile water were added and the suspension was centrifuged (5 
minutes, 16000 g, 4°C). The aqueous top layer was transferred into a new tube and the DNA 
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was ethanol precipitated. The pellet was resuspended in 400 µl 1 x TE buffer + 3 µl RNase A 
(10µg/ml) and incubated at 55°C for 50 minutes to digest the RNA. The PCI step was 
repeated, the DNA precipitated again and resuspended in 50 µl H2O. DNA quality was 
checked on an agarose gel and the DNA concentration was determined at 260 nm. 
4.2.2.7 Isolation of RNA from yeast 
RNA was extracted from yeast cells by the hot phenol method according to Sambrook 
et al. (Sambrook et al.). Cells from a 50 ml culture with an optical density of 1 (OD600) were 
harvested, washed with sterile water and resuspended in 400 µl 50 mM sodium acetate (pH 
5.3) and 10 mM EDTA (pH 8.0). 40 µl of 10% SDS were added, mixed and incubated with 
400 µl acid phenol (pH 4.3) at 65°C for 15 minutes. After rapidly chilling on ice the broken cell 
suspension was centrifuged (5 minutes, 16000g, room temperature (RT)) and the aqueous 
phase transferred into a new tube. An equal volume of PCI was added, incubated for 5 
minutes at RT, centrifuged and the aqueous phase was transferred into a new tube. This 
step was repeated once more, followed by two steps of chloroform extraction. The purified 
RNA was precipitated with 1/10 volume of 3 M sodium acetate (pH 5.3) and 2.5 volumes of 
cold 100% ethanol. The pellet was washed with 70% ethanol, dried at 55°C and 
resuspended in 100 µl TE buffer. RNA was stored in aliquots at minus 80°C until use. RNA 
concentration was determined using a UV/Vis spectrophotometer (Nanodrop - Thermo 
Scientific) and the quality was checked using a Bioanalyzer 2100 (Agilent). For RT-PCR the 
RNA was incubated with 2U of DNaseI (Fermentas) for 15 minutes at 37°C and the DNaseI 
was inactivated by PCI extraction. RNA for microarrray analysis was precipitated with 2 M 
LiCl. 
4.2.2.8 Southern blot analysis 
Southern blot analysis was performed according to Sambrook et al (Sambrook et al.). 
25 µg of genomic DNA were digested overnight at 37°C with appropriate restriction enzymes 
and separated by gel electrophoresis (70 V) on 0.7% agarose gel in TBE. The DNA was 
denatured in 0.5 M sodium hydroxide, 1.5 M sodium chloride for one hour and neutralised for 
one hour in 0.5 M Tris/HCl pH 7.5, 1.5 M NaCl. Capillary blotting onto a nylon membrane 
(Hybond N+, Amersham) using 20 x SSC buffer was carried out over night and crosslinked 
on the membrane using a Stratagene UV Crosslinker. The membrane was incubated at 65°C 
for at least 3 h in prehybridisation solution. Probes were obtained by PCR internally labelled 
with [α-32P]dCTP (Megaprime DNA Labelling Systems, GE Healthcare) for 2 hours at 37°C 
(20-100ng DNA, 5µl primer solution, x µl sterile H2O, 33 µl total volume, 10µl labelling buffer, 
5µl [α-32P]dCTP (6000Ci/mmol), 2µl Klenow polymerase). The labelled DNA was purified with 
NICK columns (GE Healtcare) according to the manufacturer’s instructions and the activity of 
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the eluates was measured with a scintillation counter. Prior to hybridisation the probe was 
denatured for 5 minutes at 95°C. The radio-labelled probe was added to the prehybridisation 
solution and incubated overnight at 65°C. The membrane was washed twice with 2 x SSC, 
1% SDS for one hour each, twice with 1xSSC, 1% SDS for one hour each and detected on 
X-ray film (CL-Xposure Film 5x7 inches, Pierce). For stripping, the membrane was incubated 
in 0.3% SDS, 0.1 x SSC at 65°C for 20 minutes and prehybridised again before adding a 
new probe. 
4.2.3 Quantitative real-time PCR 
Primers for quantitative real-time PCR were designed using PerlPrimer according to 
recommendations and tested in a gradient PCR. RNA was extracted by the hot phenol 
method and treated with DNaseI as described above. Three independent biological 
replicates were prepared. Reverse transcription was performed in triplicates on 2 µg of total 
RNA each according to the manufacturer’s instructions (Fermentas First-strand cDNA 
synthesis Kit) with 100 pmol oligo(dT)18 and 100 pmol random hexamer primer. The sample 
mixes (4 µl 5 x reaction buffer, 0,5 µl RiboLock Rnase inhibitor (20U), 2 µl 10 mM dNTP mix, 
1 µl M-MuLV Rev. Transcriptase (200U)) were incubated for 10 minutes at 25°C followed by 
60 minutes at 42°C and final 10 minutes at 72°C, diluted 1:10 in H2O and stored at -20°C. All 
cDNA and RNA samples were tested in a regular PCR for DNA amplification with specific 
primers. Quantitative PCR was carried out in triplicates on a Realplex Mastercycler 
(Eppendorf), monitoring cDNA amplification quantitatively by SYBR Green incorporation. The 
conditions for a 20 µl reaction were as follows: 2 µl cDNA template, 7 µl H2O, 0.75 µl each 
primer (375 nM), 10 µl 2 x Mastergreen mix (Eurogentec); 95°C 5 minutes, 40 cycles 95°C 
10 s, 62°C 10 s, 72°C 20 s; melting curve 95°C 20 s, 62°C – 94°C gradient, 95°C 15 s. For 
analysis the Realplex data analysis program was used. 
4.2.4 Microarray analysis 
50 ml cultures of the HTL C. glabrata background strain and the Cgcbk1∆ deletion 
strain were grown in YPD to an OD600 of 1, harvested, washed and immediately frozen. Total 
RNA was prepared by hot phenol method and treated with DNaseI. RNA was additionally 
precipitated with 2 M LiCl and RNA concentration was measured and quality checked as 
described above. Three independent biological replicates were prepared. Samples of 25 μg 
total RNA were used for cDNA synthesis using 200 U of Superscript II reverse transcriptase 
(Invitrogen, USA) with either Cy3-dCTP or Cy5-dCTP. Labelled cDNAs were pooled, and 
RNA was hydrolyzed for 20 minutes in 50 mM NaOH at 65°C, followed by neutralization with 
acetic acid and probe clean-up with CyScribe GFX purifiaction kit (Amersham). Microarrays 
were incubated for at least 45 minutes at 42°C in prehybridization solution (4 x SSC, 0,1% 
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SDS, 10 mg/ml BSA). Hybridization to C. glabrata whole-genome cDNA microarrays was 
done in hybridisation solution (4 x SSC, 0.1% SDS) at 37°C overnight. Microarrays were 
washed for one minute in 2 x SSC, 0.1% SDS at 42°C, followed by a 5 minutes wash in 2 x 
SSC, 0.1% SDS at 42°C and a 10 minutes wash in 0,1 x SSC, 0,1% SDS at room 
temperature. Microarrays were washed for two minutes in 0.1 x SSC, 0.1% SDS at room 
temperature and in 0.01 x SSC for 30 seconds. Glass slides were dried for 3 minutes at 500 
rpm in a tabletop centrifuge, scanned on an Axon 4000B scanner (Molecular Devices), 
analyzed and normalized using Gene Pix Pro4.1 software (Molecular Devices). Custom 
made DNA microarrays and protocols were obtained from the laboratory of Dr. Steffen Rupp, 
Fraunhofer Institute, Stuttgart. Oligonucleotides were obtained from Dr Ken Haynes, Imperial 
College, London. All microarray experiments were carried out with three independent RNA 
preparations. 
4.2.5 Protein-biochemical methods 
4.2.5.1 Preparation of whole cell TCA extracts  
5 ml of a yeast culture with OD600 of 0.8 was harvested (5 min, 1000g) and the cells 
resuspend in 1 ml H2O. 150 μl Yex-lysis buffer was added, mixed and incubated for 10 
minutes on ice before adding 150 μl of cold 50% TCA (trichloracetic acid) and further 
incubation on ice for at least 10 minutes. The solution was centrifuged (5 min, 16100 g, 4°C), 
the supernatant discarded and residual liquid was carefully removed. The pellet was 
resuspended in protein sample buffer (20 μl/1 OD600), incubated for 15 minutes at 37°C on a 
shaker and centrifuged (5 min, 16100 g) to pellet cell debris. 10 μl (equivalent to 0.5 OD600) 
were loaded on a SDS PAGE and the gel was run at 200 V.  
4.2.5.2 Preparation of cell extracts and immunoblotting 
To investigate phosphorylation of CgSlt2 protein wild type and deletion strain cultures 
were grown to exponential phase with and without stress (10 ng/ml caspofungin). Cells were 
harvested at 5, 10, 30, 60 minute time points and trichloroacetic acid (TCA) extracts were 
prepared as described elsewhere (Gregori et al., 2007). Aliquots corresponding to 0.5 OD of 
cells were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. 
Immunoblotting was carried out using a phosphospecific anti-phospho p44/42 antibody 
MAPK (Erk1/2) (Cell Signaling Technologies, USA) for detection of phosphorylated CgSlt2. 
Anti-ScPgk1 antibodies recognizing CgPgk1 were used as loading control (Kuchler et al., 
1993). 
4 Materials and Methods   
 50 
4.2.6 Phenotypic profiling 
4.2.6.1 Screening conditions for growth phenotypes using robotics 
For large-scale phenotypic analysis, cells were restreaked from frozen stock and 
grown for 48 h at 30°C on fresh YPD plates. Each of the three plates containing independent 
transformants of the same set of genes was arrayed into 384 spot array formats serving as 
source plates. Phenotypic profiling of the deletion collection was performed using a robot 
(RoToR HDA, Singer Ltd., Roadwater, UK) on media plates supplemented with compounds 
at the following final concentrations: 50 µg/ml Calcofluor White (Sigma-Aldrich), 250 µg/ml 
Congo Red (Sigma-Aldrich), 0.02% SDS (Sigma-Aldrich), 7 mM Caffeine (Sigma-Aldrich), 
150 ng/ml Caspofungin, 1 mM CuSO4 (), 1.1 M NaCl, 500 mM CaCl2, 600 mM MgCl2, 8 mM 
ZnCl2, 2 mM CdCl2, 5 mM MnCl2, 40 mM LiCl (Merck). Plates were routinely incubated at 
30°C for up to 3 days and scanned with a HPScanjet G3010, using Adobe Photoshop CS3 
software or photographed with S&P Imaging system (S&P Imaging, Canada), after 24, 48 
and 72h for documentation. 
Primary hits were manually rescreened for confirmation. Exponentially growing cells 
were adjusted to an OD600 of 0.1. Equal volumes of serial dilutions (1:10, 1:100 and 1:1000) 
were spotted on YPD plates containing drugs and incubated as described above. For 
identification of mutants displaying differences in phenotypic switching, cells were spotted 
and dilutions were plated on YPD containing 1mM CuSO4 and grown for 4 days at 25°C. 
Media plates used for large-scale phenotypic screening and manual confirmation of 
growth phenotypes contained compounds listed in Table 13: 
 
Compound Stock conc. Solvent 
Screening 
conc. 
Confirmation 
conc. Manufacturer 
NaCl 5 M H2O 1.1 M 1.1 M Merck 
Calcofluor White 10 mg/ml H2O 50 µg/ml 50 µg/ml Fluka 
Congo Red 10 mg/ml H2O 250 µg/ml 250 µg/ml Sigma 
SDS 10 % H2O 0.02 % 0.02 % Fluka 
Caffeine 300 mM H2O 7 mM 7 mM Sigma 
Caspofungin 50 µg/ml H2O 200 ng/ml 150 ng/ml Merck 
Fluconazole 10 mg/ml DMSO 4 µg/ml 1.5 µg/ml Discovery Fine Chemicals 
Voriconazole 10 mg/ml DMSO 100 ng/ml 75 ng/ml Discovery Fine Chemicals 
Ketoconazole 10 mg/ml DMSO 100 ng/ml - Discovery Fine Chemicals 
Itraconazole 10 mg/ml DMSO 100 ng/ml - Discovery Fine Chemicals 
Amphotericin B 10 mg/ml DMSO 3 µg/ml 1.5 µg/ml Discovery Fine Chemicals 
5-Flucytosin 10 mg/ml H2O 5 µg/ml 5 µg/ml Discovery Fine Chemicals 
CuSO4 1 M H2O 1 mM 1 mM Merck 
CaCl2 5 M H2O 500 mM 400 mM Merck 
ZnCl2 1 M H2O 8 mM 8 mM Merck 
MgCl2 5 M H2O 600 mM 600 mM Merck 
CdCl2 1 M H2O 2 mM 2 mM Merck 
MnCl2 1 M H2O 5 mM 5 mM Sigma 
LiCl 1 M H2O 40 mM 40 mM Sigma 
 
Table 13. Compounds used for profiling analysis in the primary and conformational screen. 
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Azole susceptibility screenings were carried out by a modified endpoint method 
(Rex et al., 1997) in liquid culture in microtiter plates, using the following drug concentrations: 
4 µg/ml Fluconazole, 0.1 µg/ml Voriconazole, 0.1 µg/ml Ketoconazole, 0.1 µg/ml Itraconazole 
(all azoles from Discovery Fine Chemicals), 3 µg/ml Amphotericin B (Discovery Fine 
Chemicals), 5 µg/ml 5-Flucytosine (Sigma-Aldrich). Cells were grown overnight in deep well 
plates to stationary phase, diluted 100-fold in sterile water and 100 µl suspension mixed with 
100 µl of 2 x YPD containing a 2 x drug concentration (app. 105 cells/well). After incubation at 
30°C for 24 h and 48 h, cells were resuspended and the OD600 was measured with a Victor 
plate reader (Perkin Elmer, USA). 
4.2.6.2 Microbroth dilution assay for IC50 determination 
To determine the IC50 of antifungal drugs a modified protocol of the microbroth 
dilution assay was used (Sanglard et al., 1995). Briefly, an overnight culture was diluted 
1:100 in YPD, regrown to an OD600 of 1 and an inoculum of 2.5 x 104 cells/ml was prepared. 
Antifungal stock solutions were prepared in DMSO. Two fold serial dilutions of the drugs 
were then prepared in water in a deep well plate and stored at -20°C until use. 100 µl of two 
fold serial drug dilutions were distributed in triplicates into a flat bottom microtiter plate. The 
last wells free of antifungal drugs served as a growth control. After adding 100 µl of the 
inoculum (200 µl total volume), plates were incubated at 30°C for 24h and 48h in a humid 
environment to avoid evaporation. OD600 was determined with a plate reader. Endpoint 
readings were set as the antifungal concentrations, causing at least 90% growth inhibition 
after 24 h of growth when compared to the control. The IC50 was determined by linear 
regression using Graph Pad Prism software. 
4.2.7 In vitro interaction studies 
4.2.7.1 Cultivation of cell lines and primary bone marrow-derived macrophages 
BMDM (bone marrow-derived macrophages) media contained DMEM, 10% heat-
inactivated FCS, 20% L-conditioned medium. L-conditioned medium was produced as 
described: Ten confluent 10 cm dishes of L929 cells were divided into 20 bottles and 50 ml of 
medium (DMEM, 10% FCS) per bottle added. When the cells were 70% confluent, the 
medium was replaced with 100 ml starving medium (DMEM without FCS, no antibiotics) and 
incubated for 10 days, filter sterilized and aliquots were stored at -20°C.  
4.2.7.2 Preparation of bone-marrow derived macrophages from mice 
BMDMs were prepared and cultured as described elsewhere (Frohner et al., 2009). 
Briefly, bones from 7- to 9-week-old C57BL/6 wild-type mice were dissected and stored in 
cold sterile PBS buffer on ice. Bone marrow was collected from femur and tibia treated with 
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red blood lysis buffer (8.29 g l-1 NH4Cl, 1 g l-1 KHCO3, 0.0372 g l-1 EDTA, pH 7.2–7.4) and 
resuspended either in macrophage media to induce differentiation into BMDMs as described 
elsewhere (Hume & Gordon, 1983, Inaba et al., 1992). Frozen bone marrow of 6-to 8-week-
old gp91phox-/- C57BL/6 mice was kindly provided by Kristina Erikson (George-Chandy et 
al., 2008). Fresh medium was added after three days in culture. At day seven, BMDMs 
cultures were split 1:3 and further cultured until day 10 to 12 and used between day 10 and 
day 13 of differentiation. 
4.2.7.3 Detection of reactive oxygen species by chemiluminescent assay  
For detection of accumulated reactive oxygen species after incubation of primary 
macrophages with C. glabrata cells, the deletion strain library was screened with the ROS 
assay essentially as described in (Frohner et al., 2009). Total and extracellular ROS were 
detected using luminol and isoluminol (Sigma, USA). Briefly, 100 µl of BMDMs in prewarmed 
HBSS at a density of 4 x 105 cells/ml were distributed to a 96-well luminometer plate (Nunc, 
Roskilde, Denmark). 50 µl HBSS medium containing zymosan (100 µg/ml) or the C. albicans 
wild type strain SC5314 (MOI 5:1) were used as positive controls. Mutant strains were added 
at the indicated cell numbers, usually at a MOI of 10:1. Immediately afterwards, 50 µl HBSS 
containing either 200 µM luminol or 600 µM isoluminol and 50 µl HBSS containing 16 U 
horse radish peroxidase (HRP) were transfered to each well. Chemiluminescence was 
measured with a plate reader (Wallac VictorV3, PerkinElmer) at 2.5 minute intervals at 37°C 
for four hours. Data are expressed as relative luciferase units/min/1000 BMDM cells over 
time, or as total relative luciferase units under the curve over a period of 90 minutes. Primary 
hits were confirmed in triplicates in three independent experiments. 
4.2.8 Microscopy 
Microscopy was done on an Axioplan 2 (Zeiss, Germany) or Olympus CellR life 
imaging station microscope (Olympus, Austria). Pictures were captured with a Spot Pursuit 
camera (Sony). Cells were grown to exponential growth phase, harvested and washed with 
water before transferring them onto microscopy slides. For chitin staining, cells in the early 
exponential growth phase were incubated with calcofluor white (Fluorescent Brightener 28, 
Sigma-Aldrich) at a final concentration of 50 µg/ml in medium for 1 hour at room temperature 
in the dark. Cells were washed twice with water and transferred to a microscopy slide and 
observed with a DAPI filter. Colony pictures were taken with a Discovery.V12 
Stereomicroscope and a AxioCam MRc5 (Zeiss, Germany). Cells were grown in liquid YPD 
to logarithmic phase to take pictures of the cell morphology. 
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4.2.9 Bioinformatic analysis 
Gene selection. Genes of different functional categories were manually selected 
based on potential function in virulence and drug resistance. The categories involved genes 
of signaling pathways, kinases, ABC transporters and permeases, GPI-anchored proteins, 
cell wall associated genes, genes involved in glycosylation, phospholipid biosynthesis, 
histone modification, iron metabolisms and several genes with no obvious homologue in S. 
cerevisiae.  
The genes were selected by their homology to S. cerevisiae based on these 
functional categories (SGD annotations; http://www.yeastgenome.org/). C. glabrata 
orthologues were identified using a BLAST approach. The three best aligned hits for each 
gene were saved. These orthologues have been remapped with the help of T. Gabaldon 
(Barcelona, Spain), using a tree-based approach applying the algorithm described in 
(Huerta-Cepas et al., 2007). 
 
Primer generation. Oligonucletide sequences for generation of the deletion 
cassettes and strain verification were automatically designed, using a custom written perl 
script called PrimerList (W. Glaser, Vienna). PrimerList utilizes Bioperl (Stajich et al., 2002) to 
read and process nucleotide sequences and uses the EMBOSS (Rice et al., 2000) programs 
eprimer 3 and stssearch to find suitable primersets. The parameters used by PrimerList for 
primerdesign were: Upstream and downstream fragments were chosen to have a size 
between 450 and 550 nucleotides. 5’5’ (forward) and 3’3’ (reverse) primers were chosen to 
have a length of 20 to 30 bp, a GC content between 30 and 60% and a melting temperature 
of 50°C ± 4°C with a GC clamp. 5’3’, 3’5’ primers were chosen to have a length of 20 to 30 
bp plus the 20 bp constant overlap sequence (Figure 14, Table 11), a GC content between 
30 and 60% and a melting temperature of 50°C ± 4°C. 5’3’ (reverse), 3’5’ (forward) primers 
were chosen to bind exactly adjacent to the coding sequence, including the start codon ATG 
or the stop codon, respectively. 5c and 3c control primers have a length of 20 to 25 bp, a GC 
content between 40 and 60% and a melting temperature between 50°C to 60°C. The product 
size of the control PCR is between 750 and 900 bp. Internal control primers (5i and 3i) were 
designed to bind inside the coding sequence and to give a product of 400 to 500 bp in size. 
The primers have a length of 20 to 25 bp, a GC content between 40 and 60% and a melting 
temperature between 55°C to 60°C. 
Oligonucleotides were ordered from Eurogentec, Belgium in 96 well plate format. Six 
plates were needed per set. Each of the six plates (5’5’, 5’3’, 3’5’, 3’3’, 5c, 3c) contained the 
primers for a specific gene at the exact same well position (eg.: well A1 contains the different 
primers needed to generate the deletion cassette of a specific gene; plate 5’5’ contains all 
forward primers for the 5’ region upstream to the gene to be deleted). 
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5 Results 
5.1 Construction of the triple-auxotrophic background strain HTL 
ATCC2001 is a wild type isolate routinely used in many laboratories to study the drug 
resistance profile and virulence properties of C. glabrata. We generated a novel triple-
auxotrophic strain in the ATCC2001 wild type background to use as the recipient strain for a 
genome-wide gene deletion approach. The introduction of three auxotrophies should allow 
for the creation of double deletion strains, while still having two additional markers for 
complementation, if necessary. This is useful because the lack of a full sexual cycle in C. 
glabrata hampers the exploitation of genetic methods such as genetic crossing of two strains 
to yield double deletion strains. Also used as auxotrophic markers in the model organism S. 
cerevisiae, we selected the C. glabrata HIS3, LEU2 and TRP1 genes by homology to these 
amino acid biosynthesis genes. We avoided the use of an auxotrophic URA3 marker in the 
new C. glabrata background strain, because it is known to influence the virulence properties 
of C. albicans (Brand et al., 2004, Lay et al., 1998). 
We used the dominant recyclable nourseothricin resistance marker SAT1 (Reuss et 
al., 2004) to precisely replace each of the three coding sequences from start to stop codon. 
The repeated use of this marker allowed us to create the new C. glabrata background strain 
referred to as HTL (his3∆::FRT leu2∆::FRT trp1∆::FRT), as well as all single deletion and all 
combinations of double deletion strains (Figure 13A and Table 14) (Jungwirth H. et al., 
unpublished). 
 
Strain Genotype Reference 
   
ATCC2001 C. glabrata wild type strain www.attc.org 
HTL his3∆::FRT leu2∆::FRT trp1∆::FRT Jungwirth H., Lechner S. 
H Isogenic to ATCC2001; his3∆::FRT Jungwirth H., Lechner S. 
T Isogenic to ATCC2001; trp1∆::FRT Jungwirth H., Lechner S. 
L Isogenic to ATCC2001; leu2∆::FRT Jungwirth H., Lechner S. 
HT Isogenic to ATCC2001; his3∆::FRT trp1∆::FRT Jungwirth H., Lechner S. 
TL Isogenic to ATCC2001; trp1∆::FRT leu2∆::FRT Jungwirth H., Lechner S. 
HL Isogenic to ATCC2001; his3∆::FRT leu2∆::FRT Jungwirth H., Lechner S. 
HTL reference his3∆::FRT leu2∆::FRT trp1∆::NAT1 (barcode) this study 
deletion strains All isogenic to HTL; gene∆::NAT1 this study 
fks1∆ Isogenic to HTL; fks1∆::HIS3 this study 
ace2∆ Isogenic to HTL; ace2∆::HYGr this study 
   
 
Table 14. C. glabrata strains used in this study. All strains of the deletion strain collection are deposited in the C. glabrata 
deletion strain library (http://funpath.cdl.univie.ac.at/) 
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Moreover, a HTL reference strain was generated by deletion of the TRP1 gene in the 
HL double deletion strain using a signature-tagged NAT1 marker cassette. This reference 
strain can serve as a tractable wild type control for fitness and in vivo virulence tests, 
exploiting the barcoded mutant strain pools. All strains were verified for correct genomic 
integration, for the subsequent loss of the selection marker after induction of the 
recombinase and for the loss of the coding sequence by colony PCR and Southern blot 
analysis (data not shown). 
 
 
Figure 13. Generation of new triple auxotrophic strain HTL. (A) Cloning strategy using the SAT1 flipper for recyclable 
deletion cassettes of C. glabrata TRP1, LEU2 and HIS3 genes. 500bp homology flanking regions were ligated into ApaI/XhoI 
and SacII/SacI restriction sites in pSFS2a, the deletion cassette excised with ApaI/SacI and the resulting fragment used to 
transform C. glabrata ATCC2001. (B) Growth of ATCC2001 wild type strain, HTL and HTL reference strain on YPD alone, 
supplemented with 200 µg/ml Nourseothricin and SC plates lacking Histidine, Leucine or Tryptophan. (C) Growth of ATCC2001 
wild type strain, HTL and HTL reference strain at 30°C and 37°C on solid and in liquid YPD and minimal medium (YNB, 
ammonium sulfate, glucose, Histidine, Leucine or Tryptophan). OD600 was measured every hour in triplicates. 
 
As expected, the new background strain HTL is unable to grow on medium lacking 
one of the amino acid, whose biosynthesis gene has been disrupted. On YPD medium, the 
strain grew normally, and did not display any resistance against nourseothricin (Figure 13B). 
The growth defects indirectly confirmed correct targeting of the deletion constructs. 
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In addition, we examined the growth properties of strain HTL in comparison to 
ATCC2001 on minimal medium supplemented with histidine, leucine and tryptophan and at 
different growth temperatures (30°C and 37°C). Both strains grew as predicted on full and 
minimal medium and showed similar growth rates when cultured in liquid media (Figure 
13C). 
The reference strain showed the same growth properties on YPD and minimal 
medium. It was unable to grow on medium lacking histidine, leucine or tryptophan but grew 
on nourseothricin supplemented growth medium (Figure 13B). 
5.2 Generation of a signature-tagged deletion strain library 
To identify novel C. glabrata genes implicated in drug resistance and virulence, we 
selected 868 C. glabrata orthologous genes based on their homology to S. cerevisiae and 
assigned functional categories, using a BLAST approach. These orthologues were also 
remapped by a tree-based approach, using the algorithm described in (Huerta-Cepas et al., 
2007) (performed by Marcet-Houben M. and Gabaldon T.). The selected genes represent a 
heterogeneous group of putative non-essential genes, some of which might be implicated in 
virulence or drug resistance. Genes were assigned to the following categories: signaling 
pathways (MAPK, RIM101/pH, PKA, TOR, calcineurin pathways), zinc-finger transcription 
factors, ABC transporters, permeases, genes involved in cell wall biogenesis (glucan 
synthesis, glycosylation, GPI-anchor, adhesion), genes involved in metabolism (glyoxylate 
cycle, iron metabolism), peroxisomal genes, phospholipid biosynthesis and histone 
modification genes. Also genes with no obvious homology to S. cerevisiae genes were 
selected. 
Targeted gene disruption with short homology flanking regions is rather inefficient in 
C. glabrata. Highest targeting efficiency was obtained using 500 bp long homology flanking 
regions (Ueno et al., 2007). To achieve more efficient gene replacement suitable for a large-
scale gene deletion project, we modified a fusion PCR technique (Noble & Johnson, 2005), 
which enabled us to generate gene deletion constructs with long homology flanking regions 
in a large-scale approach. The first step involved individual PCR reactions of the homology 
flanking regions from genomic DNA and the amplification of the dominant marker NAT1 from 
plasmid pTS50 (pGEMT-U2-NAT1-D2). Vector pTS50 carries the NAT1 marker flanked by 
the constant U2 and D2 sequences needed for addition of the unique barcode sequences 
(Shen et al., 2005). The resulting three fragments were combined via the complementary 
tails (U1 and D1) in the fusion PCR reaction. The product is a deletion construct with a 
dominant selectable marker flanked by 500 bp gene-specific upstream and downstream 
sequences (Figure 14A, B and Material & Methods). 
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For future high-throughput parallel analysis of mutant strains, we adopted the 
signature-tagged mutagenesis approach (Giaever et al., 2002, Hensel et al., 1995, Liu et al., 
2008, Saenz & Dehio, 2005). For this purpose, individual mutant strains are labeled with two 
unique DNA barcode sequences to allow for the identification and quantification of each 
strain from a mixed strain pool. This way it is possible to test a large number of strains at the 
same time for their virulence properties in vivo or their fitness in vitro. We employed two 
times 96 barcode sequences originally created for the S. cerevisiae genome deletion project 
(Giaever et al., 2002, Winzeler et al., 1999). This is convenient, because the same arrays 
can be used for identification and quantification of C. glabrata mutants. These 192 tag 
sequences, as well as the constant sequences to amplify the barcodes were also checked 
for their sequence homology against the C. glabrata genome to avoid false primer binding 
(Table 9 Materials and Methods). Thus, each gene deletion cassettes consisted of a the 
dominant NAT1 marker flanked by unique upstream and downstream barcode sequences 
and 500 bp long homology regions for targeted gene replacement by homologous 
recombination. 
 
 
Figure 14. The sequential steps for generation of C. glabrata gene deletion cassettes. (A) Fusion PCR using the 
dominant selectable marker NAT1 was applied to generate barcoded gene deletion cassettes. A set of two times 96 unique 
barcode sequences was integrated in oligonucleotides to amplify the marker fragment and to add overlap sequences. (B) Gene 
disruption by replacement of the target gene based on homologous recombination. C. glabrata strain HTL was transformed by 
an electroporation method. (C) Verification of correct integration of the deletion cassette by colony PCR (forward primer outside 
flanking region, reverse primer inside marker) checking both junctions. Loss-of-gene PCR (internal primer pair) was used to 
confirm that the coding sequences has not reintegrated in the genome. Reintegration, indicating that the CDS remained in the 
genome, gave a 500 bp PCR product. 
 
For gene disruption, the background strain HTL was transformed with a modified 
parallel 96-well format electroporation protocol (Reuss et al., 2004). About 12 to 16 
transformants per transformation and targeted gene were grown on selective medium and 
each was tested for correct genomic integration by colony PCR verifying both 5’ and 3’ 
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junctions (Figure 14C). With a maximum of three transformation rounds per gene, we were 
able to delete 476 genes representing 55 % of the selected genes and 9 % of the entire C. 
glabrata genome. Because illegitimate recombination can take place in C. glabrata (Cormack 
& Falkow, 1999), we also tested the deletion strains for the absence of the open reading 
frame (ORF) with a primer pair binding inside the ORF sequence (Figure 14C). Applying this 
loss-of-gene PCR on all transformants verified by colony PCR (297 genes, 852 deletion 
strains), we were able to exclude 13 strains (4.4% of targeted genes), yielding a PCR 
product in all three independent transformants. In 20 other strains, only one or two of the 
three independent transformants gave a PCR product, indicating that at least one generated 
deletion strain is correct. Deletion strains used for more detailed functional studies were 
confirmed for correct integration of the deletion cassette by Southern analysis (data not 
shown). 
5.3 Efficient deletion of PBS2, CDR1, PDR1 and SLT2 in strain HTL 
To validate the method of using long homology flanking regions for more efficient 
gene targeting in C. glabrata, gene deletion strains with well-described phenotypes were 
generated. Genes involved in osmosensitivity (PBS2), drug resistance (CDR1, PDR1), and 
cell wall stress (SLT2) were targeted and the mutants tested for growth under restrictive 
conditions. 
Survival of S. cerevisiae under hyperosmotic conditions requires the HOG pathway. 
Deletion of the MAPKK ScPBS2 renders cells unable to grow on high osmolarity medium 
(Brewster et al., 1993). Recently, it was demonstrated that the HOG pathways of S. 
cerevisiae and C. glabrata share similar functions in osmostress adaptation (Gregori et al., 
2007). The deletion of PBS2 - generated in the large-scale deletion project – also resulted in 
a sodium chloride (NaCl) sensitive deletion strain (Figure 15A). 
C. glabrata is known to be inherently more tolerant to azoles. This resistance is 
mainly mediated by the ABC transporter Cdr1, Cdr2 and the transcription factor Pdr1 
(Sanglard et al., 1999, Vermitsky et al., 2006). Cdr1 and Cdr2 are homologues of S. 
cerevisiae ScPdr5, and Pdr1 is the only homologue of the baker’s yeast PDR transcription 
factors ScPdr1 and ScPdr3, the master regulators of pleiotropic drug resistance (PDR) (Balzi 
et al., 1987, Delaveau et al., 1994). Disruption of the C. glabrata CDR1 or PDR1 gene leads 
to drastically increased susceptibility to azoles (Sanglard et al., 1999, Vermitsky et al., 2006). 
With the C. glabrata cdr1∆ and pdr1∆ deletion strains of the library we reproduced the 
phenotypes of elevated azole susceptibility (Figure 15B). 
The conserved yeast protein kinase C (PKC) or cell wall integrity pathway (Figure 
15E) is activated in response to various stimuli such as heat stress, hypo-osmotic shock, 
mating pheromone and cell wall affecting agents (Levin, 2005). We reasoned that the PKC 
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pathway may have a strong influence on the pathogenicity and survival of C. glabrata in vivo, 
because it regulates cell wall integrity in response to external stresses (i.e. exerted by the 
host). Deletion of several PKC pathway genes in C. glabrata, including SLT2, resulted in a 
growth defect on medium supplemented with the fungal β-glucan synthase inhibitor 
caspofungin (CF) (Figure 15C). Also a mkk1∆ deletion strain showed CF sensitivity, which 
could be predicted by the lack of a redundant MKK2 gene (Figure 15E). The lack of C. 
glabrata MKK2 is also confirmed by a computational study, which found only one orthologue 
of the baker’s yeast MAPKK pair ScMkk1/ScMkk2 (Byrne & Wolfe, 2005). However, in 
contrast to S. cerevisiae, C. glabrata slt2∆ mutants are not sensitive to calcofluor white (CW) 
or congo red (CR) (data not shown) (Reinoso-Martin et al., 2003). 
 
 
Figure 15. Sensitivity of C. glabrata deletion strains to antifungals and osmostress. Deletion strains were grown to 
OD600 of 1.0, serial diluted to OD600 of 0.1, 0.01, 0.001 and 0.0001 and spotted onto YPD and YPD agar plates containing the 
indicated amounts of NaCl (A), fluconazole (B) and caspofungin (C). Plates were incubated at 30°C for 2 days and scanned. (D) 
Cultures of strain HTL and the indicated isogenic deletion strains were grown to the early-exponential-growth phase before 
adding caspofungin at a final concentration of 10 ng/ml. Samples were taken at the indicated time points and crude 
trichloroacetic acid (TCA) extracts prepared. Aliquots corresponding to 0.5 OD600 equivalents per lane were separated through 
10% SDS-PAGE gel. Immunoblotting was carried out using polyclonal anti-phospho p44/42 MAPK or anti-ScPgk1 antibodies. 
Detection of Pgk1 served as loading control. (E) Schematic drawing of the PKC cell wall integrity pathway. S. cerevisiae harbors 
two redundant MAPKKs (MKK1 and MKK2), whereas in C. glabrata only one homologue exists. cr = cross reaction 
 
Using a phospho-specific antibody raised against the dually phosphorylated p44/42 
MAP kinase, we showed that Slt2 of C. glabrata is rapidly phosphorylated upon CF stress 
(Figure 15D). Phosphorylation of Slt2 increased already after five minutes of stress. In a 
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wsc1∆ deletion strain, no increase of Slt2 phosphorylation was observed, indicating that 
Wsc1 is necessary for stress sensing and/or signal transduction. In contrast, in a fks1∆ strain 
Slt2 is constitutively phosphorylated. The loss of a fully functional glucan synthase Fks1 
probably leads to cell wall defects resulting in a constant activation of the cell wall integrity 
pathway. 
These data indicate that the PKC pathways in S. cerevisiae and C. glabrata share 
several similar functions in response to CF. However, sensitivity to other cell wall affecting 
agents such as CW or CR differs. In S. cerevisiae, the deletion of ScSLT2 results in 
hypersusceptibility to CF as well as to CR, CW, and caffeine (Reinoso-Martin et al., 2003). 
Interestingly, a Scmkk1∆ deletion strain is not sensitive, because ScMKK2 can functionally 
compensate for the loss of ScMKK1. The loss of the redundant C. glabrata homologue of 
ScMKK2 is one example for a so-called “stream-lined” C. glabrata genome, which means 
that C. glabrata lost redundant genes during its evolution possibly due to the close 
adaptation to its mammalian host (Kaur et al., 2005). 
Taken together, these data demonstrate that the employed fusion PCR approach 
combined with the adapted electroporation protocol and the use of the dominant selection 
marker comprise a reliable and efficient method of targeted gene deletion in C. glabrata.  
5.4 Large-scale phenotypic profiling of the C. glabrata gene deletion library 
With a few exceptions, virulence factors of C. glabrata are not well understood. For 
identification of genes that modify the virulence properties and alter the drug resistance 
profile of C. glabrata, the complete gene deletion strain library was screened for growth 
phenotypes under various stress conditions. The large-scale robotic-based primary 
screening scored for growth sensitivity to cell wall affecting compounds (calcofluor white 
(CW), congo red (CR), sodium dodecyl sulfate (SDS)), to temperature stress (25°C, 37°C, 
42°C), to hyperosmotic conditions (NaCl), for tolerance to metal ions (LiCl, MgCl2, CaCl2, 
MnCl2, CdCl2, ZnCl2), antifungal susceptibility (fluconazole (FLC), voriconazole (VOR), 
amphotericin B (AMB), 5-flucytosine (5FLU)) and growth on minimal medium as well as the 
identification of morphological differences on cell and colony level. These stress conditions 
were chosen, because they may mimic stress, to which C. glabrata is exposed during 
colonization and infection in the host. 
In total, we screened all 476 generated strains for growth defects or phenotypic 
changes on solid and in liquid media. For plate assays, cells were spotted from a source 
plate onto plates supplemented with the diverse compounds or drugs and routinely grown at 
30°C. After 24, 48 and 72 hours, the plates were inspected for the colony phenotypes and 
scanned for documentation. For liquid assays, cells were grown in microtiter plates, using the 
endpoint dilution method, the OD600 was determined after 24 and 48 hours for each strain 
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and compared to the growth of the untreated cells. Some 103 strains (22 % of all 476 gene 
deletion strains) showed phenotypic differences or sensitivities to the tested compounds 
under at least one condition (Table 15, Figure 16 A, Table 16). The high number of mutants 
displaying various growth defects is most likely due to the gene selection, which shows a 
bias towards cell wall and signaling mutants. Six of the 103 strains showed sensitivities to 
more than six tested conditions (wsc1∆, cdc12∆, cwh41∆, ypk1∆, tpk2∆ and bcy1∆ deletion 
strains). The former three genes are implicated in cell wall biogenesis and morphology. The 
latter three are signaling components. Notably, all six mutants already displayed slower 
growth on full medium, which putatively also influences growth under all stress conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15. Summary of strains identified in primary and confirmation screenings. 
The primary screen was done in 96- or 384-well format, using a replica plating robot or microtiter plate assays. Primary hits 
were manually rescreened by spot assays on solid plates with serial dilutions. For liquid drug susceptibility assays, sensitivities 
were confirmed in triplicates. Strains that displayed aberrant growth (slow growth, different colony morphology) were inspected 
under the microscope. Numbers are not additive, because many mutants displayed several phenotypes. CR = congo red, CW = 
calcofluor white, SDS = sodium dodecyl sulfate, morph. = morphology 
 
A remarkably high number of mutants (46 strains) displayed growth defects at 
elevated temperatures (37°C and 42°C). We noticed that many of these strains are affected 
in cell wall assembly or biogenesis. The second largest group (34 strains) identified, included 
mutants with metal ion sensitivity, although about one third of those strains were susceptible 
to cadmium chloride only. The third group contained deletion strains showing CF 
hypersensitivity (33 strains) (Figure 16A). 
Some 22 mutants showed osmosensitivity phenotypes, 13 strains were sensitive to 
CW, 15 strains to CR and 28 strains to SDS followed by azole- (14 mutants) and 
amphotericin B- (13 mutants) susceptible strains. Notably, 17 strains did not stain brown on 
CuSO4-containing media, suggesting changes in the switching phenotypes. The smallest 
groups were comprised of caffeine-sensitive deletion strains (11 strains) and mutants unable 
Stress condition Primary screen Confirmation screen 
   
Temperature 50 46 
CW, CR, SDS 18, 16, 30 13, 15, 28 
Caffeine 14 11 
NaCl 24 22 
Metal ions 49 34 
CuSO4 (phenotypic switching) 50 17 
Minimal medium 8 5 
Caspofungin 41 33 
Azoles 26 14 
Amphotericin B 26 13 
5-Flucytosin 9 3 
Altered cell morphology - 11 
Altered colony morphology 12 13 
Total 144 103 
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to grow on minimal medium (5 strains). A set of 13 strains showed altered colony 
morphology or color and 11 strains aberrant cell morphologies. 
 
 
Figure 16. Summary of phenotypic analysis of all C. glabrata deletion strains. All 476 strains of the collection were 
tested for their sensitivity to cell wall-perturbing agents and metal ions, as well as heat- and osmostress, growth on minimal 
medium and antifungal susceptibility. (A) Shown are the absolute numbers of deletion mutants found to be sensitive under the 
indicated growth conditions. (B) Distribution of identified C. glabrata genes by functional categories according to the GO 
annotation of homologues in S. cerevisiae (numbers correspond to mutants per category; % is the percentage of the total 
number of identified sensitive strains).  
 
All 103 sensitive mutants were classified into functional categories based on the 
Saccharomyces Genome Database (http://www.yeastgenome.org/), including signal 
transduction, cell wall biogenesis and maintenance, transcription, vacuolar, endosomal, ER- 
and Golgi functions, protein fate, metabolism, transport, DNA-repair, cellular morphogenesis, 
lipid, fatty acid and sterol metabolism, mating and meiosis genes, iron homeostasis, 
chromatin, cytoskeleton, miscellaneous and unknowns (Figure 16B). 
Sorting the identified genes by the functional categories of S. cerevisiae homologues (Figure 
16B) showed that one quarter of the genes is involved in signalling functions, one quarter is 
implicated in cell wall biogenesis and maintenance (including glycosylation), and 12 % of 
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genes play roles as transcriptional regulators. This distribution reflects the bias in the gene 
selection, with the exception of transcriptional regulators. The transcriptional regulators are 
underrepresented in our gene selection, because they were supposed to be deleted by a 
collaboration partner. 
To be able to compare the growth defects of each mutant to the wild type control 
strains and to distinguish qualitative differences in the strength of the defect, we introduced a 
simple scoring system for the confirmation screenings. This scoring system differentiated 
four grades: not affected or no difference to wild type growth relates to zero (full growth in all 
dilutions as wild type), a slight or weak growth defect relates to one (•, no growth at highest 
dilution), an intermediate growth defect relates to two (••, growth only at two lowest 
dilutions), and a pronounced and strong growth defect or no growth relates to three (•••, no 
growth a any dilution or weak growth only at the lowest dilution). The following Table 16 
gives an overview of all mutants, showing growth phenotypes. It lists all 103 mutants of the 
deletion strain collection, which exhibited one or more different growth phenotypes under the 
tested conditions. The S. cerevisiae gene and ORF is assigned to every C. glabrata ORF, as 
well as the cellular location and a functional description. 
In the following chapters, the results of the different screenings, including the 
identified strains, are described in more detail. 
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Table 16. Summary of all 103 mutants displaying growth phenotypes. The scoring 
system differentiates four grades: Dots correspond to ••• pronounced, •• intermediate or • 
slight growth defect. CW = calcofluor white, CR = congo red, SDS = sodium dodecyl sulfate, 
Caf= caffeine, NaCl = sodium chloride, CF = caspofungin, Azole = fluconazole or 
voriconazole, AmpB = amphotericin B, 5-Flu = 5-Flucytosine, MM = minimal medium, Metal 
ion = CaCl2, MgCl2, ZnCl2, MnCl2, CdCl2, LiCl. Loc. = cellular localization (M = 
mitochondrium, C = cytoplasm, ER = endoplasmic reticulum, PM = plasma membrane, G = 
golgi, N = nucleus, CW = cell wall, V = vacuole). 
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5.4.1 Sensitivity to cell wall-perturbing agents and elevated temperatures 
The cell wall ensures structural integrity and forms a barrier against environmental 
changes. It is further important for adhesion to host tissue and represents the structural cell 
component, which is recognized by the host’s immune cells (Brown, 2006, de Groot et al., 
2008, De Las Penas et al., 2003, Iraqui et al., 2005, Kopp & Medzhitov, 2003). Cell wall 
defects can change these properties, resulting in a different cell wall composition. 
In a primary screening for CW, CR and SDS sensitivity, we identified deletion mutants 
exhibiting cell wall defects. The fluorescent dye CW binds to chitin and interferes with its 
polymerisation; CR interferes with the cell wall glucan, thereby inhibiting growth (Ram et al., 
1994, Roncero & Duran, 1985); and the detergent SDS putatively acts on the plasma 
membrane and surface proteins, which play a role in cell wall assembly. Defective cell walls 
may also facilitate the access of SDS to the membrane, causing cell lysis (Bickle et al., 1998, 
Igual et al., 1996). In addition, we screened for growth at elevated temperatures (37°C and 
42°C), since cells deficient of a normal cell wall often display cell lysis under high 
temperature conditions. 
 
 
 
Figure 17. Sensitivity of C. glabrata deletion mutants to cell wall-perturbing agents. Cells were spotted on medium 
supplemented with calcofluor white (CW), congo red (CR) or sodium dodecyl sulfate (SDS) at the indicated concentrations and 
incubated for 48 hours at 30°C. Strains that did not show any SDS sensitivity in the large-scale screening were not screened in 
confirmation tests; n.d. = not determined, because the strains didn’t show a growth defect in the large-scale primary screening. 
(B) Venn diagram showing correlation of deletion strains exposed to different cell wall perturbing agents (CW = Calcofluor 
White, CR = Congo Red). (C) Correlation of growth deficient mutants under heat stress, exposed to Caspofungin or to cell wall-
perturbing agents (CWP). 
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A large group of mutants displayed hypersensitivity to cell wall-perturbing agents (44 
strains, Figure 18A), mainly affected in signaling transduction and cell wall biogenesis and 
maintenance. Most of the 46 identified temperature-sensitive deletion strains also lack genes 
implicated in signaling pathways and cell wall biogenesis (Figure 18B). 
Some 13 mutants were confirmed to be hypersensitive to CW, 15 to CR and 28 to 
SDS (Table 15, Figure 17 B). Several mutants displayed growth defects under all three 
stress conditions, indicating that their cell wall integrity is severely affected. Interestingly, five 
mutants (kre1∆, cna1∆, cnb1∆, pbs2∆, arb1∆) were sensitive to CW and SDS but not to CR 
and seven mutants (rot2∆, mnn10∆, big1∆, ktr2∆, mck1∆, anp1∆, ost3∆) were only sensitive 
to CR but not to the other two substances, indicating that CR has another impact on the cell 
wall than CW or SDS. Interestingly, the overlap between mutants sensitive to cell wall-
perturbing compounds and elevated temperatures was higher, than the overlap of cell wall-
perturbing compounds and CF-susceptible mutants (Figure 17C). 
Most of the mutants sensitive to cell wall-perturbing agents as well as to increased 
temperature are involved in glycosylation and cell wall biogenesis. Based on their homology 
to S. cerevisiae genes, identified C. glabrata mutants lacking KTR2, PSA1, CWH41, and 
MNN10 are involved in glycosylation and mannosylation (Ballou et al., 1989, Hashimoto et 
al., 1997, Lussier et al., 1996, Jiang et al., 1996). KRE1 is a cell wall constituent implicated in 
β-1,6 glucan synthesis (Boone et al., 1990). Lack of KRE1 results in reduced fitness as well 
as CW and SDS sensitivity. Lack of the septin homologue CDC12 results in improper cell 
separation and growth sensitivity to various cell wall-perturbing stresses (Figure 17 and 31D) 
similar as in S. cerevisiae (Cid et al., 2001). OST3, BIG1, ROT2 and ANP1 function in cell 
wall biogenesis (Azuma et al., 2002, Burda & Aebi, 1999). Remarkably, C. glabrata deletion 
mutants of the former three genes underwent cell lysis at 37°C, suggesting that their cell wall 
is severely weakened. In contrast to C. glabrata, a growth defect is documented for the S. 
cerevisiae rot2∆ mutant (Trombetta et al., 1996). Cell wall mutants lacking the protein O-
mannosyltransferase genes PMT2, PMT4 and LAS21, which are implicated in synthesis of 
the GPI-anchor core structure (Benachour et al., 1999, Girrbach & Strahl, 2003) and CWH43, 
encoding a putative transporter protein involved in cell wall biogenesis (Ram et al., 1994), 
displayed temperature and CF but no CW, CR or SDS sensitivity. 
A C. glabrata mutant lacking SSD1 was heat sensitive and additionally showed 
growth defects on NaCl and CF. The growth phenotype of the C. glabrata deletion strain 
suggests an altered cell wall composition. Likewise, the baker’s yeast ssd1∆ mutant is 
unable to grow at high temperatures and displays an altered cell wall phenotype resulting in 
flocculation (Wheeler et al., 2003). Remarkably, the S. cerevisiae SSD1 gene is connected to 
virulence, because this mutant is more virulent causing rapid death of the mice in a murine 
infection model (Wheeler et al., 2003). 
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Out of 28 mutants, 17 were hypersensitive to the detergent SDS only. Some of these 
mutants are rather involved in metabolism and membrane functions than in cell wall 
biogenesis. For example, ScFaa2 is involved in lipid metabolism and functions as a long 
chain fatty acyl-CoA synthetase (Johnson et al., 1994). A C. glabrata faa2∆ strain displayed 
growth deficiencies on SDS and at increased temperature. A cne1∆ deletion strain was also 
unable to grow on media containing SDS and under elevated temperatures. CNE1 is a 
homologue of the mammalian calnexin, an ER-located integral membrane chaperone which 
is involved in quality control of glycoproteins (Parlati et al., 1995). This suggests that, on one 
hand, SDS indirectly affects the cell wall by acting on membrane lipids and proteins, but that, 
on the other hand lipid biosynthesis-deficient mutants also become hypersensitive for SDS. 
 
 
Figure 18. Distribution of mutants sensitive to cell wall-perturbing agents and temperature stress. Functional 
categories were assigned using the Saccharomyces Genome Database GO data (http://www.yeastgenome.org/). (A) Mutants 
sensitive to the cell wall-perturbing agents CW, CR, SDS and Caffeine. (B) Mutants sensitive to elevated temperatures (37°C, 
42°C). CWP = cell wall-perturbing agents; Temp. = temperature stress. 
 
In addition to cell wall mutants, many C. glabrata signaling pathway mutants 
displayed growth defects when exposed to cell wall-perturbing agents or temperature stress. 
These genes involve the PKA pathway regulatory subunit Bcy1, the cAMP-dependent protein 
kinase Tpk2, the two calcineurin subunits (Cna1 and Cnb1) and the HOG pathway 
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components Pbs2 and Sho1. Further, the wsc1∆ mutant, lacking the PKC pathway sensor, 
was very sensitive to all tested growth conditions affecting the cell wall. The PKA-pathway 
associated genes KRH1 and PDE2 (Thevelein & de Winde, 1999) and the sphingolipid-
mediated pathway signaling components Pkh2 and Ypk1 (Levin, 2005) were only sensitive to 
heat stress but not to CR, CW or SDS. 
In summary, most of the detected C. glabrata deletion mutants with decreased 
tolerance to cell wall perturbing agents or growth deficiencies at elevated temperatures 
showed similar phenotypes as described for S. cerevisiae mutants. However, not all C. 
glabrata mutants showed an identical susceptibility pattern, suggesting that basic functions 
and regulation are similar but specific differences exist between the pathogenic C. glabrata 
and the non-pathogenic S. cerevisiae.  
5.4.2 Caffeine sensitivity 
In S. cerevisiae, exposure to the alkaloid caffeine activates the cell wall integrity 
pathway. PKC pathway mutants display an altered sensitivity to caffeine, implying that 
caffeine affects cell wall assembly or composition (de Groot et al., 2001, Martin et al., 1996, 
Martin et al., 2000). Recent findings disclosed TORC1 (target of rapamycin complex) as one 
of the major caffeine targets (Reinke et al., 2006, Wanke et al., 2008). The TOR pathway 
regulates cellular growth in response to stresses and nutrient availability (Cardenas et al., 
1999, Loewith et al., 2002). Therefore, we screened for growth on caffeine-supplemented 
medium, because the caffeine-affected TOR pathway and other caffeine targets may have 
an impact on virulence. 
 
Figure 19. Caffeine sensitivity of C. glabrata 
deletion strains. Deletion strains were grown to 
OD600 of 1.0, serial diluted to OD600 of 0.1, 0.01, 
0.001 and 0.0001 and spotted onto YPD and YPD 
agar plates containing the indicated amounts of 
caffeine and caffeine + sorbitol. Plates were 
incubated at 30°C for 2 days and pictures taken 
with the spImager system (S&P Robotics, Canada).  
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Only a small set of eleven C. glabrata genes showed caffeine sensitivity. Although we 
were not able to delete TOR1 of C. glabrata, a mutant lacking TCO89, a TORC1 subunit, 
was unable to grow on YPD supplemented with 7 mM of caffeine. The hypersusceptible 
phenotype of a tco89∆ mutant confirms that the TOR pathway is also a major target of 
caffeine in C. glabrata. 
Several strains lacking cell wall-related genes (cdc12∆, cka2∆, cwh41∆, dse2∆, 
tos6∆) showed a slight to intermediate caffeine sensitivity. A psa1∆ mutant was severely 
affected by caffeine, similar as the cell wall-related signaling pathway genes (wsc1∆, ypk1∆, 
pkh2∆ (CAGL0I07513g); Figure 19). Some caffeine-sensitive mutants were osmoremedial as 
addition of 0.5 M sorbitol rescued wsc1∆ and pkh2∆ strains. The osmoremedial growth 
phenotype of these two mutants is consistent with their implication in cell wall biogenesis. 
The tco89∆, ypk1∆ and psa1∆ deletion strains were unable to grow on caffeine and were not 
rescued by sorbitol. A sensitive strain lacking TPK2 was detected in the primary screening 
for caffeine sensitivity but could not be confirmed. The identification of caffeine-sensitive 
mutants (dse2∆, cwh41∆, tos6∆, cdc12∆), which additionally displayed altered cell 
morphologies (see Figure 29) supports the idea that caffeine indeed influences cell wall 
integrity in C. glabrata. 
5.4.3 Susceptibility to the fungal β-glucan synthase inhibitor caspofungin 
The fungal cell wall is a potential target of antifungal drugs. Caspofungin (CF) is a 
potent inhibitor of the fungal β-glucan synthase (Onishi et al., 2000). Expression of the 
glucan synthase subunits depends on the cell cycle and is regulated in response to cell wall 
integrity (Levin, 2005). Remarkably, cell wall integrity pathway mutants of S. cerevisiae are 
unable to grow on CF-supplemented medium (Reinoso-Martin et al., 2003). 
The known mechanisms for caspofungin resistance are mainly based on hot-spot 
mutations in one of the β-glucan synthase subunits (Cota et al., 2008, Park et al., 2005, 
Katiyar et al., 2006, Thompson et al., 2008, Cleary et al., 2008, Garcia-Effron et al., 2009). 
Additional data demonstrate that the calcineurin pathway might act in synergy with the PKC 
pathway to regulate the cell wall-dependent stress response (Steinbach et al., 2007, 
Wiederhold et al., 2005, Perlin, 2007). 
We performed a plate based screen on solid medium, scoring for CF-susceptible 
mutants, to identify novel C. glabrata genes implicated in CF sensitivity. The screen revealed 
a large number of genes, mainly involved in cell wall-associated and signaling functions or 
acting as transcriptional regulators (Figure 20 & 21, Table 16). As expected the glucan 
synthase mutant fks1∆ and the MAP-kinase mutant slt2∆ were susceptible to CF but also 
many novel genes not previously associated with CF sensitivity were identified. For instance, 
many cell wall biosynthesis mutants implicated in glycosylation (alg5∆, alg6∆, ost3∆) and 
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mannosylation (pmt2∆, pmt4∆, mnn10∆, anp1∆, mnt3∆, ktr1∆), as well as other cell wall-
associated functions (ssd1∆, dse2∆, cbk1∆) displayed growth defects on CF-supplemented 
media. 
The strong effect on cell wall-defective mutants suggests that CF may also target 
other cell wall components or associated proteins than the fungal β-glucan synthase. 
However, the only validated CF target so far, is the fungal glucan synthase (Perlin, 2007). 
Therefore, it appears that a functional cell wall is necessary for CF tolerance. In other words, 
a functional cell wall may buffer the negative effects of glucan synthase inhibition by CF. This 
view is confirmed by a study on C. albicans cell wall genes (Plaine et al., 2008). Mutants with 
thin cell walls were found to be more sensitive to CF, while those with thicker cell walls are 
more resistant. In addition, the transcriptional profiling of C. albicans exposed to CF 
performed in our (Gregori C., unpublished data) and other labs (Liu et al., 2005) identified 
several cell wall genes upregulated in response to CF. Expression profiling of S. cerevisiae 
also demonstrated CF-induced upregulation of many cell wall genes (Agarwal et al., 2003). 
Taken together, a weakened cell wall may result in higher CF sensitivity, while a cell 
wall strengthened with other components such as chitin helps to compensate the lack of 
glucan and to survive CF stress (Walker et al., 2008). 
 
 
Figure 20. Distribution of CF-sensitive mutants. Gene annotations were assigned as in Figure 18. A total of 33 mutants 
displayed CF sensitivity, which differ largely from the genes found to be sensitive to the other tested antifungals. 
 
The screen for CF susceptibility also identified several signaling components 
implicated in CF-stress sensing, such as the PKC (WSC1, BCK1, MKK1, SLT2, RLM1) and 
calcineurin (CNA1, CNB1, CRZ1) pathway components (Figure 21, Table 16). C. glabrata 
mutants lacking the PKC stress sensor protein Wsc1 showed a pronounced susceptibility to 
CF. In general, Wsc1 appeared to be essential for sensing a variety of stresses, which affect 
cellular integrity. Thus, Wsc1 may represent an essential surface stress sensor of C. glabrata 
and may also signal via several different pathways. Therefore, Wsc1 is also likely to be 
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involved in virulence and adaptation to diverse host niches, because it appears to be 
involved in sensing various environmental changes that affect the cell wall. 
Interestingly, the C. glabrata genes encoding the MAP-kinases of the PKC pathway 
are almost exclusively sensitive to CF. In contrast, S. cerevisiae MAPK-kinase mutants are 
sensitive to CF, CR and CW (Reinoso-Martin et al., 2003). This difference may provide an 
indication for a transcriptional rewiring of the cell wall integrity pathway in C. glabrata, 
controlling the expression of a differing set of cell wall genes. 
Remarkably, the C. glabrata YPK1 homologue was also essential for growth on CF, 
indicating a putative connection of the sphingolipid-mediated signaling and the PKC pathway. 
Ypk1 as well as Pkh2 are kinases acting in the sphingolipid-mediated signaling pathway 
(Levin, 2005). In addition, ypk1∆ and pkh2∆ mutants exhibited cell lysis at elevated 
temperatures, suggesting an implication in cell wall integrity. Furthermore, the ypk1∆ strain 
was also sensitive to a variety of metal ions, caffeine and the antifungal drug amphotericin B. 
These growth phenotypes suggest that Ypk1 functions in a second parallel cell integrity 
pathway of C. glabrata, which may be connected to the PKC pathway. 
 
 
 
Figure 21. Sensitivity of C. glabrata deletion strains to caspofungin. Wild type ATCC2001, HTL and isogenic deletion 
strains were grown to OD600 of 1.0, serial diluted to OD600 of 0.1, 0.01, 0.001 and 0.0001 and spotted onto YPD and YPD agar 
plates containing the indicated amount of caspofungin. Plates were incubated at 30°C for 2 days and scanned or photographed. 
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In S. cerevisiae the ScYpk1/Ypk2 sphingolipid-mediated pathway is thought to 
function as a putative second cell integrity pathway, which cross-talks to the PKC pathway 
(Levin, 2005). Involvement of ScYPK2 in CF response was demonstrated by induced 
ScYPK2 expression upon CF exposure (Agarwal et al., 2003). Yeast cells lacking ScYPK1 
grow slowly and show severe actin polarization defects. ScYpk2 and ScYpk1 are redundant 
kinases, both of which can be activated by ScPkh1 and ScPkh2, functional equivalents of the 
mammalian 3-phosphoinositide-dependent protein kinase-1 (PDK1) (Levin, 2005). Cellular 
targets of ScYpk1 and -2 are not clear but ScSmp1 may be a target of ScYpk1 (Roelants et 
al., 2002). ScSmp1is related to the PKC pathway transcription factor ScRlm1. 
Moreover, mutants affected in the calcineurin pathway displayed growth defects on 
CF-supplemented media. Lack of the transcriptional regulator CRZ1 resulted in a severe 
defect on CF-supplemented media, cells lacking the catalytic calcineurin subunit CNA1 
displayed a slight growth deficiency (Figure 21). Calcineurin components may buffer for the 
cell wall stress exerted by CF, suggesting that inhibition of calcineurin signaling in C. glabrata 
may act synergistic with CF. This is consistent with studies in A. fumigatus, where inhibition 
of calcineurin signaling enhances the effect of cell wall inhibitors (Steinbach et al., 2007). In 
C. albicans, this synergistic effect influences the so-called paradoxical effect at high CF 
concentrations (Wiederhold et al., 2005). 
 A variety of other genes (RPD3, CDC12, SEC13, CKB2, CUE1, YSR3, SPP1, ERG5, 
DUN1, YFH1, SEC13,) implicated in various unrelated functions also showed CF sensitivity, 
indicating that the activity of many different genes is necessary for a full response to CF. 
Comparison of our list of CF-sensitive mutants with the data set of a CF sensitivity 
screening, using the S. cerevisiae deletion strain collection, revealed only a small overlap of 
genes (Lesage et al., 2004). The fks1∆, slt2∆, mnn10∆ mutants were found in both data sets 
to be sensitive to CF. Some other genes (CgERG5 and ScERG6, CgSNF6 and ScSNF2, 
CgCKB2 and ScCKA2) found in both sets are implicated in corresponding functional 
pathways. Interestingly, two genes displayed different sensitivity patterns. The lack of CRZ1 
and WSC1 resulted in CF susceptibility of C. glabrata mutants, while in S. cerevisiae the 
mutants were more resistant. Unexpectedly, the chitin synthase mutants showed no growth 
defect on CF-supplemented plates. In S. cerevisiae it was shown that cell wall stress leads to 
upregulation of chitin synthesis and deletion of chitin synthases results in CF hypersensitivity 
(Lesage et al., 2004). 
Comparison of our data set to an expression profile analysis in S. cerevisiae exposed 
to CF showed an overlap of several genes as well (Agarwal et al., 2003). PKC pathway 
genes (SLT2, RLM1) and several cell wall genes were identified in both studies. The overlap 
between the C. glabrata set and a data set of the genomic response to CF in C. albicans 
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gave only two similarly regulated genes, ERG5 and a glucan synthase subunit (Liu et al., 
2005). 
5.4.4 Azole susceptibility 
Reduced susceptibility to azole drugs is considered one of the major virulence factors 
of C. glabrata. Its resistance is mediated by upregulation of the ABC transporter genes CDR1 
and PDH1. These genes are controlled by the transcription factor Pdr1 (Sanglard et al., 
1999, Miyazaki et al., 1998, Izumikawa et al., 2003, Vermitsky & Edlind, 2004). 
To determine which genes further contribute to the decreased susceptibility of C. 
glabrata, we screened the mutant strain collection to commonly used antifungals in liquid 
medium containing either 6 µg/ml Fluconazole or 100 ng/ml Voriconazole, using an endpoint 
dilution assay in a 96-well microtiter plate format. The optical density was determined after 
24 and 48 hours of incubation at 30°C. Strains showing reduced growth of more than 50 % 
when compared to the wild type control were scored and rescreened in triplicates. Positive 
hits were used to perform a broth microdilution assay to determine the IC50 as described in 
Material and Methods. 
 
Figure 22. Distribution of azole-susceptible mutants. Gene annotations were assigned as in Figure 18. A total of 14 
mutants displayed azole susceptibility (fluconazole, voriconazole), which differ largely from the set of genes found to be 
sensitive to CF, AMB, and 5FLU. 
 
As expected, deletion of PDR1 and CDR1 resulted in a severe growth deficiency of 
the mutants exposed to azole stress (Figure 23 and 15B) (Sanglard et al., 1999, Vermitsky et 
al., 2006). A strain lacking PDH1 (CDR2) was not susceptible, which is consistent with the 
data that Cdr1 is more potent to confer azole resistance (Sanglard et al., 2001). 
We identified four cell wall mutants (ktr2∆, cwh41∆, ssd1∆, ktr6∆) with intermediate 
sensitivity to azoles (Figure 23B). This suggests that azole inhibition of ergosterol 
biosynthesis affects the cell wall due to perturbation of the fungal plasma membrane. Thus, 
inhibition of ergosterol biosynthesis may act synergistic with certain cell wall defects, perhaps 
because a perturbed cell wall facilitates the access of azoles to the plasma membrane. 
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Figure 23. Growth susceptibilities of C. glabrata mutants to azole derivatives. Susceptible strains identified in the 
primary screenings were subjected to IC50 determination. Overnight cultures were grown to OD600 of 1.0 and a microdilution 
assay was carried out in YPD to determine IC50 as described in Materials and Methods. The optical density (OD) of each well 
was determined at 600 nm on a microplate reader after 24 h and 48 h of incubation at 30°C. Each strain was tested in triplicates 
and mean values normalized to the untreated control were plotted against the antifungal concentration. The IC50 was calculated 
by nonlinear regression (curve fit), using GraphPadPrism. (A) Fluconazole, (B) voriconazole. Shown are data of 24 h 
measurement. Bars denote standard deviations. 
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Interestingly, several stress signaling mutants (slt2∆, wsc1∆, ypk1∆, cna1∆, cnb1∆, 
cka2∆) displayed also slight to intermediate azole sensitivities. Whereas wsc1∆ and ypk1∆ 
mutants showed intermediate susceptibilities to azoles, the slt2∆ strain was only very slightly 
affected. All three genes participate in cell wall integrity pathways, further indicating that 
azoles influence the cell wall integrity of C. glabrata. 
Both calcineurin pathway mutants cna1∆ and cnb1∆ also displayed azole sensitivity, 
supporting the idea that several signaling pathways participate in the response to azole 
drugs. Recent data show that calcineurin inhibitors may have a synergistic effect with azoles 
in C. glabrata (Kaur et al., 2004, Onyewu et al., 2003). The synergism between calcineurin 
inhibitors and azoles is also well-documented for C. albicans (Onyewu et al., 2003, Sanglard 
et al., 2003).  
In addition, a strain lacking CAGL0D02750g displayed increased azole sensitivity. 
CAGL0D02750g is a gene of unknown function. Also a deletion strain lacking the zinc finger 
transcription factor gene HAP1 was slightly sensitive to voriconazole. S. cerevisiae ScHap1 
is involved in regulation of gene expression in response to oxygen and heme levels (Kwast et 
al., 1998). 
5.4.5 Amphotericin B and 5-Flucytosine susceptibility 
The polyene amphotericin B (AMB) interferes with membrane ergosterol, resulting in 
cell leakage due to perturbation of the plasma membrane (Akins, 2005). Some 13 mutants 
showed increased sensitivities to AMB (Figure 22 & 23). The most sensitive strains lack 
genes, which play diverse roles in phospho- and sphingolipid regulation (ypk1∆), signaling 
(cka2∆), transcriptional regulation (dep1∆, rox1∆, snf6∆) and endocytosis (vps15∆). 
 
Figure 22. Distribution of amphotericin B-susceptible mutants. Gene annotations were assigned as in Figure 18. A 
total of 13 mutants displayed amphotericin B susceptibility. 
 
The vps15∆, ypk1∆ and cka2∆ strains showed the most pronounced susceptibilities 
(Figure 23). Deletion of CKA2 in C. glabrata caused intermediate sensitivity to AMB. Cka2 is 
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the catalytical subunit of the casein kinase and plays a role in cell growth and viability 
(Ahmed et al., 2002). Thus, C. glabrata Cka2 may function in general stress response 
needed for survival under plasma membrane stress conditions. 
A mutant lacking VPS15 was severely affected in growth on media containing AMB. 
Exposure to azoles or other drugs did not affect the vps15∆ mutant. Interestingly, the S. 
cerevisiae homologue of VPS15 is involved in membrane trafficking, vacuole segregation 
and endocytosis (Stack et al., 1995). Thus, VPS15 may be essential for maintenance of the 
C. glabrata plasma membrane under AMB stress conditions. The vps15∆ deletion strain may 
be unable to counteract the perturbation of the plasma membrane caused by AMB due to a 
membrane trafficking defect. 
 
 
 
Figure 23. Growth susceptibilities of C. glabrata mutants to amphotericin B. Susceptible strains identified in the 
primary screening were subjected to IC50 determination. Over night cultures were grown to OD600 of 1.0 and a microdilution 
assay carried out in YPD to determine IC50 as described in Materials and Methods. The optical density (OD) of each well was 
determined at 600 nm on a microplate reader after 24 h and 48 h of incubation at 30°C. Each strain was tested in triplicates and 
mean values normalized to the untreated control were plotted against the antifungal concentration. The IC50 was calculated by 
nonlinear regression (curve fit), using GraphPadPrism. Shown are data of 24 h measurement. Bars denote standard deviations. 
 
Three mutants (acf2∆, myo2∆, npr1∆) were found in the 5’-Flucytosine (5FLU) 
screening. 5FLU is a DNA and RNA synthesis inhibitor. In the cell, 5FLU is converted into 5-
fluorouracil and incorporated into RNA, leading to the disruption of protein synthesis 
(Ghannoum & Rice, 1999). In S. cerevisiae, genes implicated in sensitivity or resistance to 
5FLU are involved in protein synthesis, DNA synthesis and DNA repair functions as identified 
by genome-wide expression profiling (Agarwal et al., 2003). 
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The identified C. glabrata genes (acf2∆, myo2∆, npr1∆) showed slight sensitivities 
only after 24 hours of growth. They are functionally unrelated and thus, might have to be 
studied in more detail to investigate their role in 5FLU sensitivity. 
5.4.6 Growth on minimal medium 
C. glabrata is able to colonize different host environments with variable supplies of 
nutrients. A mutant defective in metabolic functions may be impaired in establishing full 
virulence. Increased expression of metabolic genes after internalization by macrophages 
shows that C. albicans is able to adapt its metabolism to different host environments (Lorenz 
et al., 2004). To test if some of the mutant strains depend on exogenous nutrient supply, we 
screened for growth on minimal medium. 
 
Figure 24. Growth on minimal medium.  
Deletion strains were grown to OD600 of 1.0, serial 
diluted to OD600 of 0.1, 0.01, 0.001 and 0.0001 and 
spotted onto YPD agar plates and minimal medium 
plates (YNB, ammonium sulfate, glucose, Histidine, 
Leucine and Tryptophan). Plates were incubated at 
30°C for 2 days and pictures taken with spImager 
system (S&P robotics, Canada). 
 
 
 
 
 
 
Four strains (arg81∆, met16∆, yfh1∆, kre6∆) were unable to grow on minimal 
medium, and two showed slightly reduced growth (bcy1∆, kre1∆) (Figure 24). The deletion 
strains arg81∆, met16∆ lack genes involved in arginine biosynthesis and methionine 
metabolism. These genes may have an influence on colonization of host niches with low 
nutrient availability or for survival in the nutrient-depleted phagosome. Cells impaired in 
certain metabolic reactions may fail in adapting to the harsh phagosomal conditions. 
The identification of a kre6∆ mutant in this screen was likely due to its overall very 
slow growth phenotype and was not further tested. 
5.4.7 Sensitivity to high osmolarity conditions 
As a unicellular opportunistic pathogen, C. glabrata is also exposed to fluctuations in 
the osmolarity of the host environment. Depending on the colonization of a certain host niche 
(e.g. gastro-intestinal or urogenital tract) and the course of disease (C. glabrata in blood 
stream, organ colonization, phagosome), environmental parameters such as osmolarity are 
likely to change. 
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In S. cerevisiae, the HOG pathway is essential to adapt to high-osmolarity conditions. 
This canonical MAPK pathway mediates adaptation through regulation of intracellular 
glycerol levels (Gustin et al., 1998). The two sensory branches ScSln1 and ScSho1 converge 
into one pathway, transmitting the signal to several transcription factors (Hohmann, 2002). 
Deletion of the MAPK ScHOG1 and the MAPKK ScPBS2 renders cells osmosensitive 
(Brewster et al., 1993). 
To identify C. glabrata genes involved in the adaptation to hyperosmolarity, we 
screened the mutant collection against high concentrations of NaCl (1.1 M), yielding 22 NaCl 
sensitive strains (Table 16). 
 
 
Figure 25. Distribution of osmosensitive mutants. Gene annotations were assigned as in Figure 18. A total of 22 
mutants displayed growth defects on NaCl-supplemented media. 
 
Deletion strains lacking homologous genes of the HOG pathway (pbs2∆, ste20∆, 
ste50∆, sho1∆) were unable to grow on NaCl-supplemented medium. A strong 
osmosensitive phenotype was also found for a mutant lacking the protein phosphatase 
PTP2, supporting the notion that the C. glabrata HOG pathway is indeed similarly regulated 
as the one in S. cerevisiae. ScPtp2 regulates ScHog1 localization in baker’s yeast. Its 
overexpression suppresses the toxic effect of constitutively hyperactivated ScHog1 (Mattison 
& Ota, 2000, Wurgler-Murphy et al., 1997). PTP2 is essential for adaptation to osmostress of 
C. glabrata as the ptp2∆ deletion strain is inviable under salt stress conditions. 
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Figure 26. Osmosensitivity of C. glabrata mutants. Deletion strains were grown to OD600 of 1.0, serial diluted to OD600 of 
0.1, 0.01, 0.001 and 0.0001 and spotted onto YPD and YPD agar plates supplemented with NaCl at the indicated 
concentrations. Plates were incubated at 30°C for 2 days and scanned for documentation.  
 
The baker’s yeast PKC pathway is also involved in sensing osmolarity changes, 
activating ScPkc1 in response to hypotonic shock (Davenport et al., 1995). In contrast, we 
found that a C. glabrata wsc1∆ mutant is incapable to grow under high osmolarity conditions. 
Other signaling pathway mutants (bcy1∆, tpk2∆, skn7∆) showed also sensitivities to 
hypertonic conditions. In addition, several cell wall mutants were restricted in growth on 
NaCl, indicating that the weakened cell wall may not be able to compensate the stress 
exerted by hyperosmolar conditions. 
In summary, most C. glabrata deletion strains with high osmolarity phenotypes lack 
genes, which have already been associated with osmoregulation in baker’s yeast. This 
confirms that the high osmolarity stress response of C. glabrata is similar to S. cerevisiae 
(Gregori et al., 2007). However, osmosensitive C. glabrata mutants may exhibit altered 
virulence because of their inability to adapt to osmolarity changes in the host environment. 
5.4.8 Sensitivity to metal ions 
Several metal ions are essential trace elements for all organisms. Cu2+, Co2+, Zn2+, 
Fe3+ and Mn2+ act as enzyme cofactors involved in a variety of redox reactions. However, 
accumulation of these ions or heavy metals such as Cd2+, Pb2+ and Hg2+ are toxic to cells, 
because they can interfere with biological or catalytical protein activity (Mendoza-Cozatl et 
al., 2005, Dichtl et al., 1997, Lapinskas et al., 1996, Rosen, 2002). Accumulation beyond 
physiological concentrations of ions such as Ca2+, perturbs the natural calcium ion 
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homeostasis, interfering with cell signaling and stress response (Kraus & Heitman, 2003). 
Therefore, organisms have developed several mechanisms to control metal ion homeostasis. 
 
 
Figure 27. Distribution of metal ion-sensitive mutants. Gene annotations were assigned as in Figure 18. A total of 34 
mutants displayed growth defects on various metal ion-supplemented media. A large number of strains was sensitive to CdCl2 
only and several showed overlapping sensitivities to NaCl stress. 
 
To identify C. glabrata genes involved in tolerance to metal ion stress, the deletion 
strain library was screened for growth on high concentrations of various (heavy) metal ions, 
including CaCl2, MgCl2, ZnCl2, MnCl2, CdCl2, and LiCl. Out of 49 primary hits, 34 strains were 
confirmed to be sensitive to the various ions (Table 16 & 17). Some 24 mutants were unable 
to grow on cadmium containing medium. Out of these, 10 strains showed cadmium 
sensitivity only, and were not inhibited by any other metal ion. 
Many of these metal-ion sensitive strains lack cell wall biosynthesis genes. 
Osmosensitive C. glabrata mutants lacking STE50, SHO1, PBS2, WSC1 and calcineurin 
showed additional growth deficiencies on media containing calcium, magnesium, zinc and 
lithium. 
 Deletion of the metabolic genes PFK1 and FAA2 led to severely reduced growth on any of 
the tested metal ions. Mutants lacking genes involved in vesicular transport processes 
(PEP12, DID4) also displayed decreased metal ion sensitivity. 
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CgORF Gene 500 mM CaCl2 
600 mM 
MgCl2 
8 mM 
ZnCl2 
2 mM 
CdCl2 
40 mM 
LiCl 
5 mM 
MnCl2 
        
CAGL0A04587g ALG3    ••   
CAGL0E06028g ALG5    ••   
CAGL0E02629g ALG6    ••   
CAGL0L01331g ANP1 ••• ••• ••• •••   
CAGL0L11528g BIG1    •••   
CAGL0G02035g CKA2  ••     
CAGL0I00946g CKB2    •••   
CAGL0L11110g CNA1 ••      
CAGL0L00605g CNB1 ••   •••   
CAGL0K02827g DID4   •••    
CAGL0H09460g FAA2 ••• ••• ••• ••• ••• ••• 
CAGL0I06138g FAR1 •• ••    • 
CAGL0M05841g KTR2    •••   
CAGL0B03025g LAS21    •••   
CAGL0D02442g LEM3   ••    
CAGL0E01683g MCK1    •••   
CAGL0K11231g MNN10  •  •••   
CAGL0G06864g MPS3 ••• ••• ••    
CAGL0A01892g -    •••   
CAGL0D02750g -     •••  
CAGL0J08569g OST3    •••   
CAGL0L05632g PBS2 ••• •••  •••   
CAGL0I01012g PEP12 •• • ••• •••   
CAGL0F08041g PFK1 •• •• ••• ••• ••• ••• 
CAGL0L02827g PTP2 ••• •••  ••• ••• ••• 
CAGL0K06963g ROT2    •••  • 
CAGL0B01441 RPD3    •••   
CAGL0G03597g SHO1 ••• ••• ••• ••• ••  
CAGL0D01936g SNF7 ••• •• ••    
CAGL0B00858g STE50 ••• ••• •••  •••  
CAGL0D03146g SYS1     •• ••• 
CAGL0F01507g WSC1 •• ••• •• ••• ••• •• 
CAGL0M05643g YFH1  •••  •• •••  
CAGL0K03399g YPK1   •• ••• ••• •• 
Total 34 14 15 12 24 10 8 
 
Table 17. Summary of metal ion-sensitive C. glabrata mutants. Cells were spotted on medium supplemented with metal 
ions at the indicated concentrations and incubated for 48 hours at 30°C. Plates were scanned with a HP scanner. Dots 
correspond to ••• pronounced, •• intermediate or • slight growth defect. Blue labelled genes were only sensitive to CdCl2. 
 
The mitochondrial matrix iron chaperone YFH1 is implicated in cellular iron 
homeostasis (Foury & Talibi, 2001). Deletion of the C. glabrata homologue renders cells 
sensitive to Mg2+, Cd2+ and Li+, suggesting that it probably influences also metal ion 
homeostasis. Its essential role in de novo Fe/S cluster biogenesis (Gerber et al., 2003) 
makes it an interesting candidate to analyse its survival in macrophages. 
In summary, many mutants were extremely sensitive to the heavy metal cadmium, 
probably due to its pleiotropic toxicity. Osmosensitive mutants were clearly affected by 
several ions, which change osmolarity and interfere with associated signaling pathways. 
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Thus, the ion composition of the environment influences the viability of C. glabrata and may 
possibly modify also its virulence properties. 
5.5 Phenotypic switching 
The virulence of C. albicans has been associated with the ability to switch between 
different morphologies (Berman & Sudbery, 2002). In response to different stimuli, C. 
albicans is able to switch between these morphological forms (hyphae, pseudohyphae, 
yeast) (Sudbery et al., 2004). In addition, C. albicans has to undergo the white-opaque 
transition to become mating competent (Miller & Johnson, 2002, Slutsky et al., 1987). 
Moreover, opaque cells are more efficient in colonizing the skin, while white cells are more 
virulent in a mouse model of systemic infection (Kvaal et al., 1999). 
Phenotypic switching in C. glabrata has been implicated in virulence just recently 
(Lachke et al., 2000, Srikantha et al., 2008). On CuSO4-containing media four different core 
switching phenotypes of wild type cells can be distinguished: white (Wh), light brown (LB), 
dark brown (DB) and very dark brown (vDB). The core switching phenotypes can also be 
differentiated by growth on medium supplemented with phloxine B, where Wh cells stain dark 
pink and vDB cells white (Lachke et al., 2002). 
Interestingly, DB cells are more prevalent in natural isolates. It has been 
demonstrated that these cells have a competitive advantage over other switch phenotypes 
and may even be more virulent (Srikantha et al., 2008). Differential expression of genes in 
DB versus Wh cells include sulphur metabolism, copper assimilation and stress response 
genes (Srikantha et al., 2005). Furthermore, evidence exists that different switch phenotypes 
are able to colonize different host niches (Brockert et al., 2003). 
For identification of new virulence-associated genes related to this phenotypic 
switching, the mutant collection was screened for phenotypic differences on CuSO4-
containing media. Most of the strains stained DB after four days of growth at 25°C. Due to 
the robotic primary screening, it was only possible to distinguish between clear differences 
(i.e. Wh or DB). This way, we scored for white colonies only, identifying a large number of 
mutants in the primary screening. Dilutions of these strains were then plated on CuSO4 and 
phloxine B medium for further analysis. We identified 17 strains, which predominantly did not 
stain brown and thus, showed staining patterns different from wild type colonies (Figure 28). 
Colonies of the wild type ATCC2001 cells and the triple-auxotrophic background 
strain stained predominantly DB on CuSO4 and as expected, light pink on phloxine B. 
Importantly, all but three strains showed only one phenotype as assessed by growth on 
CuSO4 medium and did not switch between the different phenotypes. Strains lacking BCY1 
and ARG81 showed a LB phenotype, whereas on phloxine B medium, they stained medium 
to light pink. This is similar to the staining pattern of wild type cells.  
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Figure 28. Switching phenotypes of C. glabrata deletion strains. Primary screening on 1mM CuSO4-containing plates 
scored for Wh colonies. Overnight cultures of the strains were grown to OD600 of 1.0, diluted to 500 cells per ml and 100 µl were 
plated on YPD plates containing 1 mM CuSO4 or 5 mg/l phloxine B. Plates were incubated at 25°C for 4 days and colony 
pictures were taken with a Zeiss Axio Stereomicroscope (9 x magnification). Core switching phenotypes are white (Wh), light 
brown (LB), dark brown (DB) and very dark brown (vDB) (Lachke et al., 2002). Growth on Phloxine B results in an inverse 
staining, Wh cells stain dark pink (DP), LB stain intermediate (MP), DB stain light pink (LP) and vDB cells do not stain pink. 
ATCC2001 and the background strain HTL stain DB and conversely, light pink. 
 
Single colonies of five strains (pkh2∆, cbk1∆, kre1∆, las21∆, chs1∆) exclusively 
displayed a Wh phenotype on CuSO4 medium and dark pink on phloxine B. No switching to 
another phenotype was observed. Remarkably, all genes are implicated in cell integrity 
signaling, cell wall biogenesis or morphogenesis. Also a rot2∆ strain displayed a different 
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phenotype (Wh colonies on CuSO4 but medium pink on phloxine B). Thus, an intact cell wall 
may be involved in the determination of the switching phenotype. 
Mutants lacking MET16, SNF1, PCK1 and MDH2 showed Wh colonies on CuSO4 and 
light pink on phloxine B. All plated colonies of these deletion strains were white on CuSO4. 
Phloxine B stained colonies were only light pink, which differs from the expected staining of 
wild type colonies (DB and LP). Interestingly, several phenotypic Wh deletion strains lacked 
metabolic genes (ARG81, MET16, PCK1). This is in agreement with an earlier study, 
demonstrating that several metabolism genes are upregulated in DB versus Wh cells 
(Srikantha et al., 2005). 
A strain lacking CAGL0I03432g showed LB and DP colonies. CAGL0I03432g has no 
homologue in S. cerevisiae. Finally, strains lacking ARB1, YFH1 or ROM2 displayed many 
differently stained colonies, suggesting that they frequently switch phenotypes. 
Since wild type C. glabrata cells display a specific switching frequency it will be of 
importance to determine the switching frequency of the mutants compared to wild type cells 
to give a detailed statement about the influence of the single genes on the switching 
phenotypes. 
5.6 Phenotypic differences in cell shape, size and colony morphology 
Mutants that showed different fitness or slow growth on YPD were investigated more 
closely for phenotypic differences in colony and cell morphology. Five types of distinct cell 
morphologies different from the wild type were found. Wild type cells grew as typically 
ellipsoidal budding yeast (Figure 29a). Some mutants formed cell chains, others large cell 
clumps or showed defective budding patterns and irregular growth size. Again other mutants 
formed regular sized but round cells. Some mutants grew in a very large and round cell 
morphology (Figure 29).  
The bni1∆ mutant showed a round cell morphology (Figure 29e). Formins are 
essential for the assembly of actin filaments and their deletion perturbs cytokinesis (Lew, 
2002). 
Deletion of the daughter cell-specific gene DSE2 resulted in improper cell separation 
and formation of cell chains (Figure 29l). The colonies looked slightly wrinkled after a several 
days of growth. ScDse2 is a daughter cell-specific putative glucanase involved in mother-
daughter cell separation (Colman-Lerner et al., 2001). 
Similarly, tos6∆ mutants had cell separation defects, displaying a pseudohyphal 
growth and causing colonies to show a slightly wrinkled morphology (Figure 29k). Tos6 of S. 
cerevisiae is a GPI-anchored cell wall protein (Hamada et al., 1998). 
Cells of the kre6∆ mutant were round, showed indications of cell lysis and were much 
larger than wild type cells (Figure 29h). Indeed, growth of kre6∆ mutants is severely affected, 
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which was also seen by its very slow growth phenotype. ScKre6 is required for synthesis of 
β1-6 glucans and also displays a round cell shape. However, no such severe growth defect 
is described in a S. cerevisiae Sckre6∆ mutant (Roemer & Bussey, 1991). 
C. glabrata cells lacking KRE1 were unable to separate properly and displayed 
budding defects (Figure 29g). ScKre1 is a glycoprotein involved in β -glucan assembly 
(Boone et al., 1990). 
 
 
Figure 29. Colony and cell morphologies of C. glabrata deletion strains. Five types of distinct cell morphologies and 
four different colony morphologies were found. Cell morphology classes: ellipsoid (a), chains (b, f, g, i, k, l), elongated (c, d), 
large clumps (j), round (e), large and round (h); colony morphologies: smooth (a, b, c, e, f, g, i), small (h), slightly wrinkled (k, l), 
wrinkled (d, j). WT = HTL background strain; colony pictures 9 x magnification, black bars correspond to 10 µm. 
 
The cell wall mutants chs3∆ and cwh41∆ also displayed impaired cell separation and 
cwh41∆ cells grew as round cells (Figure 29f, i). CHS3 encodes one of the chitin synthases 
(Pammer et al., 1992). Cwh41 is a glucosidase, which is involved in β1,6-glucan assembly 
(Jiang et al., 1996). 
Deletion of CBK1 resulted in a cell aggregation phenotype (Figure 29j), which was 
very similar to an ace2∆ deletion strain (Kamran et al., 2004). Some cells of the cbk1∆ 
mutant were very large (see Figure 30). The kinase ScCbk1 is part of the RAM network and 
controls morphogenesis, cell separation and polarised growth via the transcription factor 
ScAce2 (Nelson et al., 2003). 
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Deletion of the C. glabrata septin homologues of ScCDC12, ScCDC10 and ScGIN4 
resulted in cells unable to separate properly, often forming very long cells (Figure 29b, c, d). 
Septins are essential for septum formation and influence cytokinesis (Gladfelter et al., 2001). 
The lack of CDC12 led to a very pronounced morphology. The cells looked malformed, 
showed elongated shapes and uncontrolled budding, thereby forming large cell aggregates. 
This severe growth defect was also reflected in the heavily wrinkled colony morphology 
(Figure 29d). Interestingly, a second homologue of ScCDC12 is found in C. glabrata. 
Deletion of this ORF (CAGL0A02552g) has no influence on cell separation or growth (data 
not shown). 
Not unexpected, most of the mutants displaying morphological defects, were sensitive 
to a variety of different growth conditions, mainly affecting the cell wall (Figures 17, 19, 21, 
26). 
To investigate the altered cell morphologies in more detail, the mutants were treated 
with Calcofluor White to visualize the chitin distribution in the cell wall. Chitin mainly localizes 
to the bud scars and bud necks, and only little to the lateral cell wall. The kre6∆, kre1∆, 
cwh41∆, dcw1∆, fks1∆ and dse2∆ mutants showed increased chitin levels (Figure 30). All six 
mutants have defects in glucan synthesis and play a role in cell wall assembly and 
maintenance. Chitin probably compensates for the lack of other essential cell wall 
components such as glucans to assure proper growth. Therefore, increased integration of 
chitin into the cell wall confirms the cell wall defects of these mutants. The chitin distribution 
in the cbk1∆ and cdc12∆ cells appeared to be dislocalized, indicating a defect in correct 
targeting of chitin to its correct destination in the cell wall. 
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Figure 30. Chitin staining of C. glabrata cell wall mutants. Overnight cultures were grown to the early exponential 
growth phase and incubated with calcofluor white (CW) at a final concentration of 50 µg/ml in medium for 1 hour at room 
temperature in the dark. Cells were extensively washed twice with water, transferred to a microscopy slide and observed with a 
DAPI filter using the Olympus Cell R Life Imaging microscope (Olympus, Austria). Bars correspond to 10 µm. 
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5.7 C. glabrata mutants displaying phenotypes different from baker’s yeast 
The overall synteny and homology between the C. glabrata and S. cerevisiae genome 
is high. However, some studies revealed differences for several genes. For example, C. 
glabrata is a nicotinic acid auxotroph, because it lacks most of the BNA synthesis genes 
(Kaur et al., 2005). Also genes of the galactose, phosphate, nitrogen and sulfate metabolism 
are lost in C. glabrata (Dujon et al., 2004). Moreover, genes with redundant functions such as 
ScSSK22, ScPDR3 or ScMKK2 are not present in the genome (Gregori et al., 2007, 
Vermitsky & Edlind, 2004). Overall, it is estimated that several hundred genes are not shared 
between S. cerevisiae and C. glabrata (Kaur et al., 2005). 
One explanation for the gene reduction in C. glabrata is its close adaptation to its 
human host. This adaptation might also have led to the evolution of new genes by 
chromosomal rearrangements or gene duplications, which do not have any homologous S. 
cerevisiae genes. As shown recently, chromosomal rearrangements are indeed prevalent in 
clinical C. glabrata isolates (Polakova et al., 2009). 
A prominent example of a gene family, which is absent in S. cerevisiae, are the EPA 
genes (Kaur et al., 2005). However, EPA-related genes of S. cerevisiae exist, such as the 
flocculin (FLO) genes. We included a total of 39 C. glabrata genes for deletion, of which no 
homologue has been identified in any of the post-whole genome duplication (WGD) 
organisms. In addition, 32 genes were identified, which have recently been duplicated in C. 
glabrata but lack the same duplication in S. cerevisiae. 
Two of these C. glabrata ORFs showed growth defects in the large-scale phenotypic 
screenings. The deletion mutant lacking CAGL0D02750g displayed growth defects at 
increased temperatures, on Caffeine and LiCl-supplemented media and was susceptible to 
azole drugs (Figure 31A, B). The ORF encodes a small protein of 125 amino acid residues 
(MW=14.7 kDa) with a theoretical pI of 9.75. It shows a weak homology to myosin based on 
the homology to the myosin motor domain identified by a BLAST search. Using the Interpro 
database, a fatty acid binding motif was also found. From the phenotypic and the homology 
data together, on can speculate that the protein may function in an essential transport 
process (vesicular transport), putatively involved in plasma membrane maintenance. 
A mutant lacking CAGL0A01892g was sensitive to caspofungin (Figure 31C). It 
encodes a small 88 residue protein located between an unspecified ORF and a gene coding 
for a homologue of ScTRA1, which is a subunit of the SAGA and NuA4 histone 
acetyltransferase complexes (Grant et al., 1998). 
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Figure 31. Growth phenotypes of mutants lacking C. glabrata specific genes. (A, C, E) Deletion strains were grown to 
an OD600 of 1.0, serial diluted to OD600 of 0.1, 0.01, 0.001 and 0.0001 and spotted onto YPD and YPD agar plates containing the 
indicated amounts of LiCl, Caffeine, caspofungin. Plates were incubated at 30°C, 37°C or 42°C as indicated for 2 days and 
scanned. (B) For IC50 determination of the mutant lacking CAGL0D02750g a broth microdilution assay was carried out, 
containing voriconazole concentrations as indicated and as described in Materials and Methods. (D) C. glabrata septin mutants 
were grown in YPD to OD600 of 1.0 at the indicated temperatures, washed twice with water before taking DIC pictures taken 
(Olympus CellR microscope). 
 
Interestingly, a C. glabrata rpd3∆ mutant showed growth defects on CF (Figure 31C). 
RPD3 of S. cerevisiae encodes a histone deacetylase involved in many processes, including 
transcriptional silencing, telomeric repression of transcription (Rundlett et al., 1996), and 
modulating extension of life span in yeast (Kim et al., 1999). Cells deleted for ScRPD3 are 
sensitive to cycloheximide (Colina & Young, 2005). Recently, it has also been implicated in 
the regulation of resistance to various antifungal drugs, including azoles but not CF 
(Borecka-Melkusova et al., 2008). 
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Gene regulation by sirtuin-mediated transcriptional silencing is well-established for 
the EPA gene family and many adhesins are found in subtelomeric regions (Castano et al., 
2005). As a transcriptional regulator, Rpd3 may also control the expression of cell wall-
associated genes. Therefore, lack of Rpd3 may indeed result in reduced expression of cell 
wall genes essential to cope with CF stress. In addition, the downregulation of important cell 
wall genes may also explain the slow growth phenotype observed for the rpd3∆ deletion 
strain. Hence, the severe growth defect of a rpd3∆ mutant on CF-supplemented medium 
suggests an additional level of regulation of drug resistance in C. glabrata. 
Finally, the cdc12∆ mutant was identified by the formation of heavily wrinkled colonies 
(Figure 31D, 29). The cdc12∆ strain lacks the homologue of the baker’s yeast septin 
ScCdc12. Septins are a family of evolutionary widely conserved proteins required for 
cytokinesis by mediating septum and chitin ring formation, as well as recruitment of the 
necessary enzymes (Gladfelter et al., 2001). With the exception of one gene (ScKCC4), C. 
glabrata harbors all homologues of S. cerevisiae septin genes. Interestingly however, two 
CDC12 homologues exist in C. glabrata. The lack of CAGL0I01188g resulted in cells 
incapable to separate properly and showing aberrant chitin localization, while deletion of the 
second ORF CAGL0A02552g did not affect cell morphology. The deletion of the septin 
genes such as CDC12 and CDC10 resulted in temperature-sensitive phenotypes (Figure 
31E). Although the gin4∆ strain was not temperature-sensitive, it showed a similar defect in 
cell morphology. Hence, mutations in C. glabrata septin genes cause phenotypes similar to 
those found in S. cerevisiae, although regulation and function of the single genes may differ 
in C. glabrata.  
In summary, C. glabrata harbors numerous genes, which do not have any obvious 
homologues in baker’s yeast. Several of these genes have been identified in this study. 
Other genes show (partly) functional differences, which may have evolved due to the 
opportunistic lifestyle of C. glabrata. Alteration of gene function or evolution of novel genes 
may be a consequence of the adaptation to its human host. 
5.8 In vitro macrophage-yeast interactions 
Innate immune cells such as macrophages and dendritic cells are the first defence 
line against invading pathogens. Their recognition by specific pattern recognition receptors 
(PRRs) initiates defence mechanisms and phagocytosis of pathogens. One mechanism to 
fight pathogens upon interaction is the rapid production of reactive oxygen species (ROS) by 
immune cells. Different ROS species are thought to eliminate microbial cells (Missall et al., 
2004). However, to cope with oxidative stress, fungi as well as host cells express protective 
catalase and superoxide dismutases (SOD) (Chauhan et al., 2006). Recently, our group 
demonstrated that SOD5 of C. albicans is able to decay host-derived ROS and to escape the 
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oxidative burst exerted by the host. Using a chemiluminescent assay, it was possible to 
detect the accumulation of total ROS produced by macrophages infected with C. albicans 
(Frohner et al., 2009). 
This assay was adapted to a 96-well microtiter format to screen the C. glabrata 
deletion strain library for mutants, which induce high accumulation of ROS in mouse bone 
marrow-derived macrophages (BMDM). We reasoned that mutants with altered cell walls or 
mutants lacking enzymes to counteract ROS may elicit accumulation of ROS. Wild type C. 
glabrata ATCC2001 cells and the triple-auxotrophic background strain HTL induced very low 
ROS accumulation, when compared to BMDMs stimulated with zymosan, a cell wall 
preparation of S. cerevisiae, or the different cell wall mutants (Figure 32A & B). 
The screening revealed twelve mutants, which caused a higher accumulation of ROS 
than wild type cells. Ten mutants could be confirmed using the original ROS assay, testing 
each strain in triplicates (Figure 32A, D, E). Wild type C. albicans and zymosan served as 
positive controls for ROS induction. Interestingly, all identified strains lack cell wall genes. 
The lack of these genes leads to a defective cell wall or affects the cell morphology as shown 
by microscopic analysis. The identified genes comprised the septin genes CDC10 and 
CDC12, the chitin synthase CHS3, the formin BNI1, genes involved in β-glucan assembly 
(KRE1, KRE6, CWH41, DSE2) and two GPI-anchored proteins (Dcw1, Tos6). 
The dse2∆, tos6∆ and cdc12∆ mutants were analysed in more detail (Figure 32C-F). 
All three deletion strains showed cell separation defects and it was difficult to compare the 
strains to the wild type by OD measurement (Figure 29). Therefore, we related the number of 
cells used for infection to the amount of DNA, which corresponded to the wild type inoculum 
(4x105 cells/well; MOI 10:1). Total ROS accumulation in the presence of either one of the 
mutants was higher than those due to wild type infection.  
It is assumed that the NADPH-oxidase is assembled in the plasma or the phagosomal 
membrane (Hampton et al., 1998). Therefore, ROS may be concentrated in the phagosome 
but can also be released into the environment. To discriminate the location of ROS 
accumulation, ROS was measured, using isoluminol (Frohner et al., 2009). In contrast to 
luminol, which detects total ROS in the system, the membrane-impermeable isoluminol 
detects extracellular ROS only (Lundqvist & Dahlgren, 1996). For all tested mutants, the 
extracellular ROS levels were lower than total accumulated ROS, indicating that extracellular 
ROS partly accumulated outside of the cells (Figure 32A). 
To clarify if ROS was produced by the BMDMs or by the C. glabrata mutants, we 
used macrophages derived from gp91phox-/- mice. These mice lack an essential subunit of 
the NADPH oxidase required for ROS production (George-Chandy et al., 2008). Thus, 
gp91phox-/- BMDMs can be used as a control to determine the source of ROS (Frohner et al., 
2009). As expected, ROS could not be detected when the gp91phox-/- BMDMs were infected 
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with zymosan or the C. glabrata cell wall mutants, suggesting that a functional NADPH 
oxidase is required for ROS accumulation and that the detected ROS is mainly derived from 
the BMDMs. 
 
 
Figure 32. ROS accumulation upon incubation of wild type BMDMs with C. glabrata cell wall mutants. (A) Deletion 
strains of the primary screening inducing ROS in BMDM were retested (37°C in 2.5 min intervals over a 90 min period, MOI 
10:1) in triplicates using the standard assay for luminol- and isoluminol-dependent chemiluminescence (Frohner et al., 2009). 
The area under the curve was calculated and plotted for each mutant. Zymosan (20 µg/well) and C. albicans (MOI 5:1) were 
used as positive controls. Examples of indicated deletion strains are shown in B – D. Stimulation of ROS production of wt 
BMDM or gp91phox-/- with C. glabrata HTL strain and isogenic mutants tos6∆ (B), dse2∆ (C), cdc12∆ (D) was measured with 
luminol-dependent chemiluminescence. Due to clumping/pseudohyphal cell phenotypes the RLU/min were referred to the 
amount of genomic DNA of the wild type HTL strain. (E) RLUs under the curve were calculated for B – D and fold ROS induction 
compared to the HTL strain were plotted. 
 
In conclusion, it appears that changes in the cell wall composition lead to ROS 
accumulation, when C. glabrata interacts with host immune cells. These changes may lead 
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to exposure of certain cell wall constituents, which are recognized more easily by the PRRs 
of the macrophages, eliciting host defence mechanisms. Thus, the mutants identified by the 
ROS screening assay may be interesting for further in vitro and in vivo studies to determine 
their virulence potential. 
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6 Discussion 
C. glabrata is the second most frequent human fungal pathogen, causing systemic 
candidiasis (Pfaller et al., 2008). Inherent resistance against azole drugs and a large 
repertoire of adhesins are major virulence attributes, yet the understanding of other basic 
molecular mechanisms regulating its pathogenicity remains elusive. 
Systematic functional genomics represent a powerful tool to dissect the specific 
virulence traits of C. glabrata. In this thesis, I describe the exploitation of a new C. glabrata 
triple-auxotrophic for the generation of a gene deletion strain library as a tool to study fungal 
pathogenicity and drug resistance. 
This strain is derived from the sequenced strain ATCC2001 and was used as the 
background strain for all gene deletions. It was decided to use a strain with three 
auxotrophies (his3∆, leu2∆, trp1∆), which should allow the engineering of single and double 
gene deletion mutants, while having markers left for complementation of the gene deletions. 
Because the use of an auxotrophic URA3 marker influences the virulence properties of C. 
albicans (Brand et al., 2004, Lay et al., 1998), the introduction of the ura3∆ auxotrophy in the 
new C. glabrata background strain was avoided. I further demonstrate that the application of 
fusion PCR is suitable for the large-scale generation of disruption cassettes with long 
homology flanking regions, which enables sufficient efficiency for targeted gene deletion in C. 
glabrata. During the course of the work, a total of 476 C. glabrata gene deletion mutants 
were generated and phenotypically analysed. The phenotypic profiling of this deletion strain 
collection gives new insights in gene functions, differing from baker’s yeast and reveals 
putative factors involved in drug resistance and virulence of C. glabrata. 
 
Targeted gene deletion in C. glabrata. To understand the specific virulence factors 
of C. glabrata, targeted gene deletion is a suitable reverse-genetics approach. However, the 
gene targeting efficiency in this organism is much lower than in the model organism S. 
cerevisiae, which hampers this strategy. A few studies tried to circumvent these problems, 
using modified techniques such as the conditional expression of YKU80 to reduce non-
homologous end joining during transformation (Ueno et al., 2007). The use of long homology 
flanking regions was considered as the method of choice to be independent of the YKU80 
modification, which may have an unknown effect on the virulence properties of C. glabrata. 
Long homology flanking regions for more efficient gene replacement has also been 
successfully employed for gene deletion in C. albicans, (Noble & Johnson, 2005). Further, I 
decided to use the dominant marker NAT1, conferring resistance against nourseothricin. The 
NAT1 marker has been proofed useful for gene disruption in several Candida spp., including 
C. glabrata (Shen et al., 2005). 
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Based on the results on recombination efficiency (Ueno et al., 2007), it seemed 
reasonable to use 500 bp long flanking homology regions to achieve proper gene targeting. 
Although 55% of the selected genes could be deleted successfully, it was not possible to 
obtain correct transformants for the remaining targeted genes, despite the preselection for 
non-essential S. cerevisiae homologues. Moreover, the efficiency seems to depend strongly 
on the targeted gene in spite of the use of long homology flanking regions. 
For many genes a transformation efficiency of approximately more than 50% was 
achieved (i.e. every second transformant gave a positive signal in both colony PCR 
reactions), whereas for a number of genes the efficiency was as low as 1% or even none of 
the transformants was correct. Several explanations may exist for the differences in 
recombination efficiency. First, DNA repair and DNA regulatory mechanisms seem to be 
different in C. glabrata when compared to S. cerevisiae, including the machinery necessary 
for non-homologous end joining (Ueno et al., 2007). Second, illegitimate recombination 
(Cormack & Falkow, 1999) and chromosomal rearrangements (Polakova et al., 2009) are 
frequently observed in C. glabrata. For many transformants, only a single signal was 
detected in the colony PCR reaction, indicating that the deletion construct did not integrate 
correctly or replace the complete coding sequence. The reason for a partial integration 
remains unknown. Interestingly, a recent study reports that the C. glabrata genome is very 
dynamic  (Polakova et al., 2009). The authors suggest that these events may be due to some 
sort of telomere dysfunction. The occurring chromosomal rearrangements include 
chromosome fusions, possible circularizations, nonreciprocal translocations and generation 
of novel chromosomes. Remarkably, they even speculate that C. glabrata might had to 
sacrifice its sexual life cycle to better tolerate these genome dynamics (Polakova et al., 
2009). 
In approximately 10% of the transformations, a very large number of small 
transformant colonies arose. None of these tested transformants was positive upon 
restreaking, although being able to grow on selective media. A possible explanation is that 
autonomously replicating sequences (ARS) are located on the flanking regions, resulting in 
the formation of episomal DNA (Castano et al., 2003). Linear transforming DNA, containing 
ARS may recircularize after transformation and form episomes, giving rise to a high number 
of marker containing transformants. Eventually the episomes get lost because they lack a 
CEN sequence (Castano et al., 2003). Shortening the flanking regions may result in a non-
functional ARS, but at the expense of reduced recombination efficiency. 
Interestingly, the choice of the marker gene may also influence the recombination 
efficiency. For some targets, the generation of a correct deletion strain was impossible, when 
using the NAT1 marker construct. For example, repeated attempts to delete the glucan 
synthase gene FKS1 failed with a NAT1 disruption cassette. Using the auxotrophic HIS3 
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marker with the same flanking regions instead, resulted in several correct transformants 
lacking FKS1. Notably, many other putatively non-essential cell wall genes also could not be 
deleted. Likewise, deletion of ACE2 was only successful, using a hygromycin B instead of 
the NAT1 resistance marker. Thus, the choice of the marker gene may have an influence on 
the gene targeting efficiency in C. glabrata.  
As shown by “loss-of-gene” PCR, not all nourseothricin resistant transformants, giving 
a positive signal in the colony PCR actually lost the coding sequence. This may be explained 
by replacement of the coding sequence by the deletion construct followed by a random 
genomic reintegration of the coding sequence somewhere else in the genome. Since it is not 
possible to control the reintegration, I decided to generate three independently verified 
transformants for every gene. The same phenotypes of all three independent transformants 
would additionally confirm that the gene replacement was successful. However, this 
implicates that the deletion strains should be checked by Southern analysis, before being 
used for follow-up studies. This was done for several mutants, proofing a very high number 
of transformants to be correct. 
There is one caveat with the use of the triple-auxotrophic strain. As described 
recently, the C. glabrata ATCC2001 wild type strain carries a truncated ssk2-1 allele, which 
interrupts one branch of the high osmolarity glycerol (HOG) pathway (Gregori et al., 2007). 
Thus, the triple-auxotrophic strain and all generated gene deletions in this background carry 
the ssk2-1 mutation. The generation of the triple-auxotrophic C. glabrata strain for the 
deletion project was started before this mutation was identified. In consequence, every 
deletion strain generated by the project actually represents a double deletion strain and 
stress-related phenotypes may be due to synthetic genetic interactions. This is most 
important for the mutants displaying osmostress-related phenotypes but may also affect 
other mutants. 
 
Phenotypic analysis of the deletion strain collection. A major goal was to identify 
factors, which contribute to the specific pathogenicity and drug resistance of C. glabrata. 
Applying a number of various in vitro phenotypic screens, I identified 103 gene deletion 
strains, displaying one or more different growth sensitivities. The largest groups of sensitive 
mutants were unable to grow at elevated temperature conditions, under CF or metal ion 
stress. Many of the identified genes show similar functions as observed for their homologues 
in S. cerevisiae or C. albicans. For instance, functions in chitin synthesis, cell wall integrity 
signaling and cell wall biosynthesis (Munro et al., 2007, Reinoso-Martin et al., 2003, Lesage 
& Bussey, 2006, Levin, 2005). In general, the generated deletion strain collection shows a 
bias towards genes implicated in cell wall biogenesis, stress signaling and drug resistance, 
since I preselected these genes under the assumption that they may have an impact on 
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virulence and drug resistance of C. glabrata. It is thus not unexpected that a large number of 
cell wall and signaling mutants have been identified in the different screenings.  
 
Growth defects of cell wall mutants. Many mutants display sensitivities to more 
than one stress condition. Among all 103 mutants, six mutants are striking because they are 
sensitive to more than six different tested growth conditions. These genes are involved in cell 
wall biogenesis and morphogenesis (WSC1, CWH41 and CDC12) and/or signaling (YPK1, 
TPK2 and BCY1). This indicates that the maintenance of the cell wall and stress signaling 
play an important role and are essential for C. glabrata to cope with various external 
stresses. 
A number of mutants are affected in their growth by cell wall-perturbing agents such 
as CW, CR and SDS. Interestingly, the correlation between mutants sensitive to heat stress 
and one of the cell wall perturbing agents is quite high, while the overlap between mutants 
sensitive to cell wall-perturbing agents and CF-susceptible mutants is much lower. Only three 
C. glabrata mutants (wsc1∆, bcy1∆, mnn10∆) display major growth deficiencies under CF or 
cell wall-perturbing stress conditions. In contrast, 14 mutants show sensitivities to 
temperature stress as well as stress exerted by cell wall-perturbing agents. Thus, similar cell 
wall constituents appear to be affected by heat or cell wall perturbing agents, while CF 
seems to affect a different set of genes. However, several strains display overlapping 
sensitivities to CF as well as temperature stress. Not unexpectedly, many deletion strains 
(cwh41∆, cbk1∆, cdc12∆, cdc10∆, dse2∆) affected by cell wall-perturbing conditions display 
morphological differences, independently confirming cell wall-related defects. 
Several C. glabrata cell wall mutants show sensitivities differing from the described 
phenotypes of the S. cerevisiae mutants. This may hint at differences in individual gene 
functions, although the cell walls of both organisms principally consist of the same basic 
components. Detailed studies of the functional differences may allow the identification of C. 
glabrata specific mechanisms. 
The susceptibility of many cell wall mutants to CF establishes a chemical-genetic 
interaction between CF and several cell wall biogenesis genes of C. glabrata. The 
susceptibility of the mutants may be due to the inability to compensate cell wall defects when 
exposed to additional stresses, such as the inhibition of glucan synthesis. This view is 
confirmed by a recent study, showing that C. albicans mutants with thin cell walls are more 
sensitive to CF, while a thick cell wall renders cells more resistant (Plaine et al., 2008). The 
identification of cell wall genes also demonstrates a chemical-genetic interaction between CF 
and cell wall biogenesis genes (mannosylation, glycosylation) other than the known PKC 
pathway and glucan synthase genes. In addition, it has been shown that calcineurin signaling 
and the PKC pathway also synergize to regulate the cell wall-dependent stress response 
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(Steinbach et al., 2007, Wiederhold et al., 2005, Perlin, 2007). This notion is confirmed by the 
identification of a CF-sensitive cna1∆ mutant. The increased CF susceptibility of several cell 
wall mutants might serve as a basis to identify alternative drug targets. Novel compounds 
interfering with fungal-specific enzymes of the cell wall biogenesis may synergize with CF 
and potentiate its antifungal effect. Therefore, the identified cell wall biogenesis genes 
implicated in CF sensitivity may represent putative new drug targets. 
 
In vitro macrophage and C. glabrata interactions. Interestingly, the C. glabrata 
mutants, which stimulated high ROS accumulation when coincubated with BMDMs were cell 
wall-deficient strains. In contrast to these mutants, ROS induction by C. glabrata wild type 
strains with intact cell walls was very low. These observations support the hypothesis that 
certain cell wall components such as glucans and chitin are normally hidden from direct 
surface exposure in the wild type cells. These components may only be accessible to the 
pattern recognition receptors of the immune cells at certain sites, such as bud scars and bud 
necks (Gantner et al., 2005). Alterations in the cell wall structure due to mutations in cell wall 
biogenesis or morphogenetic genes for example, can lead to increased exposure of cell wall 
constituents and consequently result in recognition of the fungal cell by the cells of the host 
immune system. 
As observed for several mutants, some mutants display severe cell separation 
defects. Those mutants display altered morphologies, forming pseudohyphal structures or 
large cell clumps. Remarkably, most of the ten identified mutants, which induce ROS 
accumulation show these morphologies associated with cell separation defects. Thus, 
stimulation of ROS production may be triggered by the increased exposure of normally 
hidden cell wall components or by the abnormal size and appearance of the fungal cells. 
Interestingly, BMDMs have problems to phagocytose the large cell clumps formed by 
the cbk1∆ and ace2∆ mutants (see CBK1 manuscript). In addition, the ace2∆ mutant is 
hypervirulent and causes not only acute mortality but also drastically changed levels of the 
cytokines TNFα, IL-6 and IFNγ (Kamran et al., 2004). It has also been shown that large 
particles can not be internalized by macrophages (Hernanz-Falcon et al., 2009). The inability 
to internalize large particles triggers a cytokine release in a Dectin-1-dependent manner. This 
shows the important role of phagocytosis in clearance and modulation of PRP signaling 
(Hernanz-Falcon et al., 2009). Therefore, it may be interesting to study phagocytosis of the 
C. glabrata mutants and the cytokine release of the immune cells, inducing ROS 
accumulation, in vitro and in vivo. The exposure of otherwise inaccessible cell wall 
components of the cell wall mutants may facilitate the recognition by and stimulate the 
phagocytosis by immune cells. If the mutant cells can not be internalized due to size 
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restrictions, this may finally not result in clearance but rather in a dramatic cytokine release, 
leading to septicemia as it was observed for the ace2∆ mutant (Kamran et al., 2004). 
 
 A small number of mutants were unable to grow on minimal medium. These strains 
are affected in certain metabolic genes. The inability to grow under nutrient-depleted 
conditions certainly affects the virulence capabilities of a fungal pathogen. Studies in C. 
albicans demonstrated that the expression of metabolism genes changes upon 
internalization by macrophages. For example, the expression of glyoxylate, gluconeogenic 
and fatty acid metabolism genes increased in fungi recovered from phagocytic cells (Barelle 
et al., 2006, Fernandez-Arenas et al., 2007, Lorenz et al., 2004). Identified genes include 
arginine biosynthesis genes and the mitochondrial matrix iron chaperone YFH1 (Lorenz et 
al., 2004).  Notably, Yfh1 of C. glabrata is essential for growth on minimal medium, as shown 
by the screening for growth defects on minimal medium. Thus, survival of the yfh1∆ or the 
metabolic deficient mutants in a phagosomal nutrient-depleted environment may also be 
diminished. This implies that, for example, YFH1 may play a role in the pathogenicity of C. 
glabrata. However, this speculation must be interpreted with care, because these 
phenotypes may be the result of the deletion of one of the identified genes in the triple-
auxotrophic parental strain. In other words, deletion of each of these genes in the 
auxotrophic background strain may act synergistic with the impaired amino acid biosynthesis 
pathways.  
 
Azole-susceptible mutants. Several mechanisms are implicated in fungal drug 
resistance, including reduced uptake, upregulation of drug efflux pumps, sequestration of 
toxic substances in the vacuole, intracellular drug inactivation, changes in membrane 
permeability and alteration of drug targets (Cowen & Steinbach, 2008). ABC transporters 
have been characterized as the major drug efflux pumps in baker’s yeast and other Candida 
spp. (Holland et al., 2003). 
Besides the cdr1∆ and pdr1∆ deletion strains, screening for genes implicated in azole 
drug resistance yielded several signaling and cell wall mutants, showing elevated azole 
susceptibility. Among them, the cna1∆ and cnb1∆ mutants were susceptible to fluconazole 
and voriconazole. Remarkably, increasing data demonstrate synergistic effects of calcineurin 
inhibitors and azoles on different Candida species (Cruz et al., 2002, Onyewu et al., 2003, 
Uppuluri et al., 2008). For instance, calcineurin is essential for survival of C. albicans during 
membrane perturbation caused by azole inhibition of ergosterol biosynthesis (Cruz et al., 
2002, Onyewu et al., 2003, Uppuluri et al., 2008). The azole sensitivity of the C. glabrata 
cna1∆ and cnb1∆ deletion strains is consistent with these data, suggesting that calcineurin 
buffers azole stress in C. glabrata. 
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A C. glabrata mutant lacking YPK1 is sensitive to voriconazole, linking the 
sphingolipid-mediated signaling pathway to proper membrane function. Ypk1 seems to play 
an essential role for C. glabrata viability and counteracting membrane perturbations because 
the ypk1∆ mutant is severely affected by several diverse drugs such as azoles, amphotericin 
B and caffeine. Ypk1 is also implicated in cell wall integrity, as the ypk1∆ mutant is sensitive 
to CF. Ypk1 pathway-mediated activation of the PKC pathway has been demonstrated in S. 
cerevisiae (Inagaki et al., 1999). Interestingly, several C. glabrata cell wall mutants also show 
increased susceptibility to azoles. This sensitivity may be caused by an indirect effect of 
ergosterol biosynthesis inhibition on the cell wall structure. On one hand, a debilitated cell 
wall may facilitate azole uptake, thereby potentiating the fungistatic effect. On the other hand, 
the inhibition of ergosterol biosynthesis may act synergistic with certain cell wall defects and, 
consequently, cell wall mutants are unable to compensate for azole stress. 
Further, the integration of the cell wall integrity pathway in response to azole stress is 
supported by the reduced azole resistance of the wsc1∆ deletion strain. In addition, a slt2∆ 
mutant also displays slight azole sensitivity. Although the PKC pathway has not been clearly 
implicated in azole resistance yet, these data hint at a contribution of cell wall integrity 
signaling in C. glabrata. So far, only one genome-wide expression study found a down-
regulation of the PKC pathway sensor WSC1 in the resistant strain, when comparing a 
fluconazole-resistant mutant with its parent strain (Vermitsky et al., 2006). 
Taken together, perturbation of the plasma membrane by azole drugs may lead to 
growth deficiencies of certain cell wall mutants due to a synergistic effect. Likely, cell wall 
deficient mutants are unable to compensate for additional membrane perturbations and 
consequently lose viability. Cell wall integrity signaling via the PKC or the sphingolipid-
mediated Ypk1 pathways appears to be involved in counteracting azole stress. Alterations of 
the cell wall as an indirect effect of exposure to azole drugs may lead to activation of the C. 
glabrata cell integrity pathways. 
 
Phenotypic switching. Phenotypic switching is a common attribute of dimorphic 
fungi such as C. albicans (Sudbery et al., 2004). Phenotypic switching in C. glabrata has 
been implicated in virulence just recently (Lachke et al., 2000, Srikantha et al., 2008). On 
CuSO4-containing media four different core switching phenotypes of wild type cells can be 
distinguished. Interestingly, DB cells are more prevalent in natural isolates and seem to have 
a colonization advantage over other switching phenotypes (Srikantha et al., 2008). 
Screening on CuSO4-containing media revealed cell wall and metabolism-deficient 
mutants of C. glabrata, displaying only the Wh phenotype. Since DB cells are thought to be 
more virulent than Wh cells (Srikantha et al., 2008), the identified genes responsible for the 
Wh phenotype may represent new factors attenuating the virulence of C. glabrata. 
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Remarkably, the core switching phenotype differs between C. glabrata cells isolated 
from different host niches (Brockert et al., 2003). While a Wh phenotype dominated in the 
oral cavity, DB was more prevalent in vaginal samples. One explanation for this observation 
is that the selection of the switching phenotype may occur in response to differences in 
environmental factors, such as the nutrient composition, nutrient availability, the pH or the 
cell type of the host niche. Efficient colonization of different host niches may require 
differently equipped fungal cell surfaces. Thus, the expression of adhesins may vary, 
depending on the tissue or the host niche (i.e. oral cavity, intestinal tract, vaginal tract) and 
cell wall changes leading to altered adhesion properties may be beneficial for the best 
possible adhesion to a specific cell type. Wh cells, for example, may reflect the 
rearrangement of its cell wall to adapt to specific environmental host conditions. Since Wh 
cells were found to predominate the oral cavity, the specific environmental conditions of this 
host niche may favour a distinct state of C. glabrata, which becomes manifested in the Wh 
phenotype. Thus, an intact cell wall biogenesis and a functional metabolism may both 
contribute to the determination of the switching phenotype, reflecting a specific state of the 
fungal cell for a specific host niche. 
 
Novel C. glabrata genes. The screening of the deletion collection revealed many C. 
glabrata genes involved in stress response and drug resistance. Many gene functions and 
phenotypes are similar to S. cerevisiae. However, several genes have been identified, which 
show distinct phenotypes. Thus, further studies on C. glabrata-specific genes will be fruitful 
and may help to answer, which attributes turn C. glabrata into a successful fungal pathogen. 
One example is the mutant lacking CAGL0D02750g, which encodes a protein with 
homology to a myosin motor domain and a fatty acid binding motif. The protein may be 
involved in transport processes important for plasma membrane or cell wall maintenance, 
since it is essential to maintain viability under such diverse conditions as heat, caffeine and 
azole stress. The lack of CAGL0A01892g is a second example, which renders C. glabrata 
sensitive to CF. However, BLAST and protein motif searches did not lead to the identification 
of a homologue. 
Finally, the histone deacetylase Rpd3 is an interesting candidate for further detailed 
studies on the drug resistance mechanisms of C. glabrata. Scrpd3∆ mutants are sensitive to 
cycloheximide (Colina & Young, 2005) and ScRpd3 has been implicated in the regulation of 
azole drug resistance in yeast (Borecka-Melkusova et al., 2008). The C. glabrata rpd3∆ 
mutant displays a different susceptibility profile, showing slow growth and high CF sensitivity. 
Thus, Rpd3 of C. glabrata may regulate a different set of genes than its orthologue in S. 
cerevisiae. Since regulation of cell wall genes by transcriptional silencing is a well-described 
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phenomenon in C. glabrata (EPA gene family (Castano et al., 2005)), it may be possible that 
Rpd3 also plays a role in chromatin-dependent regulation of cell wall genes. 
 
In summary, the generation and phenotypic characterization of the generated C. 
glabrata gene deletion library described in this thesis mainly revealed new insights about the 
implication of C. glabrata genes in drug resistance, stress sensing and putative virulence-
associated factors. The expansion of the mutant collection and further in vitro screenings, for 
example, for host-pathogen interactions, such as phagocytosis, survival in phagocytes or the 
determination of cytokine production by immune cells upon interaction with fungal cells, will 
lead to a deeper understanding of the specific virulence attributes of C. glabrata. 
Furthermore, the future exploitation of the signature-tagged deletion strains in a suitable 
animal model will define novel C. glabrata-specific virulence factors. Therefore, this C. 
glabrata gene deletion collection represents a highly valuable tool for the future study of 
fungal pathogenicity. 
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Abstract 
Candida glabrata is an opportunistic human fungal pathogen. Like Candida albicans, 
it can cause life-threatening systemic infections in immunocompromised individuals. Cellular 
morphogenesis has to be controlled in all organisms. The RAM (Regulation of Ace2p 
transcription factor and polarized Morphogenesis) network controls polarized growth, cell 
separation and the induction of daughter cell-specific genetic programs in yeast. Inactivation 
of the C. glabrata RAM network transcription factor CgACE2 results in a hypervirulent strain 
defective in cell separation. 
We generated a C. glabrata mutant, lacking CgCBK1, which results in a similarly 
severe growth defect as seen in the Cgace2∆ mutant. Cgcbk1∆ cells are unable to separate 
properly, form large cell aggregates, and display very large growing, round cells. Exposure to 
various cell wall-perturbing compounds results in growth sensitivity of the Cgcbk1∆ mutant. 
Interestingly, transcriptional profiling identified not only genes regulated by CgCbk1 via the 
transcription factor CgAce2 but also differential expression of a CgFLO9 homologue in 
Cgcbk1∆ cells. In addition, CgCbk1 appears to control several amino acid biosynthesis-
related and metabolic genes. 
The cause for the hypervirulence phenotype of the Cgace2∆ mutant is unknown. 
Remarkably, cells lacking either CgCBK1 or CgACE2 are not phagocytosed by murine bone 
marrow-derived macrophages (BMDM) in vitro. The inability to internalize the large cell 
aggregates formed by the mutants is reversed when the cell aggregates are separated into 
single cells prior to infection or by complementation with the endogenous gene. Thus, the 
hypervirulent phenotype of the Cgace2∆ mutant may be due to a change in the immune 
response of the macrophages, which are unable to phagocytose these large cells 
aggregates. 
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Introduction 
Most cells are polarized, including unicellular organisms as well as cells in multicellular 
organisms. Cell polarity is characterized by an asymmetry in cell shape, protein distributions 
and cell functions (Nelson, 2003). Establishment and maintenance of cell polarity are crucial 
for proper development and cell functions. Although different organisms and cell types differ 
in many aspects, the core mechanisms of cell polarity establishment seem to be similar, 
including assembly of the cytoskeleton, spindle orientation, vesicle delivery to the membrane 
and site selection for polarized growth (Nelson, 2003). 
In S. cerevisiae the RAM (Regulation of Ace2p transcription factor and polarized 
Morphogenesis) network controls polarized growth and cell separation (Bidlingmaier et al., 
2001), as well as the induction of daughter cell-specific genetic programs (Colman-Lerner et 
al., 2001, Nelson et al., 2003). The transcription factor ScAce2 localizes to the daughter cell 
nucleus and is required for expression of distinct target genes, such as the chitinase ScCTS1 
or the putative glucanase ScSCW11 (O'Conallain et al., 1999, Colman-Lerner et al., 2001). 
Deletion of ScACE2 causes cell separation defects, resulting in cell aggregation, 
pseudohyphal growth and agar invasion (King & Butler, 1998, Racki et al., 2000). 
The RAM signaling network consists of several proteins required for regulation of 
polarized growth and proper budding pattern. ScKic1, ScHym1 and ScSog2 form a complex, 
which acts upstream of the ScCbk1-ScMob2 complex (Nelson et al., 2003, Bidlingmaier et 
al., 2001, Colman-Lerner et al., 2001). Tao3 interacts with ScCbk1 and ScKic1 and may 
serve as a scaffold protein to allow ScCbk1 activation by ScKic1 (Nelson et al., 2003). 
ScCbk1 is a serine/threonine kinase, which is regulated itself by phosphorylation (Jansen et 
al., 2006). Microarray analysis of the RAM network mutants revealed a unique cluster of 
coregulated genes, including ScCTS1, ScSCW11 and ScDSE1-4 (Nelson et al., 2003, 
Colman-Lerner et al., 2001). 
In the dimorphic human fungal pathogen C. albicans, the conserved RAM network 
controls cell separation and cell polarity as well (Song et al., 2008). Deletion of CaCBK1 
leads to a similar morphological defect as seen in baker’s yeast. CaCBK1 is required for 
hyphae formation and the loss of RAM network genes results in hypersensitivity against cell 
wall-perturbing agents. Interestingly, the C. albicans RAM network is involved in regulation of 
ergosterol biosynthesis genes in response to azoles as demonstrated by RT-PCR analysis 
and azole-susceptibility of a homozygous Camob2∆ deletion strain (Song et al., 2008). In 
Cryptococcus neoformans, the RAM network also regulates cell separation and polarity. 
However, disruption of the RAM network pathway resulted in hyperpolarised cells (Walton et 
al., 2006). 
The monomorphic yeast C. glabrata is the second most frequent opportunistic human 
fungal pathogen representing up to 24 percent of all Candida isolates (Perlroth et al., 2007, 
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Pfaller et al., 2008, Borg-von Zepelin et al., 2007). Like C. albicans, C. glabrata can cause a 
range of infections, ranging from superficial cutaneous and mucosal to life-threatening 
systemic infections in immunocompromised individuals (Horn et al., 2009, Mean et al., 2008, 
Pfaller & Diekema, 2007). Virulence factors of C. glabrata are less well-defined when 
compared to C. albicans, although both fungal pathogens share common virulence 
strategies. Importantly, C. glabrata exhibits an inherently reduced susceptibility to commonly 
used antifungal drugs such as azoles (Cross et al., 2000, Pfaller et al., 2004). Further, the 
regulation of epithelial adhesins (EPA) and biofilm formation by transcriptional silencing, as 
well as phenotypic switching are considered as virulence traits (Lachke et al., 2002, 
Srikantha et al., 2008). Other fungal virulence attributes such as filamentation (Kumamoto & 
Vinces, 2005b) and the secretion of hydrolases and phospholipases as known from C. 
albicans (Dolan et al., 2004, Ghannoum, 2000, Naglik et al., 2004) are absent or less 
pronounced in C. glabrata. 
Inactivation of the C. glabrata transcription factor CgACE2 results in a strain defective 
in cell separation, leading to the formation of large cell aggregates (Kamran et al., 2004). 
Remarkably, the Cgace2∆ mutant is hypervirulent in a neutropenic mice infection model. 
Vascular occlusion by the clumpy growth phenotype was excluded as a cause of the acute 
mortality. Mice infected with separated Cgace2∆ mutant cells died as well, showing that the 
cells remain hypervirulent. The hypervirulence may at least partially be caused by drastically 
elevated levels of proinflammatory cytokines (Kamran et al., 2004). Analysis of the proteomic 
changes in the Cgace2∆ mutant revealed 123 genes to be differentially regulated, including 
genes associated with metabolism, cellular transport and protein synthesis. Interestingly, the 
expression of several genes involved in morphogenesis and cell wall remodelling was down-
regulated in the Cgace2∆ mutant (Stead et al., 2005). 
Here, we describe a Cgcbk1∆ mutant, which displays a similar morphological defect 
as the S. cerevisiae Sccbk1∆ and the Cgace2∆ strains. Transcriptional profile analysis 
revealed a set of genes, involved in cell separation, which may be regulated directly or 
indirectly by the kinase CgCbk1. While CgCbk1 controls expression of CgCTS1 via CgAce2, 
the regulation of target gene CgFLO9 appears not to be controlled via CgAce2. Additionally, 
we show that Cgcbk1∆ and Cgace2∆ mutants are not phagocytosed by murine bone 
marrow-derived macrophages (BMDM) in vitro, which may give an explanation for the 
observed cytokine release in mice infected with Cgace2∆ cells.  
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Materials and Methods 
 
Strains, gene disruption, plasmids and growth conditions. 
All strains used in this study are listed in Supplementary Table 1. All deletion 
constructs were generated by a fusion PCR method using 500 bp long homology flanking 
regions and the dominant markers NAT1 or HYGB (Goldstein & McCusker, 1999). NAT1 was 
amplified with primers fp_NAT1-U2 and rp_NAT1-D2 from plasmid pJK863 (Shen et al., 
2005) to add constant U2 and D2 regions and ligated into pGEM-T vector (Promega). The 
resulting plasmid pTS50 was used to amplify the marker with primers 5M-marker and 3M-
marker to add the barcode and overlap regions needed for fusion PCR (5’-
ccgctgctaggcgcgccgtg-3’; 5’-gcagggatgcggccgctgac-3’). For gene disruption using the HYGB 
marker, we amplified the marker from plasmid pAG32 with primers fpHyg-U1 and rpHyg-D1, 
adding the overlap regions. Fusion PCR was carried out as described elsewhere (Noble & 
Johnson, 2005). Transformants were verified by colony PCR, using marker-specific primers 
(heukan2, heukan3) and gene-specific primers (5c, 3c primers) binding about 150 bp 
upstream and downstream of the homology regions. In addition, deletion strains were 
checked by loss-of-gene PCR, using a primer pair binding to the coding sequence. All 
oligonucleotide sequences used for gene disruption are listed in Table 2. 
Rich medium (YPD) and synthetic medium (SC) were prepared as described 
elsewhere (Kaiser et al., 1994). Unless otherwise indicated, all strains were grown routinely 
at 30°C. 
For transformation, we used a modified electroporation protocol (Reuss et al., 2004). 
50 ml of a C. glabrata culture in YPD at an optical density of 600nm (OD600) of 1.3 were 
harvested, washed with H2O, resuspended in 1x TE buffer, 100mM LiAc and incubated at 
30°C for 30 min with slow shaking (130rpm). After addition of 250 µl 1M DTT and further 
incubation at 30°C for 60 min (130rpm), 40 ml of H2O were added and the cells were 
harvested at 1000g for 5 min at 4°C. The cells were washed with 25 ml H2O, subsequently 
with 5 ml 1 M cold sorbitol, finally resuspended in 550 µl 1 M sorbitol and kept on ice until 
use. Sterile electroporation cuvettes were precooled on ice and loaded with a mix of 40 - 45 
µl electrocompetent cells and 5 - 10 µl linear DNA deletion construct (app. 2 - 3 µg DNA). 
Cells were left on ice for 10 min and electroporation was carried out with a BioRad 
GenePulser (200Ω, 1.5kV, 25µF). For recovery, 950 µl YPD was added and cells incubated 
for 4 h shaking at 30°C, before plating on YPD supplemented with 200 µg/ml Nourseothricin 
(Werner Bioagents, Jena) or 300 µg/ml Hygromycin (Sigma). The plates were incubated for 
48 hours at 30°C. Transformants were patched on YPD/Nourseothricin plates for colony 
PCR. Strains were transformed with plasmids essentially as described in (Gietz et al., 1992). 
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For auxotrophic marker constructs, cells were recovered for 1 h at 30°C before plating on 
selective SC medium.  
For complementation of the Cgdse2∆, we used the pGEM-ACT plasmid harbouring 
CgSHO1 (Gregori et al., 2007), replacing CgSHO1 with CgDSE2, including endogenous 
promoter and terminator using EcoRI restriction sites. CgDSE2 was ligated into plasmid 
pBM51 (received from Biao Ma) for constitutive expression under control of the ScPGK1 
promoter using XbaI and XhoI restriction sites. For constitutive expression of CgCBK1, the 
coding sequence was ligated into pBM51, using the restriction sites BamHI and EcoRI, and 
the CDS of CgACE2 was cloned into pBM51, using EcoRI and SalI. 
 
Growth assays. Growth inhibition assays were performed by spotting serial dilutions of 
exponentially growing cultures adjusted to an optical density at 600nm (OD600) of 0.1 on YPD 
and SC plates supplemented with various concentrations of SDS, calcofluor white (CW), 
congo red (CR), fluconazole (FLC), voriconazole (VOR), caspofungin (CF), CaCl2 or on SC 
plates, lacking lysine, methionine or arginine and on minimal medium plates (YNB 
supplemented with (histidine,) leucine and tryptophan). Plates were incubated at 30°C for 48 
hours and scanned with a HPScanjet G3010, using Adobe Photoshop CS3 software or 
pictures were taken with a digital Canon EOS Rebel camera using S&P Robotics imaging 
software (S&P Robotics, Canada). 
 
Sonication. Cell aggregates were separated using a sonication bath. A 2 ml aliquot of cells 
with an OD600 of 1-2 was transferred into a thin-walled glass tube and subjected to three 
times 30 seconds of sonication interrupted by 30 second breaks on ice. Complete cell 
separation was checked under a microscope. The cell numbers were determined with a 
CASY cell counter (Schärfe Systems, Germany). 
 
Microarray analysis. 50 ml cultures of the C. glabrata background strain HTL and the 
Cgcbk1∆ deletion strain were grown in YPD to an OD600 of 1, harvested, washed and 
immediately frozen. Total RNA was prepared by hot phenol method (Sambrook et al.) and 
treated with DNaseI. RNA was additionally precipitated with 2 M LiCl and RNA concentration 
was measured on a Nanodrop (ThermoScientific, USA) and quality checked, using a 
Bioanalyzer (Agilent Technologies, Austria). Three independent biological RNA replicates 
were prepared. Samples of 25 μg total RNA were used for cDNA synthesis using 200 U of 
Superscript II reverse transcriptase (Invitrogen, USA) with either Cy3-dCTP or Cy5-dCTP 
(GE Healthcare, Austria). Labelled cDNAs were pooled, and the RNA hydrolyzed for 20 
minutes in 50 mM NaOH at 65°C, followed by neutralization with acetic acid and probe clean-
up with CyScribe GFX purification kit (GE Healthcare, Austria). Microarrays were incubated 
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for 45 min at 42°C in prehybridization solution (4 x SSC, 0,1% SDS, 10 mg/ml BSA). 
Hybridization to C. glabrata whole-genome cDNA microarrays was done in hybridisation 
solution (4 x SSC, 0.1% SDS) at 37°C overnight. Microarrays were washed for one minute in 
2 x SSC, 0.1% SDS at 42°C, followed by a 5 minutes wash in 2 x SSC, 0.1% SDS at 42°C 
and a 10 minutes wash in 0,1 x SSC, 0,1% SDS at room temperature. Microarrays were 
washed then for two minutes in 0.1 x SSC, 0.1% SDS at room temperature and in 0.01 x 
SSC for 30 seconds. Glass slides were dried for 3 minutes at 500 rpm in a tabletop 
centrifuge, scanned on an Axon 4000B scanner (Molecular Devices), analyzed and 
normalized using Gene Pix Pro4.1 software (Axon). All microarray experiments were carried 
out with three independent RNA preparations (three biological replicates plus one technical) 
and dye swaps were performed. For preprocessing, the arrays were background corrected 
with the normexp method and normalized, using the print-tip loess method of the limma 
bioconductor/R package (Smyth, 2005). To identify differentially expressed genes a linear 
model was used with cut-off values of 0.01 for the adjusted p-value and a 2-fold expression 
change. Custom made DNA microarrays and protocols were obtained from the laboratory of 
Dr. Steffen Rupp, Fraunhofer Institute, Stuttgart. Oligonucleotides were obtained from Dr. 
Ken Haynes, Imperial College, London. 
 
qPCR. Primers for quantitative real-time PCR were designed, using PerlPrimer software 
(http://perlprimer.sourceforge.net/) according to recommendations and tested in a gradient 
PCR. RNA was extracted by the hot phenol method and treated with DNaseI as described 
above. Three independent biological replicates were prepared. Reverse transcription was 
performed in triplicates on 2 µg of total RNA each according to the manufacturer’s 
instructions (Fermentas First-strand cDNA synthesis Kit) with 100 pmol oligo(dT)18 and 
100pmol random hexamer primer. The sample mixes (4 µl 5 x reaction buffer, 0,5 µl 
RiboLock RNase inhibitor (20U), 2 µl 10 mM dNTP mix, 1 µl M-MuLV Rev. Transcriptase 
(200U)) were incubated for 10 min at 25°C followed by 60 min at 42°C and final 10 min at 
72°C, diluted 1:10 in H2O and stored at -20°C. All cDNA and RNA samples were tested in a 
regular PCR for DNA amplification with the specific primers. Quantitative PCR was carried 
out in triplicates on a Realplex Mastercycler (Eppendorf, Austria) monitoring cDNA 
amplification quantitatively by SYBR Green incorporation. The conditions for a 20 µl reaction 
were as follows: 2 µl cDNA template, 7 µl H2O, 0.75 µl each primer (375 nM), 10 µl 2 x 
Mastergreen mix (Eurogentec, Belgium); 95°C 5 min, 40 cycles 95°C 10 s, 62°C 10 s, 72°C 
20 s; melting curve 95°C 20 s, 62°C – 94°C gradient, 95°C 15 s. For analysis the Realplex 
data analysis program was used. 
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Microscopy. Microscopy was done on an Olympus CellR life imaging station microscope 
(Olympus, Austria). Pictures were captured with a Hamamatsu ORCA-ER camera. Cells 
were grown to exponential growth phase, harvested and washed twice with water before 
transferring them onto microscopy slides. For chitin staining, cells in the early exponential 
growth phase were incubated with calcofluor white (Fluorescent Brightener 28, Sigma-
Aldrich) at a final concentration of 50 µg/ml in medium for 1 hour at room temperature in the 
dark. Cells were washed twice with water and transferred to a microscopy slide and 
observed with a DAPI filter. Colony pictures were taken with a Zeiss Discovery.V12 
Stereomicroscope and a AxioCam MRc5 camera (Zeiss, Germany). Cells were grown in 
liquid YPD to logarithmic phase, diluted and plated on a fresh YPD plated. After 3 days of 
growth at 30°C pictures of the colony morphology were taken. 
 
Infection experiments and FACS analysis. Murine bone marrow-derived macrophages 
(BMDMs) were prepared and cultured as described elsewhere (Frohner et al., 2009). 
BMDMs (bone marrow-derived macrophages) media contained DMEM, 10% heat-inactivated 
FCS, 20% L-conditioned medium. BMDMs were routinely grown at 37°C and 5 % CO2. 
BMDMs were seeded into 24 well dishes 24 hours prior to infection. Fungal cells from an 
exponential culture were prestained with FUN-1 for 20 minutes in PBS buffer at 30°C in the 
dark, washed twice with PBS and used for infection of BMDMs at an MOI of 5:1 (C. glabrata : 
BMDMs). Fungal cells were added in 100 µl aliquots and cells were co-incubated at 37°C, 
5% CO2 for 90 minutes. During addition of the fungal cells, BMDMs were kept on ice. As a 
phagocytosis negative control, BMDMs were infected the same way in parallel but kept on 
ice for 90 minutes. After infection, non-phagocytosed fungal cells were washed away by five 
extensive washes with PBS. BMDMS were collected with a tissue scraper and resuspended 
in 1 ml PBS, 0.1 %BSA. To determine the number of macrophages with internalized fungal 
cells FACS analysis was performed (10,000 counts), using a FACSCalibur flow cytometer 
(Becton Dickinson, USA), and data were analyzed with FlowJo software (Treestar, USA). 
For microscopy, macrophages were seeded onto round glass cover slides and infection was 
performed essentially as described above. After infection, glass slides were washed in cold 
PBS and fixed in 2 % paraformaldehyde. After 1 hour of incubation at 4°C in blocking buffer 
(PBS, 4 % BSA), a Candida cell wall-specific primary antibody was added (1:500) in blocking 
buffer and incubated at 4°C overnight. Secondary Cy5-conjugated anti-rabbit antibody 
(1:350; Jackson ImmunoResearch, UK) was added after three PBS washes and incubated 
for 2 hours at RT in the dark. Cover slides were washed in PBS and inverted on a drop of 
mounting medium (Dako Cytomation, Denmark) containing 1 µg/ml DAPI. Slides were 
observed, using DIC and fluoresceine, DAPI and Cy5-specific filters on an Olympus CellR life 
imaging station microscope (Olympus, Austria). 
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Results 
 
The kinase CgCbk1 is involved in determination of cell morphology. 
Screening our C. glabrata gene deletion library (Schwarzmüller et al., unpublished) 
for colony morphology phenotypes, we found a mutant with a pronounced wrinkled colony 
and cell morphology. This mutant lacked the cell wall biosynthesis kinase gene CgCBK1. 
ScCbk1 is the major regulator of the RAM network in S. cerevisiae and controls the 
expression of cell separation genes via the transcriptional regulator ScAce2. In addition, the 
Cgace2∆ deletion strain has been associated with hypervirulence (Kamran et al., 2004). 
Therefore, we investigated the role of CgCBK1 in cell separation in more detail. To compare 
the phenotypes of Cgcbk1∆ and Cgace2∆ deletion strains, we also generated a gene 
deletion strain lacking CgACE2. Further, CgDSE2 is a possible target gene of CgCbk1. The 
putative glucanase CgDse2 may be involved in cell separation by septum degradation. 
The Cgcbk1∆ and Cgace2∆ gene deletion strains displayed similarly wrinkled colony 
morphologies, while the Cgdse2∆ mutant showed smooth colonies, which get slightly 
wrinkled only after several days of growth (Figure 1A). However, the cellular morphology of 
the Cgdse2∆ strain was clearly affected, with cells displaying a pseudohyphal growth 
phenotype, which indicated a separation defect. In contrast, the Cgcbk1∆ mutant formed 
large cell aggregates very similar to the appearance of the Cgace2∆ strain (Kamran et al., 
2004). Although the morphology of both strains looked similar, differences were visible. Cells 
of the Cgace2∆ strain were composed of ellipsoid, wild type-sized cells, which were unable 
to separate properly. Cells of the Cgcbk1∆ mutant had a heterogeneous appearance. All 
Cgcbk1∆ cells displayed a pronounced round cell morphology. In addition, we observed that 
some cells grew very large, forming large vacuoles (Figure 1A, lower panel). When 
compared to the single cells of the wild type strain or the Cgdse2∆ mutant, the large cell 
aggregates of the Cgcbk1∆ and Cgace2∆ settled much faster (Figure 1B). After 30 minutes 
on the bench, both strains formed a loose pellet. This was not observed for the wild type 
strains or the complemented strains, carrying the wild type allele on a plasmid. 
In S. cerevisiae, ScAce2 regulates the expression of the chitinase ScCTS1 
(Dohrmann et al., 1992). This seems to be true for the C. glabrata homologue as well 
(Kamran et al., 2004). Therefore, the lack of CgACE2 may lead to decreased expression of 
CgCTS1 and in consequence to the accumulation of chitin in the cell wall. Likewise, a 
Cgcbk1∆ mutant may have more chitin embedded in the cell wall. To investigate the cell 
separation defect more closely, we stained the cells with calcofluor white, which interferes 
with cell wall chitin. Chitin was mainly localized to the bud neck of the cells in the Cgace2∆ 
cell aggregate (Figure 2). This localization is similar as the chitin distribution in the parental 
HTL strain. However, in the middle of the cell aggregate much more chitin appeared to be 
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accumulated. In contrast, in the Cgcbk1∆ cell aggregates, the chitin distribution appeared to 
be more dislocalized and some large cells were intensively stained by calcofluor white, 
suggesting a more severe defect in cell wall assembly and maintenance. 
Due to its aggregation phenotype, it is difficult to directly compare growth of the 
Cgcbk1∆ mutant to the wild type. To reassure that the Cgcbk1∆ cells have a cell separation 
defect and do not simply flocculate during growth, we separated the cells by sonication in a 
water bath. Three subsequent 30 seconds sonication steps were used to separate Cgcbk1∆, 
Cgace2∆ and wild type cells. This treatment did not influence the viability, as tested by CFU 
counts (data not shown). The separated cells were then grown in YPD and the degree of cell 
aggregation over time was determined by OD measurement directly after inoculation, and 
after three and seven hours of growth at 30°C. At these time points, aliquots were diluted in 
water, mixed and the OD600 was measured after 30 minutes to give the cell particles time to 
settle. At the three hours time point, there was no difference between mutants and wild type 
cells (Figure 3A). After seven hours, a clear difference was seen between wild type and 
mutant cells. Cgcbk1∆ and Cgace2∆ strains settled almost completely in 30 minutes, 
indicating that the initially separated cells formed aggregates again. In contrast, the wild type 
and the complemented strains did not settle so fast and showed high OD600 values. 
To further confirm the cell separation defect, we filmed the growth of the Cgcbk1∆ 
mutant and compared it to the growth of the wild type strain, using a CellASIC microfluidic 
platform (CellASIC, USA). The growth of sonication-separated cells was monitored over 12 
hours, taking single pictures every 10 minutes. The hourly pictures of the movie demonstrate 
that the Cgcbk1∆ cells formed cell plaques over time due to their inability to separate 
properly (Figure 3B). Also the round cell morphology of the Cgcbk1∆ mutant was very 
apparent (magnified picture). At the seven hour time point the formation of large cells with 
large vacuoles is clearly visible (black arrows). In contrast, the wild type parental cells formed 
ellipsoid cells, displaying a bipolar budding pattern like it is usually seen for diploid S. 
cerevisiae cells (Figure 3B). 
 
A Cgcbk1∆ deletion strain is sensitive to cell wall-perturbing agents. 
In S. cerevisiae, ScCbk1 regulates several genes implicated in cell wall remodelling 
and maintenance, including the chitinase ScCTS1, the putative daughter-specific genes 
ScDSE1-4 and the glucanase ScSCW11 (Colman-Lerner et al., 2001). To analyze the 
growth phenotype of the Cgcbk1∆ strain in more detail, we spotted cells on media containing 
various cell wall-perturbing agents, such as calcofluor white (CW), congo red (CR), SDS and 
the antifungal drug fluconazole (FLC). Cgcbk1∆ cells were unable to grow on SDS-
supplemented media but grew on CW, CR and FLC (Figure 4A). Complementation of 
Cgcbk1∆ cells with the endogenous C. glabrata gene resulted in restoration of the wild type 
phenotype on YPD but only partially restored growth on SDS. Interestingly, Cgace2∆ cells 
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were only slightly impaired in growth on SDS, indicating that CgCbk1 may have a broader 
effect on cell wall biogenesis then CgAce2. Deletion of CgSCW11 (CAGL0E02915g) did not 
result in a growth defect. We could not generate a strain lacking the other CgSCW11 
homologue CAGL0A01474g to test its growth phenotypes. 
Due to the formation of the large cell aggregates, it was difficult to prepare 
comparable inocula of the Cgcbk1∆ and Cgace2∆ strains for the spotting assays. Therefore, 
we also separated the cells by sonication to be able to prepare serial dilutions, starting from 
the same cell number. The growth assays were repeated, testing for sensitivity to CW, CR, 
CaCl2 and caffeine (CAF), and susceptibility to the antifungal drugs FLC, voriconazole (VOR) 
and caspofungin (CF). In this modified growth assay, the Cgcbk1∆ strain showed growth 
sensitivities to all tested compounds as well as a slight susceptibility to azole drugs. 
Exposure to the glucan synthase inhibitor CF resulted in a very pronounced growth defect 
(Figure 4B). Interestingly, the Cgace2∆ cells displayed no growth deficiency under any tested 
condition. The Cgcbk1∆ strain also grew slower on SC medium when compared to the other 
strains. Complementation of Cgcbk1∆ cells with the endogenous CgCBK1 gene under 
control of the ScPGK1 promoter (pBM51-CgCBK1) resulted in normal growth.  
Taken together, the Cgcbk1∆ deletion strain showed several growth deficiencies 
under cell wall-perturbing conditions, indicating that its cell wall composition is severely 
changed. Interestingly, the lack of CgACE2 did not result in similar phenotypes. Therefore, it 
seems likely that CgCbk1 controls one set of genes, which may be regulated through the 
transcriptional regulator CgAce2, and an additional different set of genes, which is CgAce2-
independently regulated. Indeed, CgAce2 may only control a small set of target genes 
subject to CgCbk1. 
 
Transcriptional profiling of the Cgcbk1∆ deletion strain revealed regulation of genes 
implicated in cell wall biogenesis and metabolism. 
ScAce2 is a transcription factor required for expression of early G1-specific genes.  
After cytokinesis it localizes to the daughter cell nucleus. In S. cerevisiae, ScCbk1 controls 
activity of ScAce2 by phosphorylation (Nelson et al., 2003, Bidlingmaier et al., 2001, Colman-
Lerner et al., 2001). Since deletion of CgCBK1 resulted in a C. glabrata mutant displaying 
growth phenotypes different from the Cgace2∆ strain, we decided to perform microarray 
analysis, comparing the HTL background strain with the Cgcbk1∆ deletion strain under 
normal growth conditions in YPD at 30°C to identify potential CgCbk1 target genes. 
Therefore, we used custom-made C. glabrata microarray chips (spotting and preparation of 
arrays were done by Dr. Steffen Rupp, Fraunhofer IGB, Stuttgart; oligonucleotides were 
kindly provided by Dr. Ken Haynes, Imperial College, London). Three biological replicates of 
total RNA were prepared, and four microarray experiments (three biological plus one 
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technical replicate) were performed, including dye swaps. For preprocessing, the arrays were 
background corrected with the normexp method and normalized using the print-tip loess 
method of the limma bioconductor/R package (Smyth, 2005). To identify differentially 
expressed genes a linear model was used with cut-off values of 0.01 for the adjusted p-value 
and a 2-fold expression change. 
In total, 99 genes were found to be differentially regulated at least two-fold. Some 70 
genes were upregulated and 29 genes were down-regulated (Figure 5, Table 1 & 2). About 
one third of the genes represented uncharacterized or unknown ORFs. The largest group of 
CgCbk1-regulated genes comprised cell wall biogenesis genes. The expression of several 
transcriptional regulators was also affected in the Cgcbk1∆ mutant, as well as genes involved 
in amino acid and nucleic acid biosynthesis, metabolism, plasma membrane transport and 
signaling genes. Moreover, expression of a heterogeneous group of genes implicated in 
cytokinesis, fatty acid biosynthesis, actin organization and chromatin remodelling appeared 
to be controlled by CgCbk1. 
As expected, the expression of CgDSE2, CgCTS1, CgSCW11 genes was more than 
2.5 fold down-regulated in the microarray experiments (Table 2). Several other cell wall 
genes, such as CgFLO9 and CgTIR4 homologues were also among the strongest down-
regulated genes, as well as CgROX1 and two ORFs (CAGL0A02277g, CAGL0A02255g) 
homologous to the uncharacterized baker’s yeast ORF YCL049C (Table 2). Notably, other 
cell wall genes, such as CgSED1, CgFLO1, CgEXG1, CgSCW4, CgCRH1 were upregulated 
most strongly (Table 1). In addition, expression of amino acid biosynthesis (CgARG1, 
CgARG4, CgTMT1), plasma membrane transporters (CgPPZ1, CgMCH5) and metabolism 
(CgGLK1, CgENO1) genes was also increased. Many genes with unknown functions 
displayed elevated transcript levels as well. The microarray analysis also revealed differential 
regulation of the cell wall integrity pathway genes, such as CgSLT2 and CgRLM1, 
suggesting that the lack of CgCBK1 leads to cell wall defects activating the cell wall integrity 
pathway. 
To confirm the microarray results, quantitative RT-PCR was performed on cell wall-
associated genes (Figure 6). As expected, the daughter cell-specific gene CgDSE2 and the 
chitinase encoding gene CgCTS1 were strongly down-regulated in both deletion strains 
Cgcbk1∆ and Cgace2∆ (Figure 6A). Expression of CgCBK1 itself was not changed in a 
Cgace2∆ strain, CgACE2 expression was also not drastically affected by the lack of 
CgCBK1. In S. cerevisiae, ScCbk1 is thought to regulate ScAce2 activity by phosphorylation 
(Sbia et al., 2008, Colman-Lerner et al., 2001). Thus, CgCbk1 may also not regulate 
expression of CgAce2 but control its activation, which would explain that mRNA levels 
remained mainly unchanged. Expression of CgDSE2 and CgCTS1 was dependent on 
CgCbk1 and CgAce2 because CgDSE2 and CgCTS1 transcriptional levels were drastically 
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reduced in the Cgcbk1∆ and Cgace2∆ deletion strains. The regulation of both genes seems 
to be controlled by similar factors as in S. cerevisiae. A strain lacking CgDSE2 had no effect 
on expression of CgCTS, CgACE2 and CgCBK1. Expression levels in the ATCC2001 and 
the HTL strain were similar for all tested genes. 
The highest upregulated gene in the Cgcbk1∆ mutant was CgSED1 as confirmed by 
quantitative RT-PCR. Its S. cerevisiae homologue encodes a major stress induced structural 
GPI-anchored protein, which is required for compensation of cell wall instability in mutants 
with GPI-anchored protein defects (Hagen et al., 2004). Expression of CgKSS1 and 
CgFLO11 was also highly induced (Figure 6B). CgKSS1 is the homologue of a baker’s yeast 
MAP-kinase, controlling filamentous growth (Chen & Thorner, 2007). ScKss1 is the MAPK, 
which regulates expression of flocculins in S. cerevisiae. CgFLO11 is the closest homologue 
of a GPI-anchored glycoprotein of the flocculin family (FLO genes) in S. cerevisiae, which is 
required for pseudohyphal and invasive growth, flocculation, and biofilm formation 
(Lambrechts et al., 1996, Guo et al., 2000). Remarkably, the FLO gene family of S. 
cerevisiae is homologous to the C. glabrata-specific EPA family. The EPA genes comprise a 
family of some 23 genes encoding for GPI-anchored adhesins, which are implicated in C. 
glabrata virulence (Cormack et al., 1999, De Las Penas et al., 2003, Domergue et al., 2005). 
ScSCW11 encodes a cell wall protein with similarity to glucanases and is coregulated 
with other RAM network targets, such ScCTS1 and ScDSE1-4 (Nelson et al., 2003, Colman-
Lerner et al., 2001). C. glabrata harbors two homologous CgSCW11 genes (CAGL0E02915g 
and CAGL0A01474g), both of which showed decreased transcript levels in Cgace2∆ and 
Cgcbk1∆ cells. 
Interestingly, transcript levels of CgFLO9, another FLO homologue, were unchanged 
in Cgace2∆ cells, while in the Cgcbk1∆ deletion strain its expression was strongly decreased 
(Figure 6C). When compared to the expression of CgDSE2, CgCTS1, CgSCW11, CgKSS1, 
CgSED1, and CgFLO11, it gets apparent that CgFLO9 expression levels are only affected in 
Cgcbk1∆, supporting the hypothesis that CgCbk1 may control a specific subset of cell wall 
genes independently of CgAce2. 
Taken together, the microarray data and the spotting assays show that CgCBK1 may 
control or influence the transcription and/or activity of genes with various functions, including 
genes implicated in cell separation and morphology 
 
The Cgcbk1∆ deletion strain has a growth defect on amino acid-depleted medium. 
Remarkably, the expression of many genes involved in metabolism, amino acid 
biosynthesis and several plasma membrane transporters was also increased (Figure 5, 
Table 1). Upregulation of CgARG1, CgARG4, CgARG8, CgTMT1, CgMCH5, CgCAN1, and 
CgPUT1 suggested that CgCbk1 has an influence on amino acid biosynthesis and 
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metabolism genes. In addition, the big vacuoles observed in the Cgcbk1∆ cells (Figure 1 & 2) 
may also be due to metabolic defects indicated by the transcriptional changes of these 
genes. 
To test growth deficiencies of the Cgcbk1∆ mutant on amino acid-depleted medium, 
we spotted the strain on minimal medium and on medium lacking arginine, lysine or 
methionine (Figure 7). In contrast to the Cgace2∆ and Cgdse2∆, the Cgcbk1∆ strains 
displayed a strong growth defect on minimal medium and medium depleted of both lysine 
and methionine. On medium lacking only one of the amino acids the Cgcbk1∆ mutant 
showed a slight growth deficiency. This effect was seen much stronger for the cells 
separated by sonication before spotting, although even visible for not sonicated cells (Figure 
7). 
Taken together, the microarray data and the spotting assays show that the lack of 
CgCBK1 causes transcriptional changes, leading to metabolic defects and dependence on 
the supply of exogenous amino acids. 
 
Cgcbk1∆ and Cgace2∆ deletion strains are not phagocytosed by murine bone marrow-
derived macrophages. 
Inactivation of the C. glabrata transcription factor CgACE2 results in a strain defective 
in cell separation, leading to the formation of large cell aggregates (Kamran et al., 2004). 
Moreover, the Cgace2∆ mutant is hypervirulent in a neutropenic mice infection model. 
Although the cause for this hypervirulence is not clear, drastically elevated levels of 
proinflammatory cytokines, such as TNFα and IL-6, may explain the acute mortality of the 
mice (Kamran et al., 2004). 
Phagocytic cells such as macrophages and dendritic cells represent the first defence 
line of the mammalian immune system. In vitro, small particles are readily internalized by 
macrophages, while phagocytosis of large particles (>100µm) is hindered (Hernanz-Falcon 
et al., 2009). Therefore, it may be possible that macrophages are unable to phagocytose the 
large cell aggregates, which are formed by cells lacking CgCBK1 or CgACE2. 
To test the hypothesis, we infected murine bone marrow-derived macrophages 
(BMDM) with C. glabrata wild type, Cgace2∆ and Cgcbk1∆ cells and additionally compared 
the effect of cells separated by sonication and unseparated cell aggregates. Fungal cells 
were prestained with the FUN-1 dye (Millard et al., 1997) before infection and incubated with 
BMDMs for 90 minutes to allow phagocytosis. For microscopic analysis, non-phagocytosed 
cells were detected with an anti-Candida antibody and nuclei of BMDMs were DAPI stained. 
After 90 minutes of infection most of the wild type cells were phagocytosed as seen 
by the low number of undetected non-phagocytosed cells and the large number of FUN-1 
stained cells inside the macrophages (Figure 8). In contrast, the large cell aggregates 
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detected by the anti-Candida antibody suggests that these cell aggregates of the Cgcbk1∆ 
and Cgace2∆ mutants were attached to the macrophages but not phagocytosed. However, 
separation of these cell aggregates into single cells reversed that phenotype and resulted in 
internalization of the majority of cells (Figure 8). 
This observation was also confirmed by FACS analysis (Figure 9). About 80 % of wild 
type cells were phagocytosed, while only a very low number of macrophages carried labelled 
fungal cells when infected with the Cgcbk1∆ (4 %) and Cgace2∆ (1 %) mutants. Some 68 % 
of BMDMs carried Cgcbk1∆ cells separated by sonication and 67 % internalized 
complemented Cgcbk1∆ cells, carrying a plasmid with the endogenous CgCBK1 gene. This 
indicated that the BMDMs were unable to internalize the large cell aggregates formed by the 
mutants. 
In summary, murine BMDMs appeared to be unable to phagocytose the large cell 
aggregates formed by the Cgcbk1∆ and Cgace2∆ mutants. This effect was not due to 
putative changes in the cell wall but rather due to the size of the cell particles, since uptake 
of separated cells was almost at wild type levels. 
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Discussion 
This study shows that the deletion of the cell wall biosynthesis kinase CgCBK1 in C. 
glabrata results in a severe cell separation defect, which is similar to the phenotype of the 
Cgace2∆ mutant. In addition to the known phenotype, we could show that the Cgcbk1∆ 
deletion strain is sensitive to a variety of compounds, affecting the cell wall. Moreover, 
transcriptional profiling led to the identification of differentially expressed genes and to the 
hypothesis that CgCbk1 controls at least two different sets of genes. Expression of one set is 
CgAce2-dependent, the other one may be regulated by CgCbk1 directly. Finally, the large 
cell aggregates of the Cgcbk1∆ and Cgace2∆ deletion strains are not well phagocytosed by 
BMDMs in vitro, suggesting an explanation for the hypervirulent phenotype observed for the 
Cgace2∆ mutant. 
The particular morphology of the Cgcbk1∆ deletion strain, its growth phenotypes and 
the results of the transcriptional profiling strongly indicate that its cell wall composition is 
severely altered. To be sure that the cells do not separate properly instead of exhibiting 
regular flocculation, we developed a sonication protocol to separate the cells. As expected 
from the S. cerevisiae mutant, the separated cells regrew from single cells to large cell 
aggregates and did not simply flocculate after some time of growth. Interestingly, we 
observed that the wild type cells showed a bipolar budding pattern, which is usually seen for 
diploid S. cerevisiae cells. The cell wall defects of the Cgcbk1∆ strain are further confirmed 
by several other facts. First, the expression of the chitinase CgCTS1 and the daughter-
specific putative glucanase CgDSE2 is abandoned in the Cgcbk1∆ mutant. Second, the 
chitin distribution appears to be affected in the Cgcbk1∆ strain. This would be expected in a 
strain, which is unable to express CgCTS1 and consequently, is impaired in chitin 
degradation. Third, cells lacking CgCBK1 are sensitive to various cell wall-perturbing agents. 
Finally, many cell wall genes are differentially regulated in the Cgcbk1∆ strain, with CgSED1 
most strongly upregulated. In S. cerevisiae, ScSed1 is a major stress-induced structural GPI-
anchored protein. In cell wall mutants, ScSed1 is highly abundant and required for 
compensation of cell wall instability (Hagen et al., 2004). 
Transcriptional profiling of the Sccbk1∆ and other components of the RAM signaling 
network in S. cerevisiae demonstrated the differential regulation of a specific gene cluster, 
including ScCTS1, ScSCW11 and ScDSE1-4 (Colman-Lerner et al., 2001, Nelson et al., 
2003). We found C. glabrata homologues of these genes differentially regulated, suggesting 
that the control of cell separation is a conserved function in both organisms. A series of other 
cell wall-related genes implicated in glucan assembly, is additionally up- or down-regulated, 
indicating that the cell wall of the Cgcbk1∆ strain is severely affected. 
Most interestingly, expression of CgFLO9 (CAGL0L13332g) is down-regulated in the 
Cgcbk1∆ mutant but not affected in the Cgace2∆ strain, which displays CgFLO9 expression 
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levels similar to the wild type. In contrast, CgFLO1 expression is induced in both, Cgcbk1∆ 
and Cgace2∆ strains. The baker’s yeast homologues ScFLO1 and ScFLO9 belong to the 
flocculin gene family (Verstrepen & Klis, 2006). Several of these flocculins (ScFLO1, 
ScFLO5, ScFLO9, ScFLO10) are implicated in cell-cell adhesion, while ScFLO11 is 
necessary for adhesion to substrates (Guo et al., 2000, Verstrepen & Klis, 2006). The down-
regulation of CgFLO9 solely in the Cgcbk1∆ mutant suggests that CgCbk1 may control a set 
of genes independently of the transcription factor CgAce2. In addition, there are also 
differences between the C. glabrata and the baker’s yeast RAM network for other target 
genes. For instance, C. glabrata harbors two homologues of the glucanase ScSCW11. S. 
cerevisiae encodes four daughter-specific genes ScDSE1-4, while no ScDSE4 homologue 
can be found in C. glabrata. The flocculin family is also related to the C. glabrata EPA1 gene 
family, encoding adhesins responsible for adherence to human epithelial cells (Cormack et 
al., 1999, De Las Penas et al., 2003), and to the ALS genes of C. albicans (Hoyer, 2001, 
Kumamoto & Vinces, 2005a). In general, C. glabrata harbors a large number of adhesin-like 
GPI-anchored proteins, including the EPA gene family and the recently identified putative 
adhesins Awp1-4 (de Groot et al., 2008). Interestingly, the abundance of these proteins in 
the cell wall of C. glabrata partly depends on the growth stage. All these proteins may 
contribute to C. glabrata virulence through modification of the cell wall properties and 
therefore its adaptability to changing environmental conditions. Taken together, while the 
main functions of the RAM network seem to be conserved in of C. glabrata, differences can 
be found in the set of target genes and the transcriptional regulators, putatively affecting the 
composition of the cell wall.  
Beside several cell wall genes, CgCbk1 also seems to regulate genes involved in 
amino acid biosynthesis and other metabolic functions. This hypothesis is supported by a 
number of genes, which are found upregulated in the microarray analysis and the growth 
defect displayed by Cgcbk1∆ cells on medium lacking methionine, lysine or arginine. The 
defects in the amino acid biosynthesis pathway may cause depletion of some metabolites. 
This starvation may explain the formation of the large vacuoles, which become visible in the 
sporadic very large cells of the Cgcbk1∆ cell aggregates. Large vacuoles often indicate 
starving cells, which use autophagy to survive nutrient starvation conditions (Levine & 
Klionsky, 2004). However, the deletions were made in a triple-auxotrophic background, 
which influence the amino acid biosynthesis. Thus, it is not unlikely that the observed growth 
defects and changes in gene expression are due to synergistic effects. 
The hypervirulent phenotype of the Cgace2∆ mutant raises two questions. First, does 
a Cgcbk1∆ strain cause a similar strong phenotype in infected mice? Second, do the 
differences in the cell aggregates and the cell wall composition result in a different immune 
response? Drastically elevated levels of proinflammatory cytokines, such as TNFα and IL-6, 
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in mice infected with Cgace2∆ cells, may give an explanation for the acute mortality of the 
mice (Kamran et al., 2004). Fungal pathogens are recognized by pattern-recognition 
receptors (PRR) of macrophages and dendritic cells. Dectin-1 is a PRR and can function as 
phagocytic receptor, mediating internalization of fungal cells and expression of cytokine 
response genes (Gantner et al., 2003, Gantner et al., 2005, Goodridge et al., 2007, Rogers 
et al., 2005). Inhibition of dectin-1 ligand-dependent internalization by large β-glucan particles 
or by inhibition of actin polymerization and dynamin results in constant activation of the 
downstream signaling pathways and increased cytokine production (Hernanz-Falcon et al., 
2009). Mice infected with Cgace2∆ cells showed high levels of cytokine, such as TNF-α and 
IL-6 (Kamran et al., 2004). Therefore, the cytokine release may be explained by our 
observation that Cgace2∆ and also Cgcbk1∆ cells are not phagocytosed at least in vitro. 
Interestingly, it is the size of the cell aggregates, which prevents internalization. Separated 
mutant cells are phagocytosed similar to wild type cells. If dectin-1 elicits a strong cytokine 
response because dectin-1 signaling is not attenuated through internalization of the receptor 
(Hernanz-Falcon et al., 2009) due to the inability to phagocytose the large cell aggregates, 
the constant signaling may explain the observed septicemia, which causes the acute 
mortality of Cgace2∆ infected mice. It has to be tested if Cgcbk1∆ cells cause the same 
dramatic effect in mice. 
Future studies on phagocytosis and the cytokine response due to interaction between 
BMDMs and Cgcbk1∆ cells may help to determine the profile of cytokine release and also 
give an idea about the involvement of immune cell receptors.  
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Figure legends 
 
Figure 1. Cell and colony morphologies of Cgdse2∆, Cgcbk1∆, and Cgace2∆ mutants. (A) 
Dilutions of cells were plated on YPD plates and incubated at 30°C for 3 days, before taking 
pictures (Zeiss Discovery.V12 Stereomicroscope, AxioCam MRc5, Germany). Cells were 
grown in YPD to an OD600 of 1 and pictures were taken on an Olympus CellR (Olympus, 
Austria) microscope at 400 x magnification. The arrow points to the large cells seen in the 
Cgcbk1∆ mutant (bar = 10 µm). (B) Cells from an overnight culture were grown to an OD600 
of 5 on a shaker at 30°C, vortexed and pictures were taken before and after 30 minutes on 
the bench. 
 
Figure 2. Chitin staining of Cgcbk1∆, and Cgace2∆ mutants. Cells were grown in YPD to an 
OD600 of 1 and stained with 50 µg/ml calcofluor white for one hour in the dark to visualize 
chitin. Pictures were taken on an Olympus CellR (Olympus, Austria) microscope at 400 x 
magnification after washing of cells with water. The arrow points to the large cells seen in the 
Cgcbk1∆ mutant (bar = 10 µm). 
 
Figure 3. Growth of Cgcbk1∆ strain from separated cells. (A) Cells were separated by 
sonication (three times for 30 seconds in a sonication water bath), the cell number 
determined and cells were inoculated to an OD600 of 0.3 in YPD and grown at 30°C on a 
shaker for 0, 3 and 7 hours. Then 100 µl aliquots were diluted in water and the OD600 was 
measured after 30 minutes sitting on the bench to let cells settle. OD measurement was 
done in triplicates and the experiment repeated two times; shown is one representative 
experiment. (B) Cells from an exponential culture were separated by sonication as described 
above and 50 µl of an inoculum (107 cells/ml) in YPD were transferred into the Y2 microfluidic 
plate (Cellasic, USA). Cells were grown in YPD at a constant medium flow of 6 psi. 
Microscopy was done with the Olympus CellR life imaging station microscope (Olympus, 
Austria). Pictures were taken every 10 minutes over 12 hours. The upper panel shows the 
Cgcbk1∆ mutant, the lower panels shows the parental strain HTL. 200 x magnification. Black 
arrows indicate very large cells. 
 
Figure 4. Growth sensitivities of Cgdse2∆, Cgcbk1∆, and Cgace2∆ mutants. (A) Cells from 
an exponential culture were diluted to an OD600 of 0.1 and 10 fold serial dilutions were 
spotted on YPD and YPD supplemented with the indicated amounts of compounds. (B) Cells 
from an exponential culture were separated by sonication (three times for 30 seconds in a 
sonication water bath). OD600 was determined, cells were diluted to an OD600 of 0.1 and serial 
10 fold dilutions were spotted on SC plates without histidine supplemented with the indicated 
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amounts of compounds. All plates were incubated at 30°C for 48 hours. * cells form cell 
aggregates. 
 
Figure 5. Distribution of genes found differentially regulated in a Cgcbk1∆ deletion strain. 
Genes were assigned to functional categories using gene ontology (GO) terms of the 
Saccharomyces genome data base (SGD; http://www.yeastgenome.org/): cell wall 
biogenesis, transcriptional regulators, amino acid biosynthesis, metabolism, plasma 
membrane transporters, signalling components, fatty acid metabolism, chromatin 
modifications, miscellaneous and unknowns. An annotated list of all genes up- and down-
regulated can be found in Table 1 and Table 2. Percent refers to the percentage of genes 
assigned to a functional category from the total number of genes differentially regulated. 
 
Figure 6. Confirmation of CgCbk1-regulated genes by qRT-PCR analysis. The most strongly 
regulated genes found in the microarray analysis were confirmed by individual qRT-PCR 
analysis. All transcript levels were related to the transcript level of CgPGK1 and normalized 
to the HTL parental strain. cDNA was isolated from three independent cultures and qRT-PCR 
reactions were performed in triplicates. Data are shown as mean +/- SD of one 
representative experiment. (A) Regulation of CgCBK1, CgACE2, CgDSE2 and CgCTS1 in 
the ATCC2001, HTL, Cgcbk1∆, Cgace2∆ and Cgdse2∆ strains. (B) Upregulation of CgSED1, 
CgFLO11 and CgKSS1 in HTL, Cgcbk1∆, Cgace2∆ strains. (C) Down-regulation of both 
SCW11 homologues and CgFLO9 in HTL, Cgcbk1∆, Cgace2∆ strains. 
 
Figure 7. Growth of Cgcbk1∆ cells on amino acid-depleted and minimal medium. Cells from 
an exponential culture were separated by sonication (three times for 30 seconds in a 
sonication water bath) and serial 1:10 dilutions of ATCC2001, HTL Cgcbk1∆, Cgace2∆ and 
Cgdse2∆ cells, carrying an empty or complementing vector, were spotted on SC plates, 
lacking the indicated amino acids and incubated for 48 hours at 30°C. * cells form cell 
aggregates. 
 
Figure 8. Microscopic analysis of BMDMs infected with Cgcbk1∆ and Cgace2∆ cells. Cells 
from an exponential culture were prestained with FUN-1 and used for infection of BMDMs at 
an MOI of 5:1 (C. glabrata : BMDMs) after extensive washing in PBS. BMDMs were 
pregrown on round microscopy cover slides in cell culture medium. Fungal cells were added 
in 100 µl aliquots and cells were co-incubated at 37°C, 5 % CO2 for 90 minutes. After 
infection, slides were washed, blocked and incubated with anti-Candida antibody. 
Macrophage nuclei were stained with DAPI. 
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Figure 9. FACS analysis of BMDMs infected with Cgcbk1∆ and Cgace2∆ cells. Cells from an 
exponential culture were prestained with FUN-1 and used for infection of BMDMs at an MOI 
of 5:1 (C. glabrata : BMDMs) after extensive washing with PBS. Fungal cells were added in 
100 µl aliquots and co-incubated with BMDMs at 37°C, 5 % CO2 for 90 minutes. After 
infection, non-phagocytosed fungal cells were washed away by five extensive washes with 
PBS, the BMDMS were collected with a tissue scraper and resuspended in FACS buffer.  
 
Table 1. List of genes upregulated in the Cgcbk1∆ mutant. For each C. glabrata ORF the 
homologous S. cerevisiae ORF and gene are annotated. Fold corresponds to fold 
upregulation of a given gene in the Cgcbk1∆ mutant compared to the parental HTL strain. To 
identify differentially expressed genes a linear model was used with cut-off values of 0.01 for 
the adjusted p-value and a 2-fold expression change. Descriptions of homologous genes are 
taken from SGD (http://www.yeastgenome.org/). References relate to S. cerevisiae data. 
 
Table 2. List of genes down-regulated in the Cgcbk1∆ mutant. For each C. glabrata ORF the 
homologous S. cerevisiae ORF and gene are annotated. Fold corresponds to fold down-
regulation of a given gene in the Cgcbk1∆ mutant compared to the parental HTL strain. To 
identify differentially expressed genes a linear model was used with cut-off values of 0.01 for 
the adjusted p-value and a 2-fold expression change. Descriptions are taken from SGD 
(http://www.yeastgenome.org/). * p-value refers to the adjusted p-value. # refers to 
references relate to S. cerevisiae data. 
 
Supplementary Table 1. Strains used in this study. All gene deletion strains are isogenic to 
strain HTL, which is derived from ATCC2001 
 
Supplementary Table 2. Primers used in this study. Bold and italic sequences were used for 
adding the barcode sequences to the marker, bold sequences in lower case were used for 
fusion of two DNA sequences in a PCR reaction to generate the deletion cassettes. Bold 
capital sequences mark restriction sites used for cloning. 
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Figure 1. Cell and colony morphologies of Cgdse2∆, Cgcbk1∆, and Cgace2∆ mutants. 
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Figure 2. Chitin staining of Cgcbk1∆, and Cgace2∆ mutants. 
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Figure 3. Growth of Cgcbk1∆ strain from separated cells. 
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Figure 4. Growth sensitivities of Cgdse2∆, Cgcbk1∆, and Cgace2∆ mutants. 
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Figure 5. Distribution of genes found differentially regulated in a Cgcbk1∆ deletion strain. 
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Figure 6. Confirmation of CgCbk1-regulated genes by qRT-PCR analysis. 
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Figure 7. Growth of Cgcbk1∆ cells on amino acid-depleted and minimal medium. 
 
 
 
Figure 8. Microscopic analysis of BMDMs infected with Cgcbk1∆ and Cgace2∆ cells. 
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Figure 9. FACS analysis of BMDMs infected with Cgcbk1∆ and Cgace2∆ cells. 
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Table 1. 
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Table 2.  
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Supplementary Table 1. Strains used in this study 
Strain Genotype Reference or source 
ATCC2001 Wild type ATCC collection 
HTL Isogenic to ATCC2001 Jungwirth/Schwarzmüller, unpub. 
cbk1∆ Isogenic to HTL; cbk1∆::NAT1 This study 
dse2∆ Isogenic to HTL; dse2∆:: NAT1 This study 
ace2∆ Isogenic to HTL; ace2∆::HygB This study 
scw11∆ Isogenic to HTL; scw11∆:: NAT1 This study 
 
 
Supplementary Table 2. Oligonucleotides used in this study 
Name Sequence 
fp_NAT1-U2 5’-CGTACGCTGCAGGTCGACagcttgcctcgtccccgccg-3’ 
rp_NAT1-D2 5’-CTACGAGACCGACACCGctggatggcggcgttagtatcg-3’ 
fpHyg-U1 5’-ccgctgctaggcgcgccgtgCCCATAAAGCACGTGGCCTC-3’ 
rpHyg-D1 5’-gcagggatgcggccgctgacCCTGCAGCCCCTTTACCTC-3’ 
Heukan2 5’-CGTCAAGACTGTCAAGGAGGG-3’ 
Heukan3 5’-CATCATCTGCCCAGATGCGAAG-3’ 
5M-marker 5’-ccgctgctaggcgcgccgtgBARCODE-UPcgtacgctgcaggtcgac-3’ 
3M-marker 5’-gcagggatgcggccgctgacBARCODE-DOWNctacgagaccgacaccg-3’ 
55_CBK1 5’-AGGGTCAGAACTACTGGAAG-3’ 
53_CBK1 5’-cacggcgcgcctagcagcggCATACTGGTTTTTGCTCTAC-3’ 
35_CBK1 5’-gtcagcggccgcatccctgcTAAGTTTTTTCCTTAGTTTC-3’ 
33_CBK1 5’-TTTGATTTCAATATCTTTGC-3’ 
5c_CBK1 5’-GGTCAGAGAGTAAGGATGGATG-3’ 
3c_CBK1 5’-TGAGTCTGGGTGTACAGGTG-3’ 
5i_CBK1 5’-ATGCAATCGAGAGGAACGAG-3’ 
3i_CBK1 5’-TCACCACCCGGTAGAAACTC-3’ 
55_DSE2 5’-TGTTGAACAACTGTTTTAATG-3’ 
53_DSE2 5’-cacggcgcgcctagcagcggCATTATAAAAATCTTTGATGG-3’ 
35_DSE2 5’-gtcagcggccgcatccctgcTAAATGATTTCAAACAGTTTTC-3’ 
33_DSE2 5’-AGTGCTGTGATCAGTTGAAG-3’ 
5c_DSE2 5’-CTATGCAGATACTGCCTCACC-3’ 
3c_DSE2 5’-CTCAAACTGCACCATTCTTC-3’ 
5i_DSE2 5’-AGTACATTGGCTCCAGCATC-3’ 
3i_DSE2 5’-TCGACAGAGGATGGCATAAAG-3’ 
55_ACE2 5’-GTCCCTTAGGAGGGTATAAG-3’ 
53_ACE2 5’-cacggcgcgcctagcagcggCATTATTTTAGAACGACGAG-3’ 
35_ACE2 5’-gtcagcggccgcatccctgcTAGTATATAGTACAAACTTCACATGC-3’ 
33_ACE2 5’-TGTAATCACACAACTAAATTCC-3’ 
5c_ACE2 5’-CAAGTGTTAGGGTTGTTACGC-3’ 
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3c_ACE2 5’-GCTGTGCTTGGTACACTTTG-3’ 
55_SCW11 5’-GCTTTGTATAATAGGTAAATC-3’ 
53_SCW11 5’-cacggcgcgcctagcagcggCATCTTATATTTTAATAGAAC-3’ 
35_SCW11 5’-gtcagcggccgcatccctgcTGAACCTAGAAGATCCAAAC-3’ 
33_SCW11 5’-ATATTAGACGTTAGCAACAG-3’ 
5c_SCW11 5’-CAGCATTTTGTACACTGTAGCC-3’ 
3c_SCW11 5’-CTAAGAGGCAGCAAATTGAG-3’ 
fCBK1_BamHI 5’-agtGGATCCatgtttggtggcgagtatgatcac-3’ 
rCBK1_EcoRI 5’-atcGAATTCttataatgcattctttctcgtcaagtag-3’ 
fCBK1_EP_EcoRI 5’-tcaGAATTCgcattggcggctatgactgtg-3’ 
rCBK1_EP_EcoRI 5’-tgaGAATTCacacacatgcataggcacacag-3’ 
fDSE2_Xba 5’-agtcTCTAGAatgcaattccgtgccgctacac-3’ 
rDSE2_Xho 5’-gactCTCGAGttaattagcagaaacagttttgtataccg-3’ 
fDSE2_EcoRI 5’-agtcGAATTCaacccctatgaaatcaggggc-3’ 
rDSE2_EcoRI 5’-gactGAATTCggacagtgaatagaatgctggc-3’ 
fACE2_EcoRI 5’-agtcGAATTCatgaatactttccaggcggattgg-3’ 
rACE2_SalI 5’-agtcGTCGACtatactactcctcaatcgtccc-3’ 
fp-CBK1 5’-TGATATACCTCAGTTACACCCTTCC-3’ 
rp-CBK1 5’-GTTGTTCATGTTACTTGTGCTCGG-3’ 
fp-ACE2 5’-GACAGGAGAGCATCAACATCGT-3’ 
rp-ACE2 5’-GACAGGAGAGCATCAACATCGT-3’ 
fp-DSE2 5’-ATCTGCTTCCTCTAGTAGTGTTTCC-3’ 
rp-DSE2 5’-TACACTTGAGCTATCGTTGTCTAGG-3’ 
fp-CTS1 5’-AATGTCCATACCCAGATGCCTC-3’ 
rp-CTS1 5’-GAAATTCTTCCAGTCGTCCCAG-3’ 
fp-PGK1 5’-TCATTGCTGACGCTTTCTCC-3’ 
rp-PGK1 5’-CGAACAACTTTCTGGACTCTGG-3’ 
fp_cgFLO9 5’-GTGAGTAAGACTATTTCCAGCGG-3’ 
rp_cgFLO9 5’-GGTCCCACCATCACTTACAG-3’ 
fp_cgSED1 5’-ACTACCACTGTCTCTTCTACTACC-3’ 
rp_cgSED1 5’-GTAAGCAGTAACAACTTCGATCTC-3’ 
fp_cgMUC1 5’-GCTAACAAATCCGTCATCTACTG-3’ 
rp_cgMUC1 5’-ATTGTCAGGTCCCGTAATATAGG-3’ 
fp_cgKSS1 5’-CATCCTTTCTTAGCAACATACCAC-3’ 
rp_cgKSS1 5’-CTGTCGTCTGTCCCATATCC-3’ 
fp-cgSCW4  5’-ATGCTCATGCTTACTTTGACCA-3’ 
rp-cgSCW4  5’-CTTTCTTACCGTCACAAGCAGTC-3’ 
fp-EPA1 5’-GCGTAATCAAGGAAACCAAAGAC-3’ 
rp-EPA1 5’-GTTCCACCTAAAGACTCATAACTG-3’ 
fp-EPA7 5’-AGATCCGAACCCTGTAATAGAC-3’ 
rp-EPA7 5’-TCAACACCGATGATTGTAGATGAG-3’ 
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fp-EXG1 5’-CCGCTTTAACCGATTGTACCA-3’ 
rp-EXG1 5’-TGAACCTATGTAAGAAGAGCCC-3’ 
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Transcriptional loops meet chromatin: a dual-layer network controls white-opaque 
switching in C. albicans 
 
Denes Hnisz, Tobias Schwarzmüller, Karl Kuchler 
 
Molecular Microbiology, 2009 
 
Long homology flanking regions increase the recombination efficiency needed for target 
gene deletion in several Candida spp, including C. albicans (Noble & Johnson, 2005). After 
setting up and optimizing the generation of gene deletion constructs using fusion PCR for C. 
glabrata, we adopted this method also for the generation of C. albicans deletion strains. The 
deletion constructs carry auxotrophic markers (CdHIS1, CmLEU2, CdARG4) based on the 
pSN plasmids (Noble & Johnson, 2005). This technique is also used for generation of 
deletion constructs based on the dominant marker SAT1 (Reuss et al., 2004). 
My contribution to the following work published in Molecular Microbiology comprises the 
generation of all auxotrophic marker-based gene deletion cassettes used for the generation 
of the single gene deletion strains and their preparation for transformation by electroporation. 
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The High-Osmolarity Glycerol Response Pathway in the Human Fungal Pathogen 
Candida glabrata Strain ATCC2001 Lacks a Signaling Branch That Operates in Baker’s 
Yeast 
Christa Gregori, Christoph Schüller, Andreas Rötzer, Tobias Schwarzmüller, Gustav 
Ammerer, Karl Kuchler 
 
Eukaryotic Cell, 2007 
 
The work presented in this publication comprises the characterization of the C. glabrata high 
osmolarity glycerol (HOG) pathway. This work describes also the identification of the ssk2-1 
mutation of the ATCC2001 strain, which disables the Sln1 branch of the HOG pathway. The 
strain is used as the parental strain for the triple-auxotrophic strain, which serves as the 
background strain for the C. glabrata gene deletion project presented in this thesis. This 
means, every gene deletion strain effectively represents a double deletion with ssk2-1. 
My contribution to this work comprises the generation of the NAT1 marker-based gene 
deletion construct for the CgSSK2 gene. 
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A mutation of the H-loop selectively affects rhodamine transport by the yeast 
multidrug ABC transporter Pdr5 
 
Robert Ernst, Petra Kueppers, Cornelia Klein, Tobias Schwarzmüller, Karl Kuchler, Lutz 
Schmitt 
 
PNAS, 2008 
 
ABC transporters of S. cerevisiae are a well-studied family of membrane proteins. Many ABC 
pumps contribute to pleitotropic drug resistance PDR, transporting a huge variety of 
structurally and functionally diverse compounds. However, the mechanism of action of these 
pumps is poorly understood. Mutational studies and structural analysis of this protein class 
can give valuable information about the mode of action. 
My contribution to this work included the drug resistance assays of the different pdr5 mutants 
testing for sensitivity to azoles, cycloheximide and rhodamine 123 and rhodamine G6 
transport assays. 
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Some things in life are bad 
They can really make you mad 
Other things just make you swear and curse. 
When you're chewing on life's gristle 
Don't grumble, give a whistle 
And this'll help things turn out for the best... 
 
(Eric Idle) 
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